SampleID	Label	Plate	Position	BarcodeSequence	LinkerPrimerSequence	ForwardBarcodeSequence	ReversePrimerSequence	ReverseBarcodeSequence	TruSeqAdapter	Patient	Health_status	Age	Sex	Sex_Dg	Height	Weight	BMI	BMI_category	Smoker	Smoker_Dg	Dg	Drug	Brand	Disease_duration_years	Age_at_diagnosis	Comorbidities	Comorbidities_type	Indication_for_biological_treatment	Past_biological_therapy	Past_biological_therapy_type	Age_at_diagnosis_category	CD_behaviour	CD_localisation	L4	UC_extent	EIM	EIM_type	Intestil_surgery	Intestil_surgery_type	Dg_StartFinish_All	Drug_StartFinish_All	Dg_Drug_StartFinish_All	StartFinish_AllTogether	StartFinish	StartFinish_AllTogether_weeks	StartFinish_weeks	Visit_AllTogether	Visit	Week_AllTogether	Week	Week_num	Date	Aplication	Dose	5_ASA	5_ASA_type	Immunosuppression	Immunosuppression_type	Corticosteroids	Corticosteroid_type	Other_medication	Other_medication_type	CRP	CRP_category	WBC	PLT	Ferritin	Hb	FC	FC_category	Drug_level	Antibodies	HBI	HBI_num	pMayo	pMayo_num	HBI_pMayo	Disease_severity_scale2	Disease_severity_scale4	Response_scale2	Response_scale3	RS3	Sampling_site	SSEco	SAE	SAE_Localization	SAE_BT_Localization	SAE_Drug_Localization	SAE_Drug_Eco	SAE_place	SAE_Eco	SAE_A	SAE_B	SAE_C	SAE_D	SAE_E	SAE_F	SAE_O	SAE_P	SAE_type	Other_skin_manifestations	Other_skin_manifestation_types	Notes	Dg_Drug	Dg_Drug_SSEco	Dg_Drug_SAE	Dg_Drug_SAE_SAE_Eco	Dg_Drug_SAE_BT	Dg_SS	Dg_SAE	Dg_SS_SAE	Dg_SSEco	Dg_SSEco_SAE	Dg_SAE_place	Dg_SAE_Eco	Dg_SAE_BT_Localization	Dg_Visit_AllTogether	Dg_Visit	Dg_Drug_Visit_AllTogether	Dg_Drug_Visit	Dg_Drug_SAE_ImSup	Patient_Visit_AllTogether_SAE	Patient_Visit_SAE	Patient_Visit_AllTogether_SS_SAE	Patient_Visit_SS_SAE	Patient_Visit_AllTogether_SAE_place	Patient_Visit_SAE_place	Patient_Visit_AllTogether_SAE_Eco	Patient_Visit_SAE_Eco	Dg_RS3	Dg_Drug_RS3	Dg_SAE_RS3	Dg_SS_SAE_RS3	Dg_SSEco_SAE_RS3
P3_PK97_I_C	IS_P3_PK97_I_C	plate_1	A1	AAAGCACCTTCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACCTTCC	ACAGTG	P3	patient	21	F	CD_F	167	63	22.59	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	3	18	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_Start	ADA_Start	CD_ADA_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	07/11/2018	SC	160	no	none	no	none	yes	Budesonid	yes	B12_Caltrate_HAK	1.8	low	8.6	289	49.22	131	120	slightly_increased	0	positive	3	3	CD		3	inactive	remission	baseline	partial_response	Part	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_1	CD_visit_1	CD_ADA_visit_1	CD_ADA_visit_1	CD_ADA_no_no	P3_visit_1_no	P3_visit_1_no	P3_visit_1_C_no	P3_visit_1_C_no	P3_visit_1_none	P3_visit_1_none	P3_visit_1_none	P3_visit_1_none	CD_Part	CD_ADA_Part	CD_no_Part	CD_C_no_Part	CD_SeS_no_Part
P3_PK97_I_E	IS_P3_PK97_I_E	plate_1	B1	AAAGCAGCCACCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGCCACC	ACAGTG	P3	patient	21	F	CD_F	167	63	22.59	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	3	18	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_Start	ADA_Start	CD_ADA_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	07/11/2018	SC	160	no	none	no	none	yes	Budesonid	yes	B12_Caltrate_HAK	1.8	low	8.6	289	49.22	131	120	slightly_increased	0	positive	3	3	CD		3	inactive	remission	baseline	partial_response	Part	E	Mo	no	none	BT_E	ADA_E	ADA_Mo	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_Mo	CD_ADA_no	CD_ADA_none	CD_ADA_BT_E	CD_E	CD_no	CD_E_no	CD_Mo	CD_Mo_no	CD_none	CD_none	CD_BT_E	CD_visit_1	CD_visit_1	CD_ADA_visit_1	CD_ADA_visit_1	CD_ADA_no_no	P3_visit_1_no	P3_visit_1_no	P3_visit_1_E_no	P3_visit_1_E_no	P3_visit_1_none	P3_visit_1_none	P3_visit_1_none	P3_visit_1_none	CD_Part	CD_ADA_Part	CD_no_Part	CD_E_no_Part	CD_Mo_no_Part
P3_PK97_II_C	IS_P3_PK97_II_C	plate_1	C1	AAAGCAACAGCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AACAGCC	ACAGTG	P3	patient	21	F	CD_F	167	63	22.59	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	3	18	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	20/11/2018	SC	80	no	none	no	none	yes	Budesonid	yes	B12_Caltrate_HAK	0.6	low	5.7	289	41.33	136	176	slightly_increased	13.2	positive	3	3	CD		3	inactive	remission	response	partial_response	Part	C	SeS	yes	"C,E"	SAE_C	SAE.ADA_C	SAE.ADA_SeS	C	SeS	none	none	C	none	none	none	none	none	drug_exanthema	yes	itchy_rash_on_the_sides_of_the_torso	"post-application_usea,_sweating"	CD_ADA	CD_ADA_SeS	CD_ADA_yes	CD_ADA_SeS	CD_ADA_SAE_C	CD_C	CD_yes	CD_C_yes	CD_SeS	CD_SeS_yes	CD_C	CD_SeS	CD_SAE_C	CD_visit_2	CD_visit_2	CD_ADA_visit_2	CD_ADA_visit_2	CD_ADA_yes_no	P3_visit_2_yes	P3_visit_2_yes	P3_visit_2_C_yes	P3_visit_2_C_yes	P3_visit_2_C	P3_visit_2_C	P3_visit_2_SeS	P3_visit_2_SeS	CD_Part	CD_ADA_Part	CD_yes_Part	CD_C_yes_Part	CD_SeS_yes_Part
P3_PK97_II_E	IS_P3_PK97_II_E	plate_1	D1	AAAGCACGGCCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACGGCCC	ACAGTG	P3	patient	21	F	CD_F	167	63	22.59	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	3	18	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	20/11/2018	SC	80	no	none	no	none	yes	Budesonid	yes	B12_Caltrate_HAK	0.6	low	5.7	289	41.33	136	176	slightly_increased	13.2	positive	3	3	CD		3	inactive	remission	response	partial_response	Part	E	Mo	yes	"C,E"	SAE_E	SAE.ADA_E	SAE.ADA_Mo	E	Mo	none	none	none	none	E	none	none	none	drug_exanthema	yes	itchy_rash_on_the_sides_of_the_torso	"post-application_usea,_sweating"	CD_ADA	CD_ADA_Mo	CD_ADA_yes	CD_ADA_Mo	CD_ADA_SAE_E	CD_E	CD_yes	CD_E_yes	CD_Mo	CD_Mo_yes	CD_E	CD_Mo	CD_SAE_E	CD_visit_2	CD_visit_2	CD_ADA_visit_2	CD_ADA_visit_2	CD_ADA_yes_no	P3_visit_2_yes	P3_visit_2_yes	P3_visit_2_E_yes	P3_visit_2_E_yes	P3_visit_2_E	P3_visit_2_E	P3_visit_2_Mo	P3_visit_2_Mo	CD_Part	CD_ADA_Part	CD_yes_Part	CD_E_yes_Part	CD_Mo_yes_Part
P3_PK97_III_C	IS_P3_PK97_III_C	plate_1	E1	AAAGCACTGGCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACTGGCC	ACAGTG	P3	patient	21	F	CD_F	167	63	22.59	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	3	18	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	03/01/2019	SC	40	no	none	no	none	no	none	yes	B12_Caltrate_HAK	1.7	low	7.4	296	43.21	128	843	significantly_increased	8.4	negative	2	2	CD		2	inactive	remission	response	partial_response	Part	C	SeS	yes	"C,E"	SAE_C	SAE.ADA_C	SAE.ADA_SeS	C	SeS	none	none	C	none	none	none	none	none	drug_exanthema	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_yes	CD_ADA_SeS	CD_ADA_SAE_C	CD_C	CD_yes	CD_C_yes	CD_SeS	CD_SeS_yes	CD_C	CD_SeS	CD_SAE_C	CD_visit_3	CD_visit_3	CD_ADA_visit_3	CD_ADA_visit_3	CD_ADA_yes_no	P3_visit_3_yes	P3_visit_3_yes	P3_visit_3_C_yes	P3_visit_3_C_yes	P3_visit_3_C	P3_visit_3_C	P3_visit_3_SeS	P3_visit_3_SeS	CD_Part	CD_ADA_Part	CD_yes_Part	CD_C_yes_Part	CD_SeS_yes_Part
P3_PK97_III_E	IS_P3_PK97_III_E	plate_1	F1	AAAGCAAGGACCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AAGGACC	ACAGTG	P3	patient	21	F	CD_F	167	63	22.59	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	3	18	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	03/01/2019	SC	40	no	none	no	none	no	none	yes	B12_Caltrate_HAK	1.7	low	7.4	296	43.21	128	843	significantly_increased	8.4	negative	2	2	CD		2	inactive	remission	response	partial_response	Part	E	Mo	yes	"C,E"	SAE_E	SAE.ADA_E	SAE.ADA_Mo	E	Mo	none	none	none	none	E	none	none	none	drug_exanthema	none	none	none	CD_ADA	CD_ADA_Mo	CD_ADA_yes	CD_ADA_Mo	CD_ADA_SAE_E	CD_E	CD_yes	CD_E_yes	CD_Mo	CD_Mo_yes	CD_E	CD_Mo	CD_SAE_E	CD_visit_3	CD_visit_3	CD_ADA_visit_3	CD_ADA_visit_3	CD_ADA_yes_no	P3_visit_3_yes	P3_visit_3_yes	P3_visit_3_E_yes	P3_visit_3_E_yes	P3_visit_3_E	P3_visit_3_E	P3_visit_3_Mo	P3_visit_3_Mo	CD_Part	CD_ADA_Part	CD_yes_Part	CD_E_yes_Part	CD_Mo_yes_Part
P3_PK97_IV_C	IS_P3_PK97_IV_C	plate_1	G1	AAAGCACGCTCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACGCTCC	ACAGTG	P3	patient	21	F	CD_F	167	63	22.59	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	3	18	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	14/02/2019	SC	40	no	none	no	none	no	none	yes	B12_Caltrate_HAK	1.1	low	4.9	246	32.42	132	341	significantly_increased	8.4	negative	2	2	CD		2	inactive	remission	response	partial_response	Part	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	yes	post-injection_allergic_exanthema_abdomen_and_legs	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_4	CD_visit_4	CD_ADA_visit_4	CD_ADA_visit_4	CD_ADA_no_no	P3_visit_4_no	P3_visit_4_no	P3_visit_4_C_no	P3_visit_4_C_no	P3_visit_4_none	P3_visit_4_none	P3_visit_4_none	P3_visit_4_none	CD_Part	CD_ADA_Part	CD_no_Part	CD_C_no_Part	CD_SeS_no_Part
P3_PK97_IV_E	IS_P3_PK97_IV_E	plate_1	H1	AAAGCAGCGCCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGCGCCC	ACAGTG	P3	patient	21	F	CD_F	167	63	22.59	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	3	18	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	14/02/2019	SC	40	no	none	no	none	no	none	yes	B12_Caltrate_HAK	1.1	low	4.9	246	32.42	132	341	significantly_increased	8.4	negative	2	2	CD		2	inactive	remission	response	partial_response	Part	E	Mo	no	none	BT_E	ADA_E	ADA_Mo	none	none	none	none	none	none	none	none	none	none	none	yes	post-injection_allergic_exanthema_abdomen_and_legs	none	CD_ADA	CD_ADA_Mo	CD_ADA_no	CD_ADA_none	CD_ADA_BT_E	CD_E	CD_no	CD_E_no	CD_Mo	CD_Mo_no	CD_none	CD_none	CD_BT_E	CD_visit_4	CD_visit_4	CD_ADA_visit_4	CD_ADA_visit_4	CD_ADA_no_no	P3_visit_4_no	P3_visit_4_no	P3_visit_4_E_no	P3_visit_4_E_no	P3_visit_4_none	P3_visit_4_none	P3_visit_4_none	P3_visit_4_none	CD_Part	CD_ADA_Part	CD_no_Part	CD_E_no_Part	CD_Mo_no_Part
IS_P3_PK97_V_C	IS_P3_PK97_V_C	plate_1	A2	AAAGCAATTAGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AATTAGC	ACAGTG	P3	patient	21	F	CD_F	167	61	21.87	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	3	18	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_Finish	ADA_Finish	CD_ADA_Finish	Finish	Finish	Finish.22	Finish.22	visit_5	visit_5	week_22	week_22	22	08/04/2019	SC	40	no	none	no	none	no	none	yes	B12_Caltrate_HAK	2.3	low	7.1	256	42.8	129	146	slightly_increased	2.3	negative	8	8	CD		8	active	moderate	response	partial_response	Part	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_5	CD_visit_5	CD_ADA_visit_5	CD_ADA_visit_5	CD_ADA_no_no	P3_visit_5_no	P3_visit_5_no	P3_visit_5_C_no	P3_visit_5_C_no	P3_visit_5_none	P3_visit_5_none	P3_visit_5_none	P3_visit_5_none	CD_Part	CD_ADA_Part	CD_no_Part	CD_C_no_Part	CD_SeS_no_Part
IS_P3_PK97_V_E	IS_P3_PK97_V_E	plate_1	B2	AAAGCATCCTCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ATCCTCC	ACAGTG	P3	patient	21	F	CD_F	167	61	21.87	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	3	18	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_Finish	ADA_Finish	CD_ADA_Finish	Finish	Finish	Finish.22	Finish.22	visit_5	visit_5	week_22	week_22	22	08/04/2019	SC	40	no	none	no	none	no	none	yes	B12_Caltrate_HAK	2.3	low	7.1	256	42.8	129	146	slightly_increased	2.3	negative	8	8	CD		8	active	moderate	response	partial_response	Part	E	Mo	no	none	BT_E	ADA_E	ADA_Mo	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_Mo	CD_ADA_no	CD_ADA_none	CD_ADA_BT_E	CD_E	CD_no	CD_E_no	CD_Mo	CD_Mo_no	CD_none	CD_none	CD_BT_E	CD_visit_5	CD_visit_5	CD_ADA_visit_5	CD_ADA_visit_5	CD_ADA_no_no	P3_visit_5_no	P3_visit_5_no	P3_visit_5_E_no	P3_visit_5_E_no	P3_visit_5_none	P3_visit_5_none	P3_visit_5_none	P3_visit_5_none	CD_Part	CD_ADA_Part	CD_no_Part	CD_E_no_Part	CD_Mo_no_Part
IS_P6_HP77_I_D	IS_P6_HP77_I_D	plate_1	C2	AAAGCAACCCGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AACCCGC	ACAGTG	P6	patient	41	M	UC_M	186	74	21.39	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	1	40	yes	Gilberts_syndrome	EIM	no	none	A2	UC	UC	UC	E3	yes	sakroiliitis	no	none	UC_Start	ADA_Start	UC_ADA_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	12/11/2018	SC	160	yes	Pentasa	no	none	yes	Medrol	no	none	6.2	low	12.2	254	166.78	130	788	significantly_increased	0	negative	UC		2	2	2	inactive	mild	baseline	baseline	Base	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_1	UC_visit_1	UC_ADA_visit_1	UC_ADA_visit_1	UC_ADA_no_no	P6_visit_1_no	P6_visit_1_no	P6_visit_1_D_no	P6_visit_1_D_no	P6_visit_1_none	P6_visit_1_none	P6_visit_1_none	P6_visit_1_none	UC_Base	UC_ADA_Base	UC_no_Base	UC_D_no_Base	UC_SeT_no_Base
IS_P6_HP77_II_D	IS_P6_HP77_II_D	plate_1	D2	AAAGCATCCCTCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ATCCCTC	ACAGTG	P6	patient	41	M	UC_M	186	74	21.39	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	1	40	yes	Gilberts_syndrome	EIM	no	none	A2	UC	UC	UC	E3	yes	sakroiliitis	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	27/11/2018	SC	80	yes	Pentasa	no	none	yes	Medrol	no	none	0.5	low	8.2	240	83.56	152	29	normal	18	negative	UC		1	1	1	inactive	remission	response	full_response	Full	D	SeT	yes	D	SAE_D	SAE.ADA_D	SAE.ADA_SeT	D	SeT	none	none	none	D	none	none	none	none	acneiform_exanthema	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_yes	UC_ADA_SeT	UC_ADA_SAE_D	UC_D	UC_yes	UC_D_yes	UC_SeT	UC_SeT_yes	UC_D	UC_SeT	UC_SAE_D	UC_visit_2	UC_visit_2	UC_ADA_visit_2	UC_ADA_visit_2	UC_ADA_yes_no	P6_visit_2_yes	P6_visit_2_yes	P6_visit_2_D_yes	P6_visit_2_D_yes	P6_visit_2_D	P6_visit_2_D	P6_visit_2_SeT	P6_visit_2_SeT	UC_Full	UC_ADA_Full	UC_yes_Full	UC_D_yes_Full	UC_SeT_yes_Full
IS_P6_HP77_III_D	IS_P6_HP77_III_D	plate_1	E2	AAAGCACTCGCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACTCGCC	ACAGTG	P6	patient	41	M	UC_M	186	76	21.97	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	1	40	yes	Gilberts_syndrome	EIM	no	none	A2	UC	UC	UC	E3	yes	sakroiliitis	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	08/01/2019	SC	40	yes	Pentasa	no	none	no	none	yes	Vigantol	0.5	low	7	208	98.07	155	33	normal	12.6	negative	UC		0	0	0	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_3	UC_visit_3	UC_ADA_visit_3	UC_ADA_visit_3	UC_ADA_no_no	P6_visit_3_no	P6_visit_3_no	P6_visit_3_D_no	P6_visit_3_D_no	P6_visit_3_none	P6_visit_3_none	P6_visit_3_none	P6_visit_3_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
IS_P6_HP77_IV_D	IS_P6_HP77_IV_D	plate_1	F2	AAAGCAGGCCTCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGGCCTC	ACAGTG	P6	patient	41	M	UC_M	186	76	21.97	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	1	40	yes	Gilberts_syndrome	EIM	no	none	A2	UC	UC	UC	E3	yes	sakroiliitis	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	26/02/2019	SC	40	yes	Pentasa	no	none	no	none	yes	Vigantol	1.8	low	7.1	338	180.61	151	402	significantly_increased	11.2	negative	UC		2	2	2	inactive	mild	response	partial_response	Part	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_4	UC_visit_4	UC_ADA_visit_4	UC_ADA_visit_4	UC_ADA_no_no	P6_visit_4_no	P6_visit_4_no	P6_visit_4_D_no	P6_visit_4_D_no	P6_visit_4_none	P6_visit_4_none	P6_visit_4_none	P6_visit_4_none	UC_Part	UC_ADA_Part	UC_no_Part	UC_D_no_Part	UC_SeT_no_Part
IS_P6_HP77_V_D	IS_P6_HP77_V_D	plate_1	G2	AAAGCACCCAGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACCCAGC	ACAGTG	P6	patient	41	M	UC_M	186	77	22.26	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	1	40	yes	Gilberts_syndrome	EIM	no	none	A2	UC	UC	UC	E3	yes	sakroiliitis	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_22	week_22	22	09/04/2019	SC	40	yes	Pentasa	no	none	no	none	yes	Vigantol	1.4	low	5.6	273	84.49	151	194	slightly_increased	5.2	negative	UC		1	1	1	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_5	UC_visit_5	UC_ADA_visit_5	UC_ADA_visit_5	UC_ADA_no_no	P6_visit_5_no	P6_visit_5_no	P6_visit_5_D_no	P6_visit_5_D_no	P6_visit_5_none	P6_visit_5_none	P6_visit_5_none	P6_visit_5_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
IS_P6_HP77_VI_D	IS_P6_HP77_VI_D	plate_1	H2	AAAGCAAAGAGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AAAGAGC	ACAGTG	P6	patient	41	M	UC_M	186	77	22.26	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	1	40	yes	Gilberts_syndrome	EIM	no	none	A2	UC	UC	UC	E3	yes	sakroiliitis	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_6	visit_6	week_26	week_26	26	21/05/2019	SC	40	yes	Pentasa	no	none	no	none	yes	Vigantol	1.2	low	5.9	240	84.31	148	2295	significantly_increased	11.5	negative	UC		2	2	2	inactive	mild	response	partial_response	Part	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_6	UC_visit_6	UC_ADA_visit_6	UC_ADA_visit_6	UC_ADA_no_no	P6_visit_6_no	P6_visit_6_no	P6_visit_6_D_no	P6_visit_6_D_no	P6_visit_6_none	P6_visit_6_none	P6_visit_6_none	P6_visit_6_none	UC_Part	UC_ADA_Part	UC_no_Part	UC_D_no_Part	UC_SeT_no_Part
IS_P6_HP77_D	IS_P6_HP77_D	plate_1	A3	AAAGCACGGCTCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACGGCTC	ACAGTG	P6	patient	41	M	UC_M	186	77	22.26	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	1	40	yes	Gilberts_syndrome	EIM	no	none	A2	UC	UC	UC	E3	yes	sakroiliitis	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_7	visit_7	week_32	week_32	32	02/07/2019	SC	40	yes	Pentasa	no	none	no	none	no	none	0.9	low	6.1	237	60.9	139			13.4	negative	UC		1	1	1	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_7	UC_visit_7	UC_ADA_visit_7	UC_ADA_visit_7	UC_ADA_no_no	P6_visit_7_no	P6_visit_7_no	P6_visit_7_D_no	P6_visit_7_D_no	P6_visit_7_none	P6_visit_7_none	P6_visit_7_none	P6_visit_7_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
IS_P6_HP77_VIII_D	IS_P6_HP77_VIII_D	plate_1	B3	AAAGCACGACATA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACGACAT	ACAGTG	P6	patient	41	M	UC_M	186	77	22.26	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	1	40	yes	Gilberts_syndrome	EIM	no	none	A2	UC	UC	UC	E3	yes	sakroiliitis	no	none	UC_Finish	ADA_Finish	UC_ADA_Finish	Finish	Finish	Finish.38	Finish.38	visit_8	visit_8	week_38	week_38	38	13/08/2019	SC	40	yes	Pentasa	no	none	no	none	no	none	0.6	low	5.7	231	76.3	146	176	slightly_increased	16.6	negative	UC		0	0	0	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_8	UC_visit_8	UC_ADA_visit_8	UC_ADA_visit_8	UC_ADA_no_no	P6_visit_8_no	P6_visit_8_no	P6_visit_8_D_no	P6_visit_8_D_no	P6_visit_8_none	P6_visit_8_none	P6_visit_8_none	P6_visit_8_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
IS_P7_DL73_I_D	IS_P7_DL73_I_D	plate_1	C3	AAAGCATCCCGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ATCCCGC	ACAGTG	P7	patient	44	F	CD_F	165	54	19.83	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	19	25	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B1	L1	non-L4	CD	no	none	no	none	CD_Start	ADA_Start	CD_ADA_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	14/11/2018	SC	160	no	none	no	none	yes	Budesonid	no	none	4.5	low	6.7	299	31.59	127	513	significantly_increased	0	negative	0	0	CD		0	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_1	CD_visit_1	CD_ADA_visit_1	CD_ADA_visit_1	CD_ADA_no_no	P7_visit_1_no	P7_visit_1_no	P7_visit_1_D_no	P7_visit_1_D_no	P7_visit_1_none	P7_visit_1_none	P7_visit_1_none	P7_visit_1_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
IS_P7_DL73_II_D	IS_P7_DL73_II_D	plate_1	D3	AAAGCAGTGCGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGTGCGC	ACAGTG	P7	patient	44	F	CD_F	165	54	19.83	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	19	25	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B1	L1	non-L4	CD	no	none	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	28/11/2018	SC	80	no	none	no	none	yes	Budesonid	no	none	0.5	low	8.1	257	16.15	131	174	slightly_increased	20	negative	0	0	CD		0	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_2	CD_visit_2	CD_ADA_visit_2	CD_ADA_visit_2	CD_ADA_no_no	P7_visit_2_no	P7_visit_2_no	P7_visit_2_D_no	P7_visit_2_D_no	P7_visit_2_none	P7_visit_2_none	P7_visit_2_none	P7_visit_2_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
IS_P7_DL73_III_D	IS_P7_DL73_III_D	plate_1	E3	AAAGCAGACTCTA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGACTCT	ACAGTG	P7	patient	44	F	CD_F	165	54	19.83	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	19	25	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B1	L1	non-L4	CD	no	none	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	09/01/2019	SC	40	no	none	no	none	no	none	no	none	1	low	6.5	191	15.57	128	148	slightly_increased	16.8	negative	0	0	CD		0	inactive	remission	response	full_response	Full	D	SeT	yes	D	SAE_D	SAE.ADA_D	SAE.ADA_SeT	D	SeT	none	none	none	D	none	none	none	none	discreet_erythema	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_yes	CD_ADA_SeT	CD_ADA_SAE_D	CD_D	CD_yes	CD_D_yes	CD_SeT	CD_SeT_yes	CD_D	CD_SeT	CD_SAE_D	CD_visit_3	CD_visit_3	CD_ADA_visit_3	CD_ADA_visit_3	CD_ADA_yes_no	P7_visit_3_yes	P7_visit_3_yes	P7_visit_3_D_yes	P7_visit_3_D_yes	P7_visit_3_D	P7_visit_3_D	P7_visit_3_SeT	P7_visit_3_SeT	CD_Full	CD_ADA_Full	CD_yes_Full	CD_D_yes_Full	CD_SeT_yes_Full
IS_P7_DL73_IV_D	IS_P7_DL73_IV_D	plate_1	F3	AAAGCAGGGGTTA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGGGGTT	ACAGTG	P7	patient	44	F	CD_F	165	54	19.83	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	19	25	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B1	L1	non-L4	CD	no	none	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	20/02/2019	SC	40	no	none	no	none	no	none	no	none	1	low	6.5	191	15.57	128	218	significantly_increased	16.8	negative	0	0	CD		0	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_4	CD_visit_4	CD_ADA_visit_4	CD_ADA_visit_4	CD_ADA_no_no	P7_visit_4_no	P7_visit_4_no	P7_visit_4_D_no	P7_visit_4_D_no	P7_visit_4_none	P7_visit_4_none	P7_visit_4_none	P7_visit_4_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
IS_P7_DL73_V_D	IS_P7_DL73_V_D	plate_1	G3	AAAGCACTAGGGA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACTAGGG	ACAGTG	P7	patient	44	F	CD_F	165	54	19.83	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	19	25	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B1	L1	non-L4	CD	no	none	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_22	week_22	22	10/04/2019	SC	40	no	none	no	none	no	none	no	none	1.7	low	7.2	243	22.78	126	182	slightly_increased	13.2	negative	0	0	CD		0	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_5	CD_visit_5	CD_ADA_visit_5	CD_ADA_visit_5	CD_ADA_no_no	P7_visit_5_no	P7_visit_5_no	P7_visit_5_D_no	P7_visit_5_D_no	P7_visit_5_none	P7_visit_5_none	P7_visit_5_none	P7_visit_5_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
IS_P7_DL73_VI_D	IS_P7_DL73_VI_D	plate_1	H3	AAAGCATAGCCGA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ATAGCCG	ACAGTG	P7	patient	44	F	CD_F	165	54	19.83	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	19	25	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B1	L1	non-L4	CD	no	none	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_6	visit_6	week_26	week_26	26	09/05/2019	SC	40	no	none	no	none	no	none	no	none	1.7	low	7.2	243	22.78	126	311	significantly_increased	13.2	negative	0	0	CD		0	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_6	CD_visit_6	CD_ADA_visit_6	CD_ADA_visit_6	CD_ADA_no_no	P7_visit_6_no	P7_visit_6_no	P7_visit_6_D_no	P7_visit_6_D_no	P7_visit_6_none	P7_visit_6_none	P7_visit_6_none	P7_visit_6_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
IS_P7_DL73_VII_D	IS_P7_DL73_VII_D	plate_1	A4	ACGAAACCTTCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACCTTCC	ACAGTG	P7	patient	44	F	CD_F	165	57	20.94	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	19	25	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B1	L1	non-L4	CD	no	none	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_7	visit_7	week_32	week_32	32	20/06/2019	SC	40	no	none	no	none	no	none	no	none	0.9	low	7.4	213	18.9	132	130	slightly_increased	15.9	negative	0	0	CD		0	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_7	CD_visit_7	CD_ADA_visit_7	CD_ADA_visit_7	CD_ADA_no_no	P7_visit_7_no	P7_visit_7_no	P7_visit_7_D_no	P7_visit_7_D_no	P7_visit_7_none	P7_visit_7_none	P7_visit_7_none	P7_visit_7_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
IS_P7_DL73_VIII_D	IS_P7_DL73_VIII_D	plate_1	B4	ACGAAAGCCACCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGCCACC	ACAGTG	P7	patient	44	F	CD_F	165	57	20.94	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	19	25	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B1	L1	non-L4	CD	no	none	no	none	CD_Finish	ADA_Finish	CD_ADA_Finish	Finish	Finish	Finish.38	Finish.38	visit_8	visit_8	week_38	week_38	38	01/08/2019	SC	40	no	none	no	none	no	none	no	none	1.3	low	5.9	208	14.55	129			15.2	negative	1	1	CD		1	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_8	CD_visit_8	CD_ADA_visit_8	CD_ADA_visit_8	CD_ADA_no_no	P7_visit_8_no	P7_visit_8_no	P7_visit_8_D_no	P7_visit_8_D_no	P7_visit_8_none	P7_visit_8_none	P7_visit_8_none	P7_visit_8_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
IS_P15_SN93_I_C	IS_P15_SN93_I_C	plate_1	C4	ACGAAAACAGCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AACAGCC	ACAGTG	P15	patient	25	F	CD_F	178	62	19.57	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	7	18	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B2	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_Start	ADA_Start	CD_ADA_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	06/12/2018	SC	160	no	none	yes	AZA	no	none	yes	Vigantol	1	low	4.8	251	67.34	120	162	slightly_increased	0	negative	0	0	CD		0	inactive	remission	baseline	full_response	Full	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_1	CD_visit_1	CD_ADA_visit_1	CD_ADA_visit_1	CD_ADA_no_yes	P15_visit_1_no	P15_visit_1_no	P15_visit_1_C_no	P15_visit_1_C_no	P15_visit_1_none	P15_visit_1_none	P15_visit_1_none	P15_visit_1_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
IS_P15_SN93_II_C	IS_P15_SN93_II_C	plate_1	D4	ACGAAACGGCCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACGGCCC	ACAGTG	P15	patient	25	F	CD_F	178	62	19.57	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	7	18	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B2	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	20/12/2018	SC	80	no	none	yes	AZA	no	none	yes	Vigantol	0.3	low	3.7	266	46.5	112	163	slightly_increased	20	positive	0	0	CD		0	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	before_shingles	none	before_shingles	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_2	CD_visit_2	CD_ADA_visit_2	CD_ADA_visit_2	CD_ADA_no_yes	P15_visit_2_no	P15_visit_2_no	P15_visit_2_C_no	P15_visit_2_C_no	P15_visit_2_none	P15_visit_2_none	P15_visit_2_none	P15_visit_2_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
IS_P15_SN93_IIxIII_C	IS_P15_SN93_IIxIII_C	plate_1	E4	ACGAAACTGGCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACTGGCC	ACAGTG	P15	patient	25	F	CD_F	178	62	19.57	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	7	18	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B2	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_extra_between_2_and_3	visit_extra_between_2_and_3	week_between_2_and_8	week_between_2_and_8	5	20/12/2018	SC	80	no	none	yes	AZA	no	none	yes	Vigantol										positive	0	0	CD		0	inactive	remission	response	full_response	Full	C	SeS	yes	C	SAE_C	SAE.ADA_C	SAE.ADA_SeS	C	SeS	none	none	C	none	none	none	none	none	shingles	yes	none	we_do_not_have_results_from_blood_markers_from_this_sampling_/herpes	CD_ADA	CD_ADA_SeS	CD_ADA_yes	CD_ADA_SeS	CD_ADA_SAE_C	CD_C	CD_yes	CD_C_yes	CD_SeS	CD_SeS_yes	CD_C	CD_SeS	CD_SAE_C	CD_visit_extra_between_2_and_3	CD_visit_extra_between_2_and_3	CD_ADA_visit_extra_between_2_and_3	CD_ADA_visit_extra_between_2_and_3	CD_ADA_yes_yes	P15_visit_extra_between_2_and_3_yes	P15_visit_extra_between_2_and_3_yes	P15_visit_extra_between_2_and_3_C_yes	P15_visit_extra_between_2_and_3_C_yes	P15_visit_extra_between_2_and_3_C	P15_visit_extra_between_2_and_3_C	P15_visit_extra_between_2_and_3_SeS	P15_visit_extra_between_2_and_3_SeS	CD_Full	CD_ADA_Full	CD_yes_Full	CD_C_yes_Full	CD_SeS_yes_Full
IS_P15_SN93_III_C	IS_P15_SN93_III_C	plate_1	F4	ACGAAAAGGACCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AAGGACC	ACAGTG	P15	patient	25	F	CD_F	178	62	19.57	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	7	18	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B2	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	14/02/2019	SC	40	no	none	no	none	no	none	yes	Utrogestan	5.2	low	5.7	265	50.15	117	76	slightly_increased	13.5	negative	0	0	CD		0	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	after_shingles	none	after_shingles	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_3	CD_visit_3	CD_ADA_visit_3	CD_ADA_visit_3	CD_ADA_no_no	P15_visit_3_no	P15_visit_3_no	P15_visit_3_C_no	P15_visit_3_C_no	P15_visit_3_none	P15_visit_3_none	P15_visit_3_none	P15_visit_3_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
IS_P15_SN93_IV_C	IS_P15_SN93_IV_C	plate_1	G4	ACGAAACGCTCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACGCTCC	ACAGTG	P15	patient	25	F	CD_F	178	64	20.2	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	7	18	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B2	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	28/03/2019	SC	40	no	none	no	none	no	none	yes	Vigantol	1.3	low	6.8	237	76.69	117	13	normal	20	negative	0	0	CD		0	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_4	CD_visit_4	CD_ADA_visit_4	CD_ADA_visit_4	CD_ADA_no_no	P15_visit_4_no	P15_visit_4_no	P15_visit_4_C_no	P15_visit_4_C_no	P15_visit_4_none	P15_visit_4_none	P15_visit_4_none	P15_visit_4_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
IS_P15_SN93_VI_C	IS_P15_SN93_VI_C	plate_1	H4	ACGAAAGCGCCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGCGCCC	ACAGTG	P15	patient	25	F	CD_F	178	64	20.2	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	7	18	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B2	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_22	week_22	22	09/05/2019	SC	40	no	none	no	none	no	none	yes	Vigantol	7	low	9	217	46.73	109	82	slightly_increased	20	negative	0	0	CD		0	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_5	CD_visit_5	CD_ADA_visit_5	CD_ADA_visit_5	CD_ADA_no_no	P15_visit_5_no	P15_visit_5_no	P15_visit_5_C_no	P15_visit_5_C_no	P15_visit_5_none	P15_visit_5_none	P15_visit_5_none	P15_visit_5_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
IS_P15_SN93_C	IS_P15_SN93_C	plate_1	A5	ACGAAAATTAGCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AATTAGC	ACAGTG	P15	patient	25	F	CD_F	178	64	20.2	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	7	18	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B2	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_6	visit_6	week_26	week_26	26	16/06/2019	SC	40	no	none	no	none	no	none	yes	Vigantol	3.4	low	8.7	193	18.67	95	46	normal	17.8	negative	0	0	CD		0	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_6	CD_visit_6	CD_ADA_visit_6	CD_ADA_visit_6	CD_ADA_no_no	P15_visit_6_no	P15_visit_6_no	P15_visit_6_C_no	P15_visit_6_C_no	P15_visit_6_none	P15_visit_6_none	P15_visit_6_none	P15_visit_6_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
IS_P15_SN93_VIII_C	IS_P15_SN93_VIII_C	plate_1	B5	ACGAAATCCTCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ATCCTCC	ACAGTG	P15	patient	25	F	CD_F	178	72	22.72	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	7	18	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B2	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_Finish	ADA_Finish	CD_ADA_Finish	Finish	Finish	Finish.38	Finish.38	visit_8	visit_8	week_38	week_38	38	30/07/2019	SC	40	no	none	no	none	no	none	yes	Vigantol	0.6	low	9.2	191	13.71	97	6	normal	20	negative	0	0	CD		0	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_8	CD_visit_8	CD_ADA_visit_8	CD_ADA_visit_8	CD_ADA_no_no	P15_visit_8_no	P15_visit_8_no	P15_visit_8_C_no	P15_visit_8_C_no	P15_visit_8_none	P15_visit_8_none	P15_visit_8_none	P15_visit_8_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
IS_P15_SN93_IX_C	IS_P15_SN93_IX_C	plate_1	C5	ACGAAAACCCGCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AACCCGC	ACAGTG	P15	patient	25	F	CD_F	178	64	20.2	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	7	18	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B2	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_7	visit_7	week_32	week_32	32	09/05/2019	SC	40	no	none	no	none	no	none	yes	Vigantol	7	low	9	217	46.73	109	82	slightly_increased	20	negative	0	0	CD		0	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_7	CD_visit_7	CD_ADA_visit_7	CD_ADA_visit_7	CD_ADA_no_no	P15_visit_7_no	P15_visit_7_no	P15_visit_7_C_no	P15_visit_7_C_no	P15_visit_7_none	P15_visit_7_none	P15_visit_7_none	P15_visit_7_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
IS_P20_KP82_I_C	IS_P20_KP82_I_C	plate_1	D5	ACGAAATCCCTCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ATCCCTC	ACAGTG	P20	patient	36	F	UC_F	181	85	25.95	overweight	non-smoker	UC_non-smoker	UC	IFX	Remsima	11	26	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_Start	IFX_Start	UC_IFX_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	10/01/2019	IV	5	yes	Salofalk	no	none	no	none	no	none	2.4	low	10.5	350	23.67	130	4474	significantly_increased	0	negative	UC		6	6	6	active	moderate	baseline	baseline	Base	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeS	UC_IFX_no	UC_IFX_none	UC_IFX_BT_C	UC_C	UC_no	UC_C_no	UC_SeS	UC_SeS_no	UC_none	UC_none	UC_BT_C	UC_visit_1	UC_visit_1	UC_IFX_visit_1	UC_IFX_visit_1	UC_IFX_no_no	P20_visit_1_no	P20_visit_1_no	P20_visit_1_C_no	P20_visit_1_C_no	P20_visit_1_none	P20_visit_1_none	P20_visit_1_none	P20_visit_1_none	UC_Base	UC_IFX_Base	UC_no_Base	UC_C_no_Base	UC_SeS_no_Base
IS_P20_KP82_I_D	IS_P20_KP82_I_D	plate_1	E5	ACGAAACTCGCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACTCGCC	ACAGTG	P20	patient	36	F	UC_F	181	85	25.95	overweight	non-smoker	UC_non-smoker	UC	IFX	Remsima	11	26	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_Start	IFX_Start	UC_IFX_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	10/01/2019	IV	5	yes	Salofalk	no	none	no	none	no	none	2.4	low	10.5	350	23.67	130	4474	significantly_increased	0	negative	UC		6	6	6	active	moderate	baseline	baseline	Base	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeT	UC_IFX_no	UC_IFX_none	UC_IFX_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_1	UC_visit_1	UC_IFX_visit_1	UC_IFX_visit_1	UC_IFX_no_no	P20_visit_1_no	P20_visit_1_no	P20_visit_1_D_no	P20_visit_1_D_no	P20_visit_1_none	P20_visit_1_none	P20_visit_1_none	P20_visit_1_none	UC_Base	UC_IFX_Base	UC_no_Base	UC_D_no_Base	UC_SeT_no_Base
IS_P20_KP82_II_C	IS_P20_KP82_II_C	plate_1	F5	ACGAAAGGCCTCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGGCCTC	ACAGTG	P20	patient	36	F	UC_F	181	85	25.95	overweight	non-smoker	UC_non-smoker	UC	IFX	Remsima	11	26	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	23/01/2019	IV	5	yes	Salofalk	no	none	no	none	yes	Algifen	0.4	low	10.7	297	29.82	132	143	slightly_increased	20	negative	UC		1	1	1	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeS	UC_IFX_no	UC_IFX_none	UC_IFX_BT_C	UC_C	UC_no	UC_C_no	UC_SeS	UC_SeS_no	UC_none	UC_none	UC_BT_C	UC_visit_2	UC_visit_2	UC_IFX_visit_2	UC_IFX_visit_2	UC_IFX_no_no	P20_visit_2_no	P20_visit_2_no	P20_visit_2_C_no	P20_visit_2_C_no	P20_visit_2_none	P20_visit_2_none	P20_visit_2_none	P20_visit_2_none	UC_Full	UC_IFX_Full	UC_no_Full	UC_C_no_Full	UC_SeS_no_Full
IS_P20_KP82_II_D	IS_P20_KP82_II_D	plate_1	G5	ACGAAACCCAGCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACCCAGC	ACAGTG	P20	patient	36	F	UC_F	181	85	25.95	overweight	non-smoker	UC_non-smoker	UC	IFX	Remsima	11	26	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	23/01/2019	IV	5	yes	Salofalk	no	none	no	none	yes	Algifen	0.4	low	10.7	297	29.82	132	143	slightly_increased	20	negative	UC		1	1	1	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeT	UC_IFX_no	UC_IFX_none	UC_IFX_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_2	UC_visit_2	UC_IFX_visit_2	UC_IFX_visit_2	UC_IFX_no_no	P20_visit_2_no	P20_visit_2_no	P20_visit_2_D_no	P20_visit_2_D_no	P20_visit_2_none	P20_visit_2_none	P20_visit_2_none	P20_visit_2_none	UC_Full	UC_IFX_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
IS_P20_KP82_III_C	IS_P20_KP82_III_C	plate_1	H5	AAAGAGCACGAAA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AAAGAGC	ACAGTG	P20	patient	36	F	UC_F	181	85	25.95	overweight	non-smoker	UC_non-smoker	UC	IFX	Remsima	11	26	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	20/02/2019	IV	5	no	none	no	none	no	none	yes	Vigantol	0.8	low	9.3	293	27.27	130	84	slightly_increased	20	negative	UC		1	1	1	inactive	remission	response	partial_response	Part	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeS	UC_IFX_no	UC_IFX_none	UC_IFX_BT_C	UC_C	UC_no	UC_C_no	UC_SeS	UC_SeS_no	UC_none	UC_none	UC_BT_C	UC_visit_3	UC_visit_3	UC_IFX_visit_3	UC_IFX_visit_3	UC_IFX_no_no	P20_visit_3_no	P20_visit_3_no	P20_visit_3_C_no	P20_visit_3_C_no	P20_visit_3_none	P20_visit_3_none	P20_visit_3_none	P20_visit_3_none	UC_Part	UC_IFX_Part	UC_no_Part	UC_C_no_Part	UC_SeS_no_Part
IS_P20_KP82_III_D	IS_P20_KP82_III_D	plate_1	A6	ACGAAACGGCTCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACGGCTC	ACAGTG	P20	patient	36	F	UC_F	181	85	25.95	overweight	non-smoker	UC_non-smoker	UC	IFX	Remsima	11	26	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	20/02/2019	IV	5	no	none	no	none	no	none	yes	Vigantol	0.8	low	9.3	293	27.27	130	84	slightly_increased	20	negative	UC		1	1	1	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeT	UC_IFX_no	UC_IFX_none	UC_IFX_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_3	UC_visit_3	UC_IFX_visit_3	UC_IFX_visit_3	UC_IFX_no_no	P20_visit_3_no	P20_visit_3_no	P20_visit_3_D_no	P20_visit_3_D_no	P20_visit_3_none	P20_visit_3_none	P20_visit_3_none	P20_visit_3_none	UC_Part	UC_IFX_Part	UC_no_Part	UC_D_no_Part	UC_SeT_no_Part
IS_P20_KP82_IIIxIV_C	IS_P20_KP82_IIIxIV_C	plate_1	B6	ACGAAACGACATA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACGACAT	ACAGTG	P20	patient	36	F	UC_F	181	85	25.95	overweight	non-smoker	UC_non-smoker	UC	IFX	Remsima	11	26	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_Finish	IFX_Finish	UC_IFX_Finish	Finish	Finish	Finish.14	Finish.14	visit_4	visit_4	week_14	week_14	14																						UC										C	SeS	yes	"C,D"	SAE_C	SAE.IFX_C	SAE.IFX_SeS	C	SeS	none	none	C	none	none	none	none	none	papulopustular_reaction	none	none	switch__VEDO	UC_IFX	UC_IFX_SeS	UC_IFX_yes	UC_IFX_SeS	UC_IFX_SAE_C	UC_C	UC_yes	UC_C_yes	UC_SeS	UC_SeS_yes	UC_C	UC_SeS	UC_SAE_C	UC_visit_4	UC_visit_4	UC_IFX_visit_4	UC_IFX_visit_4	UC_IFX_yes_	P20_visit_4_yes	P20_visit_4_yes	P20_visit_4_C_yes	P20_visit_4_C_yes	P20_visit_4_C	P20_visit_4_C	P20_visit_4_SeS	P20_visit_4_SeS	UC_	UC_IFX_	UC_yes_	UC_C_yes_	UC_SeS_yes_
IS_P20_KP82_IIIxIV_D	IS_P20_KP82_IIIxIV_D	plate_1	C6	ACGAAATCCCGCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ATCCCGC	ACAGTG	P20	patient	36	F	UC_F	181	85	25.95	overweight	non-smoker	UC_non-smoker	UC	IFX	Remsima	11	26	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_Finish	IFX_Finish	UC_IFX_Finish	Finish	Finish	Finish.14	Finish.14	visit_4	visit_4	week_14	week_14	14																						UC										D	SeT	yes	"C,D"	SAE_D	SAE.IFX_D	SAE.IFX_SeT	D	SeT	none	none	none	D	none	none	none	none	papulopustular_reaction	none	none	switch__VEDO	UC_IFX	UC_IFX_SeT	UC_IFX_yes	UC_IFX_SeT	UC_IFX_SAE_D	UC_D	UC_yes	UC_D_yes	UC_SeT	UC_SeT_yes	UC_D	UC_SeT	UC_SAE_D	UC_visit_4	UC_visit_4	UC_IFX_visit_4	UC_IFX_visit_4	UC_IFX_yes_	P20_visit_4_yes	P20_visit_4_yes	P20_visit_4_D_yes	P20_visit_4_D_yes	P20_visit_4_D	P20_visit_4_D	P20_visit_4_SeT	P20_visit_4_SeT	UC_	UC_IFX_	UC_yes_	UC_D_yes_	UC_SeT_yes_
IS_P21_PP94_I_D	IS_P21_PP94_I_D	plate_1	D6	ACGAAAGTGCGCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGTGCGC	ACAGTG	P21_IFX	patient	24	F	CD_F	165	60	22.04	normal	smoker	CD_smoker	CD	IFX	Flixabi	2	23	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B2	L3	non-L4	CD	yes	joints	no	none	CD_Start	IFX_Start	CD_IFX_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	11/01/2019	IV	5	yes	Salofalk	no	none	yes	Budesonid	yes	Calcichew_Emanera_HAK	9.3	low	9.5	368	59.93	126	1055	significantly_increased	0	negative	7	7	CD		7	inactive	mild	baseline	baseline	Base	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_1	CD_visit_1	CD_IFX_visit_1	CD_IFX_visit_1	CD_IFX_no_no	P21_visit_1_no	P21_visit_1_no	P21_visit_1_D_no	P21_visit_1_D_no	P21_visit_1_none	P21_visit_1_none	P21_visit_1_none	P21_visit_1_none	CD_Base	CD_IFX_Base	CD_no_Base	CD_D_no_Base	CD_SeT_no_Base
IS_P21_PP94_II_D	IS_P21_PP94_II_D	plate_1	E6	ACGAAAGACTCTA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGACTCT	ACAGTG	P21_IFX	patient	24	F	CD_F	165	60	22.04	normal	smoker	CD_smoker	CD	IFX	Flixabi	2	23	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B2	L3	non-L4	CD	yes	joints	no	none	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	25/01/2019	IV	5	yes	Salofalk	no	none	yes	Budesonid	yes	Calcichew_Emanera_HAKA	10.9	high	9.2	310	66.7	124	1072	significantly_increased	12.7	negative	5	5	CD		5	inactive	mild	response	partial_response	Part	D	SeT	yes	D	SAE_D	SAE.IFX_D	SAE.IFX_SeT	D	SeT	none	none	none	D	none	none	none	none	none	none	none	diskrétní_erytém__obličeji_a_kštici_-_lokalizace_D	CD_IFX	CD_IFX_SeT	CD_IFX_yes	CD_IFX_SeT	CD_IFX_SAE_D	CD_D	CD_yes	CD_D_yes	CD_SeT	CD_SeT_yes	CD_D	CD_SeT	CD_SAE_D	CD_visit_2	CD_visit_2	CD_IFX_visit_2	CD_IFX_visit_2	CD_IFX_yes_no	P21_visit_2_yes	P21_visit_2_yes	P21_visit_2_D_yes	P21_visit_2_D_yes	P21_visit_2_D	P21_visit_2_D	P21_visit_2_SeT	P21_visit_2_SeT	CD_Part	CD_IFX_Part	CD_yes_Part	CD_D_yes_Part	CD_SeT_yes_Part
IS_P21_PP94_III_D	IS_P21_PP94_III_D	plate_1	F6	ACGAAAGGGGTTA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGGGGTT	ACAGTG	P21_IFX	patient	24	F	CD_F	165	60	22.04	normal	smoker	CD_smoker	CD	IFX	Flixabi	2	23	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B2	L3	non-L4	CD	yes	joints	no	none	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_6	week_6	6	22/02/2019	IV	5	yes	Salofalk	no	none	yes	Budesonid	yes	Calcichew_Emanera_HAK	20.9	high	14.5	334	68.49	125	727	significantly_increased	9.8	negative	4	4	CD		4	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_3	CD_visit_3	CD_IFX_visit_3	CD_IFX_visit_3	CD_IFX_no_no	P21_visit_3_no	P21_visit_3_no	P21_visit_3_D_no	P21_visit_3_D_no	P21_visit_3_none	P21_visit_3_none	P21_visit_3_none	P21_visit_3_none	CD_Part	CD_IFX_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
IS_P21_PP94_IV_D	IS_P21_PP94_IV_D	plate_1	G6	ACGAAACTAGGGA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACTAGGG	ACAGTG	P21_IFX	patient	24	F	CD_F	165	60	22.04	normal	smoker	CD_smoker	CD	IFX	Flixabi	2	23	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B2	L3	non-L4	CD	yes	joints	no	none	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	16/04/2019	IV	5	yes	Salofalk	no	none	yes	Budenosid	yes	Calcichew_Emanera_HAK	32.4	high	8.8	335	51.94	134	652	significantly_increased	5.3	negative	3	3	CD		3	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_4	CD_visit_4	CD_IFX_visit_4	CD_IFX_visit_4	CD_IFX_no_no	P21_visit_4_no	P21_visit_4_no	P21_visit_4_D_no	P21_visit_4_D_no	P21_visit_4_none	P21_visit_4_none	P21_visit_4_none	P21_visit_4_none	CD_Part	CD_IFX_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
IS_P21_PP94_V_D	IS_P21_PP94_V_D	plate_1	H6	ACGAAATAGCCGA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ATAGCCG	ACAGTG	P21_IFX	patient	24	F	CD_F	165	60	22.04	normal	smoker	CD_smoker	CD	IFX	Flixabi	2	23	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B2	L3	non-L4	CD	yes	joints	no	none	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_22	week_22	22	16/05/2019			no	none	no	none	yes	Budesonid	yes	Emanera_Calcichew_HAK	4.3	low	8.1	313	56.27	131							CD								D	SeT								none	none	none	none	none	none	none	none	none	none	none	"IFX_neaplikován_-_pauza_v_podávání,_jelikož_byla_pacientka_indiková_k_ileocékální_resekci_(poslední_aplikace_16.4.2019,_dále_až_25.7.2019"	CD_IFX	CD_IFX_SeT	CD_IFX_	CD_IFX_	CD_IFX_	CD_D	CD_	CD_D_	CD_SeT	CD_SeT_	CD_	CD_	CD_	CD_visit_5	CD_visit_5	CD_IFX_visit_5	CD_IFX_visit_5	CD_IFX__no	P21_visit_5_	P21_visit_5_	P21_visit_5_D_	P21_visit_5_D_	P21_visit_5_	P21_visit_5_	P21_visit_5_	P21_visit_5_	CD_	CD_IFX_	CD_	CD_D_	CD_SeT_
IS_P21_PP94_0T_D	IS_P21_PP94_0T_D	plate_1	A7	ATAATACCTTCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACCTTCC	ACAGTG	P21_ADA	patient	25	F	CD_F	165	60	22.04	normal	smoker	CD_smoker	CD	ADA	Hulio	2	23	no	none	biological_therapy_ineffectiveness_IFX_switch_without_washout	yes	IFX	A2	B3	L3	non-L4	CD	yes	joints	yes	draige	CD_Start	ADA_Start	CD_ADA_Start	Start	Start_switch_ADA	Start.0	Start.0_switch_ADA	visit_1	visit_1_switch_ADA	week_0	week_0_switch_ADA	0	14/11/2019	SC	160	no	none	no	none	no	none	yes	Emanera_Calcichew	7.8	low	7.2	412	31.17	137	222	significantly_increased	0	negative	1	1	CD		1	inactive	remission	baseline	baseline	Base	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_1	CD_visit_1_switch_ADA	CD_ADA_visit_1	CD_ADA_visit_1_switch_ADA	CD_ADA_no_no	P21_visit_1_no	P21_visit_1_switch_ADA_no	P21_visit_1_D_no	P21_visit_1_switch_ADA_D_no	P21_visit_1_none	P21_visit_1_switch_ADA_none	P21_visit_1_none	P21_visit_1_switch_ADA_none	CD_Base	CD_ADA_Base	CD_no_Base	CD_D_no_Base	CD_SeT_no_Base
IS_P21_PP94_8T_D	IS_P21_PP94_8T_D	plate_1	B7	ATAATAGCCACCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGCCACC	ACAGTG	P21_ADA	patient	25	F	CD_F	165	60	22.04	normal	smoker	CD_smoker	CD	ADA	Hulio	2	23	no	none	biological_therapy_ineffectiveness_IFX_switch_without_washout	yes	IFX	A2	B3	L3	non-L4	CD	yes	joints	yes	draige	CD_Finish	ADA_Finish	CD_ADA_Finish	Finish	Finish	Finish.8	Finish.8	visit_3	visit_3	week_8	week_8	8	23/01/2020	SC	40	no	none	no	none	no	none	yes	Emanera_Calcichew	5.2	low	10.4	358	43.76	128	287	significantly_increased	20	negative	3	3	CD		3	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_3	CD_visit_3	CD_ADA_visit_3	CD_ADA_visit_3	CD_ADA_no_no	P21_visit_3_no	P21_visit_3_no	P21_visit_3_D_no	P21_visit_3_D_no	P21_visit_3_none	P21_visit_3_none	P21_visit_3_none	P21_visit_3_none	CD_Part	CD_ADA_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
IS_P21_PP94_VI_D	IS_P21_PP94_VI_D	plate_1	C7	ATAATAACAGCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AACAGCC	ACAGTG	P21_IFX	patient	24	F	CD_F	165	60	22.04	normal	smoker	CD_smoker	CD	IFX	Flixabi	2	23	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B2	L3	non-L4	CD	yes	joints	no	none	CD_Finish	IFX_Finish	CD_IFX_Finish	Finish	Finish	Finish.30	Finish.30	visit_6	visit_6	week_30	week_30	30	18/09/2019	IV	5	no	none	no	none	no	none	yes	Emanera_Calcichew_HAK	9.2	low	8.5	389	27.16	130	129	slightly_increased	0.2	positive	5	5	CD		5	inactive	mild	no_response	no_response	NoRe	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_6	CD_visit_6	CD_IFX_visit_6	CD_IFX_visit_6	CD_IFX_no_no	P21_visit_6_no	P21_visit_6_no	P21_visit_6_D_no	P21_visit_6_D_no	P21_visit_6_none	P21_visit_6_none	P21_visit_6_none	P21_visit_6_none	CD_NoRe	CD_IFX_NoRe	CD_no_NoRe	CD_D_no_NoRe	CD_SeT_no_NoRe
IS_P25_KB89_I_C	IS_P25_KB89_I_C	plate_1	D7	ATAATACGGCCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACGGCCC	ACAGTG	P25	patient	22	F	UC_F	167	58	20.8	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	8	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	yes	joints	no	none	UC_Start	IFX_Start	UC_IFX_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	13/02/2019	IV	5	yes	Asacol	yes	AZA	yes	Budesonid	no	none	0.4	low	4.6	306	13.44	143	2383	significantly_increased	0	negative	UC		7	7	7	active	moderate	baseline	baseline	Base	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeS	UC_IFX_no	UC_IFX_none	UC_IFX_BT_C	UC_C	UC_no	UC_C_no	UC_SeS	UC_SeS_no	UC_none	UC_none	UC_BT_C	UC_visit_1	UC_visit_1	UC_IFX_visit_1	UC_IFX_visit_1	UC_IFX_no_yes	P25_visit_1_no	P25_visit_1_no	P25_visit_1_C_no	P25_visit_1_C_no	P25_visit_1_none	P25_visit_1_none	P25_visit_1_none	P25_visit_1_none	UC_Base	UC_IFX_Base	UC_no_Base	UC_C_no_Base	UC_SeS_no_Base
IS_P25_KB89_I_D	IS_P25_KB89_I_D	plate_1	E7	ATAATACTGGCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACTGGCC	ACAGTG	P25	patient	22	F	UC_F	167	58	20.8	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	8	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	yes	joints	no	none	UC_Start	IFX_Start	UC_IFX_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	13/02/2019	IV	5	yes	Asacol	yes	AZA	yes	Budesonid	no	none	0.4	low	4.6	306	13.44	143	2383	significantly_increased	0	negative	UC		7	7	7	active	moderate	baseline	baseline	Base	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeT	UC_IFX_no	UC_IFX_none	UC_IFX_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_1	UC_visit_1	UC_IFX_visit_1	UC_IFX_visit_1	UC_IFX_no_yes	P25_visit_1_no	P25_visit_1_no	P25_visit_1_D_no	P25_visit_1_D_no	P25_visit_1_none	P25_visit_1_none	P25_visit_1_none	P25_visit_1_none	UC_Base	UC_IFX_Base	UC_no_Base	UC_D_no_Base	UC_SeT_no_Base
IS_P25_KB89_II_C	IS_P25_KB89_II_C	plate_1	F7	ATAATAAGGACCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AAGGACC	ACAGTG	P25	patient	22	F	UC_F	167	58	20.8	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	8	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	yes	joints	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	27/02/2019	IV	5	yes	Asacol	yes	AZA	no	none	no	none							5336	significantly_increased	11.8	negative	UC		4	4	4	inactive	mild	response	partial_response	Part	C	SeS	yes	"C,D"	SAE_C	SAE.IFX_C	SAE.IFX_SeS	C	SeS	none	none	C	none	none	none	none	none	acneiform_exanthema	none	none	lokalisation_C+_D	UC_IFX	UC_IFX_SeS	UC_IFX_yes	UC_IFX_SeS	UC_IFX_SAE_C	UC_C	UC_yes	UC_C_yes	UC_SeS	UC_SeS_yes	UC_C	UC_SeS	UC_SAE_C	UC_visit_2	UC_visit_2	UC_IFX_visit_2	UC_IFX_visit_2	UC_IFX_yes_yes	P25_visit_2_yes	P25_visit_2_yes	P25_visit_2_C_yes	P25_visit_2_C_yes	P25_visit_2_C	P25_visit_2_C	P25_visit_2_SeS	P25_visit_2_SeS	UC_Part	UC_IFX_Part	UC_yes_Part	UC_C_yes_Part	UC_SeS_yes_Part
IS_P25_KB89_II_D	IS_P25_KB89_II_D	plate_1	G7	ATAATACGCTCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACGCTCC	ACAGTG	P25	patient	22	F	UC_F	167	58	20.8	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	8	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	yes	joints	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	27/02/2019	IV	5	yes	Asacol	yes	AZA	no	none	no	none							5336	significantly_increased	11.8	negative	UC		4	4	4	inactive	mild	response	partial_response	Part	D	SeT	yes	"C,D"	SAE_D	SAE.IFX_D	SAE.IFX_SeT	D	SeT	none	none	none	D	none	none	none	none	acneiform_exanthema	none	none	lokalisation_C+_D	UC_IFX	UC_IFX_SeT	UC_IFX_yes	UC_IFX_SeT	UC_IFX_SAE_D	UC_D	UC_yes	UC_D_yes	UC_SeT	UC_SeT_yes	UC_D	UC_SeT	UC_SAE_D	UC_visit_2	UC_visit_2	UC_IFX_visit_2	UC_IFX_visit_2	UC_IFX_yes_yes	P25_visit_2_yes	P25_visit_2_yes	P25_visit_2_D_yes	P25_visit_2_D_yes	P25_visit_2_D	P25_visit_2_D	P25_visit_2_SeT	P25_visit_2_SeT	UC_Part	UC_IFX_Part	UC_yes_Part	UC_D_yes_Part	UC_SeT_yes_Part
IS_P25_KB89_III_C	IS_P25_KB89_III_C	plate_1	H7	ATAATAGCGCCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGCGCCC	ACAGTG	P25	patient	22	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	8	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	yes	joints	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	27/03/2019	IV	5	yes	Asacol	yes	AZA	no	none	no	none	0.2	low	4.2	207	8.63	142	37	normal	8.9	negative	UC		4	4	4	inactive	mild	response	full_response	Full	C	SeS	yes	"C,D"	SAE_C	SAE.IFX_C	SAE.IFX_SeS	C	SeS	none	none	C	none	none	none	none	none	acneiform_exanthema	none	none	mild_manifestation	UC_IFX	UC_IFX_SeS	UC_IFX_yes	UC_IFX_SeS	UC_IFX_SAE_C	UC_C	UC_yes	UC_C_yes	UC_SeS	UC_SeS_yes	UC_C	UC_SeS	UC_SAE_C	UC_visit_3	UC_visit_3	UC_IFX_visit_3	UC_IFX_visit_3	UC_IFX_yes_yes	P25_visit_3_yes	P25_visit_3_yes	P25_visit_3_C_yes	P25_visit_3_C_yes	P25_visit_3_C	P25_visit_3_C	P25_visit_3_SeS	P25_visit_3_SeS	UC_Full	UC_IFX_Full	UC_yes_Full	UC_C_yes_Full	UC_SeS_yes_Full
IS_P25_KB89_III_D	IS_P25_KB89_III_D	plate_1	A8	ATAATAATTAGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AATTAGC	ACAGTG	P25	patient	22	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	8	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	yes	joints	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	27/03/2019	IV	5	yes	Asacol	yes	AZA	no	none	no	none	0.2	low	4.2	207	8.63	142	37	normal	8.9	negative	UC		4	4	4	inactive	mild	response	full_response	Full	D	SeT	yes	"C,D"	SAE_D	SAE.IFX_D	SAE.IFX_SeT	D	SeT	none	none	none	D	none	none	none	none	acneiform_exanthema	none	none	mild_manifestation	UC_IFX	UC_IFX_SeT	UC_IFX_yes	UC_IFX_SeT	UC_IFX_SAE_D	UC_D	UC_yes	UC_D_yes	UC_SeT	UC_SeT_yes	UC_D	UC_SeT	UC_SAE_D	UC_visit_3	UC_visit_3	UC_IFX_visit_3	UC_IFX_visit_3	UC_IFX_yes_yes	P25_visit_3_yes	P25_visit_3_yes	P25_visit_3_D_yes	P25_visit_3_D_yes	P25_visit_3_D	P25_visit_3_D	P25_visit_3_SeT	P25_visit_3_SeT	UC_Full	UC_IFX_Full	UC_yes_Full	UC_D_yes_Full	UC_SeT_yes_Full
IS_P25_KB89_IV_C	IS_P25_KB89_IV_C	plate_1	B8	ATAATATCCTCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ATCCTCC	ACAGTG	P25	patient	22	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	8	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	yes	joints	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	23/05/2019	IV	5	yes	Asacol	yes	AZA	no	none	no	none	0.2	low	5.5	225	16.18	140	1007	significantly_increased	3.3	negative	UC		3	3	3	inactive	mild	response	partial_response	Part	C	SeS	yes	"C,D"	SAE_C	SAE.IFX_C	SAE.IFX_SeS	C	SeS	none	none	C	none	none	none	none	none	acneiform_exanthema	none	none	mild_manifestation	UC_IFX	UC_IFX_SeS	UC_IFX_yes	UC_IFX_SeS	UC_IFX_SAE_C	UC_C	UC_yes	UC_C_yes	UC_SeS	UC_SeS_yes	UC_C	UC_SeS	UC_SAE_C	UC_visit_4	UC_visit_4	UC_IFX_visit_4	UC_IFX_visit_4	UC_IFX_yes_yes	P25_visit_4_yes	P25_visit_4_yes	P25_visit_4_C_yes	P25_visit_4_C_yes	P25_visit_4_C	P25_visit_4_C	P25_visit_4_SeS	P25_visit_4_SeS	UC_Part	UC_IFX_Part	UC_yes_Part	UC_C_yes_Part	UC_SeS_yes_Part
IS_P25_KB89_IV_D	IS_P25_KB89_IV_D	plate_1	C8	ATAATAACCCGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AACCCGC	ACAGTG	P25	patient	22	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	8	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	yes	joints	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	23/05/2019	IV	5	yes	Asacol	yes	AZA	no	none	no	none	0.2	low	5.5	225	16.18	140	1007	significantly_increased	3.3	negative	UC		3	3	3	inactive	mild	response	partial_response	Part	D	SeT	yes	"C,D"	SAE_D	SAE.IFX_D	SAE.IFX_SeT	D	SeT	none	none	none	D	none	none	none	none	acneiform_exanthema	none	none	mild_manifestation	UC_IFX	UC_IFX_SeT	UC_IFX_yes	UC_IFX_SeT	UC_IFX_SAE_D	UC_D	UC_yes	UC_D_yes	UC_SeT	UC_SeT_yes	UC_D	UC_SeT	UC_SAE_D	UC_visit_4	UC_visit_4	UC_IFX_visit_4	UC_IFX_visit_4	UC_IFX_yes_yes	P25_visit_4_yes	P25_visit_4_yes	P25_visit_4_D_yes	P25_visit_4_D_yes	P25_visit_4_D	P25_visit_4_D	P25_visit_4_SeT	P25_visit_4_SeT	UC_Part	UC_IFX_Part	UC_yes_Part	UC_D_yes_Part	UC_SeT_yes_Part
IS_P25_KB89_V_C	IS_P25_KB89_V_C	plate_1	D8	ATAATATCCCTCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ATCCCTC	ACAGTG	P25	patient	22	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	8	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	yes	joints	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_22	week_22	22	16/07/2019	IV	5	no	none	yes	AZA	no	none	no	none	0.4	low	5.1	211	18.17	135	12	normal	2.6	negative	UC		1	1	1	inactive	remission	response	full_response	Full	C	SeS	yes	"C,D"	SAE_C	SAE.IFX_C	SAE.IFX_SeS	C	SeS	none	none	C	none	none	none	none	none	acneiform_exanthema	none	none	mild_manifestation	UC_IFX	UC_IFX_SeS	UC_IFX_yes	UC_IFX_SeS	UC_IFX_SAE_C	UC_C	UC_yes	UC_C_yes	UC_SeS	UC_SeS_yes	UC_C	UC_SeS	UC_SAE_C	UC_visit_5	UC_visit_5	UC_IFX_visit_5	UC_IFX_visit_5	UC_IFX_yes_yes	P25_visit_5_yes	P25_visit_5_yes	P25_visit_5_C_yes	P25_visit_5_C_yes	P25_visit_5_C	P25_visit_5_C	P25_visit_5_SeS	P25_visit_5_SeS	UC_Full	UC_IFX_Full	UC_yes_Full	UC_C_yes_Full	UC_SeS_yes_Full
IS_P25_KB89_V_D	IS_P25_KB89_V_D	plate_1	E8	ATAATACTCGCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACTCGCC	ACAGTG	P25	patient	22	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	8	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	yes	joints	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_22	week_22	22	16/07/2019	IV	5	no	none	yes	AZA	no	none	no	none	0.4	low	5.1	211	18.17	135	12	normal	2.6	negative	UC		1	1	1	inactive	remission	response	full_response	Full	D	SeT	yes	"C,D"	SAE_D	SAE.IFX_D	SAE.IFX_SeT	D	SeT	none	none	none	D	none	none	none	none	acneiform_exanthema	none	none	mild_manifestation	UC_IFX	UC_IFX_SeT	UC_IFX_yes	UC_IFX_SeT	UC_IFX_SAE_D	UC_D	UC_yes	UC_D_yes	UC_SeT	UC_SeT_yes	UC_D	UC_SeT	UC_SAE_D	UC_visit_5	UC_visit_5	UC_IFX_visit_5	UC_IFX_visit_5	UC_IFX_yes_yes	P25_visit_5_yes	P25_visit_5_yes	P25_visit_5_D_yes	P25_visit_5_D_yes	P25_visit_5_D	P25_visit_5_D	P25_visit_5_SeT	P25_visit_5_SeT	UC_Full	UC_IFX_Full	UC_yes_Full	UC_D_yes_Full	UC_SeT_yes_Full
IS_P25_KB89_VI_C	IS_P25_KB89_VI_C	plate_1	F8	ATAATAGGCCTCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGGCCTC	ACAGTG	P25	patient	22	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	8	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	yes	joints	no	none	UC_Finish	IFX_Finish	UC_IFX_Finish	Finish	Finish	Finish.32	Finish.32	visit_6	visit_6	week_32	week_32	32	16/09/2019	IV	5	no	none	yes	AZA	no	none	no	none	1.5	low	5	246	19.14	139	6000	significantly_increased	0.5	negative	UC		5	5	5	active	moderate	no_response	no_response	NoRe	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeS	UC_IFX_no	UC_IFX_none	UC_IFX_BT_C	UC_C	UC_no	UC_C_no	UC_SeS	UC_SeS_no	UC_none	UC_none	UC_BT_C	UC_visit_6	UC_visit_6	UC_IFX_visit_6	UC_IFX_visit_6	UC_IFX_no_yes	P25_visit_6_no	P25_visit_6_no	P25_visit_6_C_no	P25_visit_6_C_no	P25_visit_6_none	P25_visit_6_none	P25_visit_6_none	P25_visit_6_none	UC_NoRe	UC_IFX_NoRe	UC_no_NoRe	UC_C_no_NoRe	UC_SeS_no_NoRe
IS_P25_KB89_VI_D	IS_P25_KB89_VI_D	plate_1	G8	ATAATACCCAGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACCCAGC	ACAGTG	P25	patient	22	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	8	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	yes	joints	no	none	UC_Finish	IFX_Finish	UC_IFX_Finish	Finish	Finish	Finish.32	Finish.32	visit_6	visit_6	week_32	week_32	32	16/09/2019	IV	5	no	none	yes	AZA	no	none	no	none	1.5	low	5	246	19.14	139	6000	significantly_increased	0.5	negative	UC		5	5	5	active	moderate	no_response	no_response	NoRe	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeT	UC_IFX_no	UC_IFX_none	UC_IFX_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_6	UC_visit_6	UC_IFX_visit_6	UC_IFX_visit_6	UC_IFX_no_yes	P25_visit_6_no	P25_visit_6_no	P25_visit_6_D_no	P25_visit_6_D_no	P25_visit_6_none	P25_visit_6_none	P25_visit_6_none	P25_visit_6_none	UC_NoRe	UC_IFX_NoRe	UC_no_NoRe	UC_D_no_NoRe	UC_SeT_no_NoRe
IS_P26_HP77_I_C	IS_P26_HP77_I_C	plate_1	H8	ATAATAAAGAGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AAAGAGC	ACAGTG	P26	patient	42	F	UC_F	174	64	21.14	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	20	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	no	none	no	none	UC_Start	IFX_Start	UC_IFX_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	18/02/2019	IV	5	yes	Pentasa	no	none	yes	Medrol	yes	Helicid	71.8	high	23.7	633	51.14	110	3388	significantly_increased	0	negative	UC		9	9	9	active	severe	baseline	baseline	Base	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeS	UC_IFX_no	UC_IFX_none	UC_IFX_BT_C	UC_C	UC_no	UC_C_no	UC_SeS	UC_SeS_no	UC_none	UC_none	UC_BT_C	UC_visit_1	UC_visit_1	UC_IFX_visit_1	UC_IFX_visit_1	UC_IFX_no_no	P26_visit_1_no	P26_visit_1_no	P26_visit_1_C_no	P26_visit_1_C_no	P26_visit_1_none	P26_visit_1_none	P26_visit_1_none	P26_visit_1_none	UC_Base	UC_IFX_Base	UC_no_Base	UC_C_no_Base	UC_SeS_no_Base
IS_P26_HP77_I_D	IS_P26_HP77_I_D	plate_1	A9	ATAATACGGCTCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACGGCTC	ACAGTG	P26	patient	42	F	UC_F	174	64	21.14	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	20	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	no	none	no	none	UC_Start	IFX_Start	UC_IFX_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	18/02/2019	IV	5	yes	Pentasa	no	none	yes	Medrol	yes	Helicid	71.8	high	23.7	633	51.14	110	3388	significantly_increased	0	negative	UC		9	9	9	active	severe	baseline	baseline	Base	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeT	UC_IFX_no	UC_IFX_none	UC_IFX_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_1	UC_visit_1	UC_IFX_visit_1	UC_IFX_visit_1	UC_IFX_no_no	P26_visit_1_no	P26_visit_1_no	P26_visit_1_D_no	P26_visit_1_D_no	P26_visit_1_none	P26_visit_1_none	P26_visit_1_none	P26_visit_1_none	UC_Base	UC_IFX_Base	UC_no_Base	UC_D_no_Base	UC_SeT_no_Base
IS_P26_HP77_II_C	IS_P26_HP77_II_C	plate_1	B9	ATAATACGACATA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACGACAT	ACAGTG	P26	patient	42	F	UC_F	174	64	21.14	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	20	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	no	none	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	05/03/2019	IV	5	no	none	no	none	yes	Medrol	yes	Helicid	1.1	low	10.1	437	360.85	120	1118	significantly_increased	20	negative	UC		5	5	5	active	moderate	response	full_response	Full	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeS	UC_IFX_no	UC_IFX_none	UC_IFX_BT_C	UC_C	UC_no	UC_C_no	UC_SeS	UC_SeS_no	UC_none	UC_none	UC_BT_C	UC_visit_2	UC_visit_2	UC_IFX_visit_2	UC_IFX_visit_2	UC_IFX_no_no	P26_visit_2_no	P26_visit_2_no	P26_visit_2_C_no	P26_visit_2_C_no	P26_visit_2_none	P26_visit_2_none	P26_visit_2_none	P26_visit_2_none	UC_Full	UC_IFX_Full	UC_no_Full	UC_C_no_Full	UC_SeS_no_Full
IS_P26_HP77_II_D	IS_P26_HP77_II_D	plate_1	C9	ATAATATCCCGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ATCCCGC	ACAGTG	P26	patient	42	F	UC_F	174	64	21.14	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	20	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	no	none	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	05/03/2019	IV	5	no	none	no	none	yes	Medrol	yes	Helicid	1.1	low	10.1	437	360.85	120	1118	significantly_increased	20	negative	UC		5	5	5	active	moderate	response	full_response	Full	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeT	UC_IFX_no	UC_IFX_none	UC_IFX_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_2	UC_visit_2	UC_IFX_visit_2	UC_IFX_visit_2	UC_IFX_no_no	P26_visit_2_no	P26_visit_2_no	P26_visit_2_D_no	P26_visit_2_D_no	P26_visit_2_none	P26_visit_2_none	P26_visit_2_none	P26_visit_2_none	UC_Full	UC_IFX_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
IS_P26_HP77_III_C	IS_P26_HP77_III_C	plate_1	D9	ATAATAGTGCGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGTGCGC	ACAGTG	P26	patient	42	F	UC_F	174	64	21.14	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	20	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	no	none	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	02/04/2019	IV	5	no	none	no	none	yes	Medrol	no	none	16.6	high	11.1	373	70.35	130	75	slightly_increased	20	negative	UC		4	4	4	inactive	mild	response	partial_response	Part	C	SeS	yes	"C,D"	SAE_C	SAE.IFX_C	SAE.IFX_SeS	C	SeS	none	none	C	none	none	none	none	none	acneiform_exanthema	none	none	lokalisation_C+_D	UC_IFX	UC_IFX_SeS	UC_IFX_yes	UC_IFX_SeS	UC_IFX_SAE_C	UC_C	UC_yes	UC_C_yes	UC_SeS	UC_SeS_yes	UC_C	UC_SeS	UC_SAE_C	UC_visit_3	UC_visit_3	UC_IFX_visit_3	UC_IFX_visit_3	UC_IFX_yes_no	P26_visit_3_yes	P26_visit_3_yes	P26_visit_3_C_yes	P26_visit_3_C_yes	P26_visit_3_C	P26_visit_3_C	P26_visit_3_SeS	P26_visit_3_SeS	UC_Part	UC_IFX_Part	UC_yes_Part	UC_C_yes_Part	UC_SeS_yes_Part
IS_P26_HP77_III_D	IS_P26_HP77_III_D	plate_1	E9	ATAATAGACTCTA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGACTCT	ACAGTG	P26	patient	42	F	UC_F	174	64	21.14	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	20	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	no	none	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	02/04/2019	IV	5	no	none	no	none	yes	Medrol	no	none	16.6	high	11.1	373	70.35	130	75	slightly_increased	20	negative	UC		4	4	4	inactive	mild	response	partial_response	Part	D	SeT	yes	"C,D"	SAE_D	SAE.IFX_D	SAE.IFX_SeT	D	SeT	none	none	none	D	none	none	none	none	acneiform_exanthema	none	none	lokalisation_C+_D	UC_IFX	UC_IFX_SeT	UC_IFX_yes	UC_IFX_SeT	UC_IFX_SAE_D	UC_D	UC_yes	UC_D_yes	UC_SeT	UC_SeT_yes	UC_D	UC_SeT	UC_SAE_D	UC_visit_3	UC_visit_3	UC_IFX_visit_3	UC_IFX_visit_3	UC_IFX_yes_no	P26_visit_3_yes	P26_visit_3_yes	P26_visit_3_D_yes	P26_visit_3_D_yes	P26_visit_3_D	P26_visit_3_D	P26_visit_3_SeT	P26_visit_3_SeT	UC_Part	UC_IFX_Part	UC_yes_Part	UC_D_yes_Part	UC_SeT_yes_Part
IS_P26_HP77_IV_C	IS_P26_HP77_IV_C	plate_1	F9	ATAATAGGGGTTA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGGGGTT	ACAGTG	P26	patient	42	F	UC_F	174	66	21.8	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	20	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	no	none	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	28/05/2019	IV	5	no	none	no	none	yes	Medrol	yes	KCL_Caltrate_	4.4	low	6.8	311	35.99	127	152	slightly_increased	18.2	negative	UC		3	3	3	inactive	mild	response	partial_response	Part	C	SeS	yes	"C,D"	SAE_C	SAE.IFX_C	SAE.IFX_SeS	C	SeS	none	none	C	none	none	none	none	none	acneiform_exanthema	none	none	impproved_exanthema_C_and_D_persists	UC_IFX	UC_IFX_SeS	UC_IFX_yes	UC_IFX_SeS	UC_IFX_SAE_C	UC_C	UC_yes	UC_C_yes	UC_SeS	UC_SeS_yes	UC_C	UC_SeS	UC_SAE_C	UC_visit_4	UC_visit_4	UC_IFX_visit_4	UC_IFX_visit_4	UC_IFX_yes_no	P26_visit_4_yes	P26_visit_4_yes	P26_visit_4_C_yes	P26_visit_4_C_yes	P26_visit_4_C	P26_visit_4_C	P26_visit_4_SeS	P26_visit_4_SeS	UC_Part	UC_IFX_Part	UC_yes_Part	UC_C_yes_Part	UC_SeS_yes_Part
IS_P26_HP77_IV_D	IS_P26_HP77_IV_D	plate_1	G9	ATAATACTAGGGA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACTAGGG	ACAGTG	P26	patient	42	F	UC_F	174	66	21.8	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	20	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	no	none	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	28/05/2019	IV	5	no	none	no	none	yes	Medrol	yes	KCL_Caltrate_	4.4	low	6.8	311	35.99	127	152	slightly_increased	18.2	negative	UC		3	3	3	inactive	mild	response	partial_response	Part	D	SeT	yes	"C,D"	SAE_D	SAE.IFX_D	SAE.IFX_SeT	D	SeT	none	none	none	D	none	none	none	none	acneiform_exanthema	none	none	impproved_exanthema_C_and_D_persists	UC_IFX	UC_IFX_SeT	UC_IFX_yes	UC_IFX_SeT	UC_IFX_SAE_D	UC_D	UC_yes	UC_D_yes	UC_SeT	UC_SeT_yes	UC_D	UC_SeT	UC_SAE_D	UC_visit_4	UC_visit_4	UC_IFX_visit_4	UC_IFX_visit_4	UC_IFX_yes_no	P26_visit_4_yes	P26_visit_4_yes	P26_visit_4_D_yes	P26_visit_4_D_yes	P26_visit_4_D	P26_visit_4_D	P26_visit_4_SeT	P26_visit_4_SeT	UC_Part	UC_IFX_Part	UC_yes_Part	UC_D_yes_Part	UC_SeT_yes_Part
IS_P26_HP77_V_C	IS_P26_HP77_V_C	plate_1	H9	ATAATATAGCCGA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ATAGCCG	ACAGTG	P26	patient	42	F	UC_F	174	66	21.8	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	20	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	no	none	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_22	week_22	22	23/07/2019	IV	5	no	none	no	none	yes	Medrol	no	none	1.3	low	4.4	273	36.83	120	7	normal	19.7	negative	UC		4	4	4	inactive	mild	response	partial_response	Part	C	SeS	yes	"C,D"	SAE_C	SAE.IFX_C	SAE.IFX_SeS	C	SeS	none	none	C	none	none	none	none	none	acneiform_exanthema	none	none	impproved_exanthema_C_and_D_persists	UC_IFX	UC_IFX_SeS	UC_IFX_yes	UC_IFX_SeS	UC_IFX_SAE_C	UC_C	UC_yes	UC_C_yes	UC_SeS	UC_SeS_yes	UC_C	UC_SeS	UC_SAE_C	UC_visit_5	UC_visit_5	UC_IFX_visit_5	UC_IFX_visit_5	UC_IFX_yes_no	P26_visit_5_yes	P26_visit_5_yes	P26_visit_5_C_yes	P26_visit_5_C_yes	P26_visit_5_C	P26_visit_5_C	P26_visit_5_SeS	P26_visit_5_SeS	UC_Part	UC_IFX_Part	UC_yes_Part	UC_C_yes_Part	UC_SeS_yes_Part
IS_P26_HP77_V_D	IS_P26_HP77_V_D	plate_1	A10	AGGGTACCTTCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACCTTCC	ACAGTG	P26	patient	42	F	UC_F	174	66	21.8	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	20	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	no	none	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_22	week_22	22	23/07/2019	IV	5	no	none	no	none	yes	Medrol	no	none	1.3	low	4.4	273	36.83	120	7	normal	19.7	negative	UC		4	4	4	inactive	mild	response	partial_response	Part	D	SeT	yes	"C,D"	SAE_D	SAE.IFX_D	SAE.IFX_SeT	D	SeT	none	none	none	D	none	none	none	none	acneiform_exanthema	none	none	impproved_exanthema_C_and_D_persists	UC_IFX	UC_IFX_SeT	UC_IFX_yes	UC_IFX_SeT	UC_IFX_SAE_D	UC_D	UC_yes	UC_D_yes	UC_SeT	UC_SeT_yes	UC_D	UC_SeT	UC_SAE_D	UC_visit_5	UC_visit_5	UC_IFX_visit_5	UC_IFX_visit_5	UC_IFX_yes_no	P26_visit_5_yes	P26_visit_5_yes	P26_visit_5_D_yes	P26_visit_5_D_yes	P26_visit_5_D	P26_visit_5_D	P26_visit_5_SeT	P26_visit_5_SeT	UC_Part	UC_IFX_Part	UC_yes_Part	UC_D_yes_Part	UC_SeT_yes_Part
IS_P26_HP77_VI_C	IS_P26_HP77_VI_C	plate_1	B10	AGGGTAGCCACCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGCCACC	ACAGTG	P26	patient	42	F	UC_F	174	66	21.8	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	20	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	no	none	no	none	UC_Finish	IFX_Finish	UC_IFX_Finish	Finish	Finish	Finish.38	Finish.38	visit_7	visit_7	week_38	week_38	38	29/10/2019	IV	5	no	none	no	none	yes	Budesonid	no	none	2.8	low	6.8	313	51.81	135	1162	significantly_increased	19.1	negative	UC		7	7	7	active	moderate	no_response	no_response	NoRe	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	residual_manifestations	UC_IFX	UC_IFX_SeS	UC_IFX_no	UC_IFX_none	UC_IFX_BT_C	UC_C	UC_no	UC_C_no	UC_SeS	UC_SeS_no	UC_none	UC_none	UC_BT_C	UC_visit_7	UC_visit_7	UC_IFX_visit_7	UC_IFX_visit_7	UC_IFX_no_no	P26_visit_7_no	P26_visit_7_no	P26_visit_7_C_no	P26_visit_7_C_no	P26_visit_7_none	P26_visit_7_none	P26_visit_7_none	P26_visit_7_none	UC_NoRe	UC_IFX_NoRe	UC_no_NoRe	UC_C_no_NoRe	UC_SeS_no_NoRe
IS_P26_HP77_VI_D	IS_P26_HP77_VI_D	plate_1	C10	AGGGTAACAGCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AACAGCC	ACAGTG	P26	patient	42	F	UC_F	174	66	21.8	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	20	22	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E3	no	none	no	none	UC_Finish	IFX_Finish	UC_IFX_Finish	Finish	Finish	Finish.38	Finish.38	visit_7	visit_7	week_38	week_38	38	29/10/2019	IV	5	no	none	no	none	yes	Budesonid	no	none	2.8	low	6.8	313	51.81	135	1162	significantly_increased	19.1	negative	UC		7	7	7	active	moderate	no_response	no_response	NoRe	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	residual_manifestations	UC_IFX	UC_IFX_SeT	UC_IFX_no	UC_IFX_none	UC_IFX_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_7	UC_visit_7	UC_IFX_visit_7	UC_IFX_visit_7	UC_IFX_no_no	P26_visit_7_no	P26_visit_7_no	P26_visit_7_D_no	P26_visit_7_D_no	P26_visit_7_none	P26_visit_7_none	P26_visit_7_none	P26_visit_7_none	UC_NoRe	UC_IFX_NoRe	UC_no_NoRe	UC_D_no_NoRe	UC_SeT_no_NoRe
IS_P27_RJ99_I_D	IS_P27_RJ99_I_D	plate_1	D10	AGGGTACGGCCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACGGCCC	ACAGTG	P27	patient	19	M	CD_M	184	75	22.15	normal	non-smoker	CD_non-smoker	CD	ADA	Hulio	6	13	no	none	conventiol_therapy_ineffectiveness	no	none	A1	B3	L3	L4	CD	no	none	no	none	CD_Start	ADA_Start	CD_ADA_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	20/02/2019	SC	160	yes	Pentasa	yes	AZA	yes	Budesonid	no	none	3.4	low	5.2	263	49.01	152	247	significantly_increased	0	negative	3	3	CD		3	inactive	remission	baseline	baseline	Base	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_1	CD_visit_1	CD_ADA_visit_1	CD_ADA_visit_1	CD_ADA_no_yes	P27_visit_1_no	P27_visit_1_no	P27_visit_1_D_no	P27_visit_1_D_no	P27_visit_1_none	P27_visit_1_none	P27_visit_1_none	P27_visit_1_none	CD_Base	CD_ADA_Base	CD_no_Base	CD_D_no_Base	CD_SeT_no_Base
IS_P27_RJ99_II_D	IS_P27_RJ99_II_D	plate_1	E10	AGGGTACTGGCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACTGGCC	ACAGTG	P27	patient	19	M	CD_M	184	75	22.15	normal	non-smoker	CD_non-smoker	CD	ADA	Hulio	6	13	no	none	conventiol_therapy_ineffectiveness	no	none	A1	B3	L3	L4	CD	no	none	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	06/03/2019	SC	80	yes	Pentasa	yes	AZA	yes	Budesonid	no	none	0.5	low	4	285	43.47	162	36	normal	20	negative	2	2	CD		2	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_2	CD_visit_2	CD_ADA_visit_2	CD_ADA_visit_2	CD_ADA_no_yes	P27_visit_2_no	P27_visit_2_no	P27_visit_2_D_no	P27_visit_2_D_no	P27_visit_2_none	P27_visit_2_none	P27_visit_2_none	P27_visit_2_none	CD_Part	CD_ADA_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
IS_P27_RJ99_III_D	IS_P27_RJ99_III_D	plate_1	F10	AGGGTAAGGACCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AAGGACC	ACAGTG	P27	patient	19	M	CD_M	184	76	22.45	normal	non-smoker	CD_non-smoker	CD	ADA	Hulio	6	13	no	none	conventiol_therapy_ineffectiveness	no	none	A1	B3	L3	L4	CD	no	none	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	17/04/2019	SC	40	yes	Pentasa	yes	AZA	yes	Budesonid	no	none	0.3	low	3.7	285	53.04	165	24	normal	20	negative	2	2	CD		2	inactive	remission	response	full_response	Full	D	SeT	yes	D	SAE_D	SAE.ADA_D	SAE.ADA_SeT	D	SeT	none	none	none	D	none	none	none	none	eczema	none	none	"eczema_behind_ears,_face_and_neck_lokalisation_D"	CD_ADA	CD_ADA_SeT	CD_ADA_yes	CD_ADA_SeT	CD_ADA_SAE_D	CD_D	CD_yes	CD_D_yes	CD_SeT	CD_SeT_yes	CD_D	CD_SeT	CD_SAE_D	CD_visit_3	CD_visit_3	CD_ADA_visit_3	CD_ADA_visit_3	CD_ADA_yes_yes	P27_visit_3_yes	P27_visit_3_yes	P27_visit_3_D_yes	P27_visit_3_D_yes	P27_visit_3_D	P27_visit_3_D	P27_visit_3_SeT	P27_visit_3_SeT	CD_Full	CD_ADA_Full	CD_yes_Full	CD_D_yes_Full	CD_SeT_yes_Full
IS_P27_RJ99_IV_D	IS_P27_RJ99_IV_D	plate_1	G10	AGGGTACGCTCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACGCTCC	ACAGTG	P27	patient	19	M	CD_M	184	79	23.33	normal	non-smoker	CD_non-smoker	CD	ADA	Hulio	6	13	no	none	conventiol_therapy_ineffectiveness	no	none	A1	B3	L3	L4	CD	no	none	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	29/05/2019	SC	40	no	none	yes	AZA	yes	Budesonid	no	none	0.4	low	3.8	262	48.68	160	13	normal	20	negative	1	1	CD		1	inactive	remission	response	full_response	Full	D	SeT	yes	D	SAE_D	SAE.ADA_D	SAE.ADA_SeT	D	SeT	none	none	none	D	none	none	none	none	eczema	none	none	"eczema_behind_ears,_face_and_neck_lokalisation_D"	CD_ADA	CD_ADA_SeT	CD_ADA_yes	CD_ADA_SeT	CD_ADA_SAE_D	CD_D	CD_yes	CD_D_yes	CD_SeT	CD_SeT_yes	CD_D	CD_SeT	CD_SAE_D	CD_visit_4	CD_visit_4	CD_ADA_visit_4	CD_ADA_visit_4	CD_ADA_yes_yes	P27_visit_4_yes	P27_visit_4_yes	P27_visit_4_D_yes	P27_visit_4_D_yes	P27_visit_4_D	P27_visit_4_D	P27_visit_4_SeT	P27_visit_4_SeT	CD_Full	CD_ADA_Full	CD_yes_Full	CD_D_yes_Full	CD_SeT_yes_Full
IS_P27_RJ99_V_D	IS_P27_RJ99_V_D	plate_1	H10	AGGGTAGCGCCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGCGCCC	ACAGTG	P27	patient	19	M	CD_M	184	79	23.33	normal	non-smoker	CD_non-smoker	CD	ADA	Hulio	6	13	no	none	conventiol_therapy_ineffectiveness	no	none	A1	B3	L3	L4	CD	no	none	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_22	week_22	22	10/07/2019	SC	40	no	none	yes	AZA	yes	Budesonid	no	none	0.3	low	3.9	277	50.02	167	8	normal	20	negative	0	0	CD		0	inactive	remission	response	full_response	Full	D	SeT	yes	D	SAE_D	SAE.ADA_D	SAE.ADA_SeT	D	SeT	none	none	none	D	none	none	none	none	eczema	none	none	"eczema_behind_ears,_face_and_neck_lokalisation_D"	CD_ADA	CD_ADA_SeT	CD_ADA_yes	CD_ADA_SeT	CD_ADA_SAE_D	CD_D	CD_yes	CD_D_yes	CD_SeT	CD_SeT_yes	CD_D	CD_SeT	CD_SAE_D	CD_visit_5	CD_visit_5	CD_ADA_visit_5	CD_ADA_visit_5	CD_ADA_yes_yes	P27_visit_5_yes	P27_visit_5_yes	P27_visit_5_D_yes	P27_visit_5_D_yes	P27_visit_5_D	P27_visit_5_D	P27_visit_5_SeT	P27_visit_5_SeT	CD_Full	CD_ADA_Full	CD_yes_Full	CD_D_yes_Full	CD_SeT_yes_Full
IS_P27_RJ99_VI_D	IS_P27_RJ99_VI_D	plate_1	A11	AGGGTAATTAGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AATTAGC	ACAGTG	P27	patient	19	M	CD_M	184	79	23.33	normal	non-smoker	CD_non-smoker	CD	ADA	Hulio	6	13	no	none	conventiol_therapy_ineffectiveness	no	none	A1	B3	L3	L4	CD	no	none	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_6	visit_6	week_26	week_26	26	20/08/2019	SC	40	no	none	yes	AZA	no	none	no	none	0.4	low	3	272	62.6	170	4	normal	20	negative	0	0	CD		0	inactive	remission	response	full_response	Full	D	SeT	yes	D	SAE_D	SAE.ADA_D	SAE.ADA_SeT	D	SeT	none	none	none	D	none	none	none	none	eczema	none	none	"eczema_behind_ears,_face_and_neck_lokalisation_D"	CD_ADA	CD_ADA_SeT	CD_ADA_yes	CD_ADA_SeT	CD_ADA_SAE_D	CD_D	CD_yes	CD_D_yes	CD_SeT	CD_SeT_yes	CD_D	CD_SeT	CD_SAE_D	CD_visit_6	CD_visit_6	CD_ADA_visit_6	CD_ADA_visit_6	CD_ADA_yes_yes	P27_visit_6_yes	P27_visit_6_yes	P27_visit_6_D_yes	P27_visit_6_D_yes	P27_visit_6_D	P27_visit_6_D	P27_visit_6_SeT	P27_visit_6_SeT	CD_Full	CD_ADA_Full	CD_yes_Full	CD_D_yes_Full	CD_SeT_yes_Full
IS_P27_RJ99_VII_D	IS_P27_RJ99_VII_D	plate_1	B11	AGGGTATCCTCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ATCCTCC	ACAGTG	P27	patient	19	M	CD_M	184	84	24.81	normal	non-smoker	CD_non-smoker	CD	ADA	Hulio	6	13	no	none	conventiol_therapy_ineffectiveness	no	none	A1	B3	L3	L4	CD	no	none	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_7	visit_7	week_32	week_32	32	30/09/2019	SC	40	no	none	no	none	no	none	no	none	0.9	low	4	284	39.13	166	8	normal	20	negative	0	0	CD		0	inactive	remission	response	full_response	Full	D	SeT	yes	D	SAE_D	SAE.ADA_D	SAE.ADA_SeT	D	SeT	none	none	none	D	none	none	none	none	eczema	none	none	"eczema_behind_ears,_face_and_neck_lokalisation_D"	CD_ADA	CD_ADA_SeT	CD_ADA_yes	CD_ADA_SeT	CD_ADA_SAE_D	CD_D	CD_yes	CD_D_yes	CD_SeT	CD_SeT_yes	CD_D	CD_SeT	CD_SAE_D	CD_visit_7	CD_visit_7	CD_ADA_visit_7	CD_ADA_visit_7	CD_ADA_yes_no	P27_visit_7_yes	P27_visit_7_yes	P27_visit_7_D_yes	P27_visit_7_D_yes	P27_visit_7_D	P27_visit_7_D	P27_visit_7_SeT	P27_visit_7_SeT	CD_Full	CD_ADA_Full	CD_yes_Full	CD_D_yes_Full	CD_SeT_yes_Full
IS_P27_RJ99_VIII_D	IS_P27_RJ99_VIII_D	plate_1	C11	AGGGTAACCCGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AACCCGC	ACAGTG	P27	patient	19	M	CD_M	184	84	24.81	normal	non-smoker	CD_non-smoker	CD	ADA	Hulio	6	13	no	none	conventiol_therapy_ineffectiveness	no	none	A1	B3	L3	L4	CD	no	none	no	none	CD_Finish	ADA_Finish	CD_ADA_Finish	Finish	Finish	Finish.38	Finish.38	visit_8	visit_8	week_38	week_38	38	12/11/2019	SC	40	no	none	no	none	no	none	no	none	0.5	low	3.9	284	57.48	165	7	normal	19.5	negative	0	0	CD		0	inactive	remission	response	full_response	Full	D	SeT	yes	D	SAE_D	SAE.ADA_D	SAE.ADA_SeT	D	SeT	none	none	none	D	none	none	none	none	eczema	none	none	"eczema_behind_ears,_face_and_neck_lokalisation_D"	CD_ADA	CD_ADA_SeT	CD_ADA_yes	CD_ADA_SeT	CD_ADA_SAE_D	CD_D	CD_yes	CD_D_yes	CD_SeT	CD_SeT_yes	CD_D	CD_SeT	CD_SAE_D	CD_visit_8	CD_visit_8	CD_ADA_visit_8	CD_ADA_visit_8	CD_ADA_yes_no	P27_visit_8_yes	P27_visit_8_yes	P27_visit_8_D_yes	P27_visit_8_D_yes	P27_visit_8_D	P27_visit_8_D	P27_visit_8_SeT	P27_visit_8_SeT	CD_Full	CD_ADA_Full	CD_yes_Full	CD_D_yes_Full	CD_SeT_yes_Full
IS_P33_SP78_I_D	IS_P33_SP78_I_D	plate_1	D11	AGGGTATCCCTCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ATCCCTC	ACAGTG	P33	patient	40	F	CD_F	165	96	35.26	obesity	non-smoker	CD_non-smoker	CD	IFX	Remsima	6	34	no	none	lumil_impairment	no	none	A3	B1	L2	non-L4	CD	no	none	no	none	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_extra	visit_extra	week_X	week_X		11/03/2019	IV	5	no	none	no	none	no	none	no	none	8.3	low	8.1	296	29.55	125	24	normal	18.1	negative	2	2	CD		2	inactive	remission	response	full_response	Full	D	SeT	yes	D	SAE_D	SAE.IFX_D	SAE.IFX_SeT	D	SeT	none	none	none	D	none	none	none	none	alopecia_areata	il	il_deformation	none	CD_IFX	CD_IFX_SeT	CD_IFX_yes	CD_IFX_SeT	CD_IFX_SAE_D	CD_D	CD_yes	CD_D_yes	CD_SeT	CD_SeT_yes	CD_D	CD_SeT	CD_SAE_D	CD_visit_extra	CD_visit_extra	CD_IFX_visit_extra	CD_IFX_visit_extra	CD_IFX_yes_no	P33_visit_extra_yes	P33_visit_extra_yes	P33_visit_extra_D_yes	P33_visit_extra_D_yes	P33_visit_extra_D	P33_visit_extra_D	P33_visit_extra_SeT	P33_visit_extra_SeT	CD_Full	CD_IFX_Full	CD_yes_Full	CD_D_yes_Full	CD_SeT_yes_Full
IS_P58_NJ84_II_D	IS_P58_NJ84_II_D	plate_1	E11	AGGGTACTCGCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACTCGCC	ACAGTG	P58	patient	34	M	CD_M	180	80	24.69	normal	non-smoker	CD_non-smoker	CD	ADA	Humira	5	29	no	none	lumil_impairment	no	none	A2	B3	L1	L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_extra	visit_extra	week_X	week_X		15/06/2019	SC	40	no	none	no	none	no	none	yes	Vigantol	2.8	low	10	205	106.47	157	12	normal	12.2	negative	1	1	CD		1	inactive	remission	response	full_response	Full	D	SeT	yes	D	SAE_D	SAE.ADA_D	SAE.ADA_SeT	D	SeT	none	none	none	D	none	none	none	none	alopecia_areata	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_yes	CD_ADA_SeT	CD_ADA_SAE_D	CD_D	CD_yes	CD_D_yes	CD_SeT	CD_SeT_yes	CD_D	CD_SeT	CD_SAE_D	CD_visit_extra	CD_visit_extra	CD_ADA_visit_extra	CD_ADA_visit_extra	CD_ADA_yes_no	P58_visit_extra_yes	P58_visit_extra_yes	P58_visit_extra_D_yes	P58_visit_extra_D_yes	P58_visit_extra_D	P58_visit_extra_D	P58_visit_extra_SeT	P58_visit_extra_SeT	CD_Full	CD_ADA_Full	CD_yes_Full	CD_D_yes_Full	CD_SeT_yes_Full
IS_P60_KM88_I_D	IS_P60_KM88_I_D	plate_1	F11	AGGGTAGGCCTCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGGCCTC	ACAGTG	P60	patient	30	M	CD_M	179	75	23.41	normal	non-smoker	CD_non-smoker	CD	IFX	Remsima	14	16	no	none	perial_and_termil_ileum_infliction	yes	ADA	A1	B3	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_extra	visit_extra	week_X	week_X		20/09/2019	IV	5	no	none	no	none	no	none	no	none	5.6	low	6.3	303	46.98	155	462	significantly_increased	2.6	negative	2	2	CD		2	inactive	remission	response	partial_response	Part	D	SeT	yes	D	SAE_D	SAE.IFX_D	SAE.IFX_SeT	D	SeT	none	none	none	D	none	none	none	none	eczema	none	yes	none	CD_IFX	CD_IFX_SeT	CD_IFX_yes	CD_IFX_SeT	CD_IFX_SAE_D	CD_D	CD_yes	CD_D_yes	CD_SeT	CD_SeT_yes	CD_D	CD_SeT	CD_SAE_D	CD_visit_extra	CD_visit_extra	CD_IFX_visit_extra	CD_IFX_visit_extra	CD_IFX_yes_no	P60_visit_extra_yes	P60_visit_extra_yes	P60_visit_extra_D_yes	P60_visit_extra_D_yes	P60_visit_extra_D	P60_visit_extra_D	P60_visit_extra_SeT	P60_visit_extra_SeT	CD_Part	CD_IFX_Part	CD_yes_Part	CD_D_yes_Part	CD_SeT_yes_Part
IS_P60_KM88_I_O	IS_P60_KM88_I_O	plate_1	G11	AGGGTACCCAGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACCCAGC	ACAGTG	P60	patient	30	M	CD_M	179	75	23.41	normal	non-smoker	CD_non-smoker	CD	IFX	Remsima	14	16	no	none	perial_and_termil_ileum_infliction	yes	ADA	A1	B3	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_extra	visit_extra	week_X	week_X		20/09/2019	IV	5	no	none	no	none	no	none	no	none	5.6	low	6.3	303	46.98	155	462	significantly_increased	2.6	negative	2	2	CD		2	inactive	remission	response	partial_response	Part	O	Dr	yes	O	SAE_O	SAE.IFX_O	SAE.IFX_Dr	O	Dr	none	none	none	none	none	none	O	none	eczema	none	yes	skin_under_eye	CD_IFX	CD_IFX_Dr	CD_IFX_yes	CD_IFX_Dr	CD_IFX_SAE_O	CD_O	CD_yes	CD_O_yes	CD_Dr	CD_Dr_yes	CD_O	CD_Dr	CD_SAE_O	CD_visit_extra	CD_visit_extra	CD_IFX_visit_extra	CD_IFX_visit_extra	CD_IFX_yes_no	P60_visit_extra_yes	P60_visit_extra_yes	P60_visit_extra_O_yes	P60_visit_extra_O_yes	P60_visit_extra_O	P60_visit_extra_O	P60_visit_extra_Dr	P60_visit_extra_Dr	CD_Part	CD_IFX_Part	CD_yes_Part	CD_O_yes_Part	CD_Dr_yes_Part
IS_P60_KM88_I_P	IS_P60_KM88_I_P	plate_1	H11	AGGGTAAAGAGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AAAGAGC	ACAGTG	P60	patient	30	M	CD_M	179	75	23.41	normal	non-smoker	CD_non-smoker	CD	IFX	Remsima	14	16	no	none	perial_and_termil_ileum_infliction	yes	ADA	A1	B3	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_extra	visit_extra	week_X	week_X		20/09/2019	IV	5	no	none	no	none	no	none	no	none	5.6	low	6.3	303	46.98	155	462	significantly_increased	2.6	negative	2	2	CD		2	inactive	remission	response	partial_response	Part	P	Mo	yes	P	SAE_P	SAE.IFX_P	SAE.IFX_Mo	P	Mo	none	none	none	none	none	none	none	P	eczema	none	yes	foreskin	CD_IFX	CD_IFX_Mo	CD_IFX_yes	CD_IFX_Mo	CD_IFX_SAE_P	CD_P	CD_yes	CD_P_yes	CD_Mo	CD_Mo_yes	CD_P	CD_Mo	CD_SAE_P	CD_visit_extra	CD_visit_extra	CD_IFX_visit_extra	CD_IFX_visit_extra	CD_IFX_yes_no	P60_visit_extra_yes	P60_visit_extra_yes	P60_visit_extra_P_yes	P60_visit_extra_P_yes	P60_visit_extra_P	P60_visit_extra_P	P60_visit_extra_Mo	P60_visit_extra_Mo	CD_Part	CD_IFX_Part	CD_yes_Part	CD_P_yes_Part	CD_Mo_yes_Part
IS_P64_SZ86_I_A	IS_P64_SZ86_I_A	plate_1	A12	AGGGTACGGCTCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACGGCTC	ACAGTG	P64	patient	32	F	CD_F	167	95	34.06	obesity	smoker	CD_smoker	CD	ADA	Humira	5	27	no	none	allergic_reaction_to_IFX	yes	IFX	A2	B3	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_extra	visit_extra	week_X	week_X		26/09/2019	SC	40	no	none	no	none	no	none	yes	"Warfarin,_Cipralex,_Letrox,_Nebivolol"	1.3	low	7.6	338	12.78	136			18.9	negative	10	10	CD		10	active	moderate	response	partial_response	Part	A	Dr	yes	"A,D,E,C"	SAE_A	SAE.ADA_A	SAE.ADA_Dr	A	Dr	A	none	none	none	none	none	none	none	none	none	none	"peeling_skin_(behind_the_ears,_elbows,_groin)"	CD_ADA	CD_ADA_Dr	CD_ADA_yes	CD_ADA_Dr	CD_ADA_SAE_A	CD_A	CD_yes	CD_A_yes	CD_Dr	CD_Dr_yes	CD_A	CD_Dr	CD_SAE_A	CD_visit_extra	CD_visit_extra	CD_ADA_visit_extra	CD_ADA_visit_extra	CD_ADA_yes_no	P64_visit_extra_yes	P64_visit_extra_yes	P64_visit_extra_A_yes	P64_visit_extra_A_yes	P64_visit_extra_A	P64_visit_extra_A	P64_visit_extra_Dr	P64_visit_extra_Dr	CD_Part	CD_ADA_Part	CD_yes_Part	CD_A_yes_Part	CD_Dr_yes_Part
IS_P64_SZ86_I_D	IS_P64_SZ86_I_D	plate_1	B12	AGGGTACGACATA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACGACAT	ACAGTG	P64	patient	32	F	CD_F	167	95	34.06	obesity	smoker	CD_smoker	CD	ADA	Humira	5	27	no	none	allergic_reaction_to_IFX	yes	IFX	A2	B3	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_extra	visit_extra	week_X	week_X		26/09/2019	SC	40	no	none	no	none	no	none	yes	"Warfarin,_Cipralex,_Letrox,_Nebivolol"	1.3	low	7.6	338	12.78	136			18.9	negative	10	10	CD		10	active	moderate	response	partial_response	Part	D	SeT	yes	"A,D,E,C"	SAE_D	SAE.ADA_D	SAE.ADA_SeT	D	SeT	none	none	none	D	none	none	none	none	none	none	none	"peeling_skin_(behind_the_ears,_elbows,_groin)"	CD_ADA	CD_ADA_SeT	CD_ADA_yes	CD_ADA_SeT	CD_ADA_SAE_D	CD_D	CD_yes	CD_D_yes	CD_SeT	CD_SeT_yes	CD_D	CD_SeT	CD_SAE_D	CD_visit_extra	CD_visit_extra	CD_ADA_visit_extra	CD_ADA_visit_extra	CD_ADA_yes_no	P64_visit_extra_yes	P64_visit_extra_yes	P64_visit_extra_D_yes	P64_visit_extra_D_yes	P64_visit_extra_D	P64_visit_extra_D	P64_visit_extra_SeT	P64_visit_extra_SeT	CD_Part	CD_ADA_Part	CD_yes_Part	CD_D_yes_Part	CD_SeT_yes_Part
IS_P64_SZ86_I_E	IS_P64_SZ86_I_E	plate_1	C12	AGGGTATCCCGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ATCCCGC	ACAGTG	P64	patient	32	F	CD_F	167	95	34.06	obesity	smoker	CD_smoker	CD	ADA	Humira	5	27	no	none	allergic_reaction_to_IFX	yes	IFX	A2	B3	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_extra	visit_extra	week_X	week_X		26/09/2019	SC	40	no	none	no	none	no	none	yes	"Warfarin,_Cipralex,_Letrox,_Nebivolol"	1.3	low	7.6	338	12.78	136			18.9	negative	10	10	CD		10	active	moderate	response	partial_response	Part	E	Mo	yes	"A,D,E,C"	SAE_E	SAE.ADA_E	SAE.ADA_Mo	E	Mo	none	none	none	none	E	none	none	none	none	none	none	"peeling_skin_(behind_the_ears,_elbows,_groin)"	CD_ADA	CD_ADA_Mo	CD_ADA_yes	CD_ADA_Mo	CD_ADA_SAE_E	CD_E	CD_yes	CD_E_yes	CD_Mo	CD_Mo_yes	CD_E	CD_Mo	CD_SAE_E	CD_visit_extra	CD_visit_extra	CD_ADA_visit_extra	CD_ADA_visit_extra	CD_ADA_yes_no	P64_visit_extra_yes	P64_visit_extra_yes	P64_visit_extra_E_yes	P64_visit_extra_E_yes	P64_visit_extra_E	P64_visit_extra_E	P64_visit_extra_Mo	P64_visit_extra_Mo	CD_Part	CD_ADA_Part	CD_yes_Part	CD_E_yes_Part	CD_Mo_yes_Part
IS_P68_SA82_I_C	IS_P68_SA82_I_C	plate_1	D12	AGGGTAGTGCGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGTGCGC	ACAGTG	P64	patient	32	F	CD_F	167	95	34.06	obesity	smoker	CD_smoker	CD	ADA	Humira	5	27	no	none	allergic_reaction_to_IFX	yes	IFX	A2	B3	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_extra	visit_extra	week_X	week_X		26/09/2019	SC	40	no	none	no	none	no	none	yes	"Warfarin,_Cipralex,_Letrox,_Nebivolol"	1.3	low	7.6	338	12.78	136			18.9	negative	10	10	CD		10	active	moderate	response	partial_response	Part	C	SeS	yes	"A,D,E,C"	SAE_C	SAE.ADA_C	SAE.ADA_SeS	C	SeS	none	none	C	none	none	none	none	none	none	none	none	"peeling_skin_(behind_the_ears,_elbows,_groin)"	CD_ADA	CD_ADA_SeS	CD_ADA_yes	CD_ADA_SeS	CD_ADA_SAE_C	CD_C	CD_yes	CD_C_yes	CD_SeS	CD_SeS_yes	CD_C	CD_SeS	CD_SAE_C	CD_visit_extra	CD_visit_extra	CD_ADA_visit_extra	CD_ADA_visit_extra	CD_ADA_yes_no	P64_visit_extra_yes	P64_visit_extra_yes	P64_visit_extra_C_yes	P64_visit_extra_C_yes	P64_visit_extra_C	P64_visit_extra_C	P64_visit_extra_SeS	P64_visit_extra_SeS	CD_Part	CD_ADA_Part	CD_yes_Part	CD_C_yes_Part	CD_SeS_yes_Part
mockB_dna_I	mockB_dna_I	plate_1	E12	AGGGTAGACTCTA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGACTCT	ACAGTG	CTRL																																																																																																																CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_					
mockB_dna_II	mockB_dna_II	plate_1	F12	AGGGTAGGGGTTA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGGGGTT	ACAGTG	CTRL																																																																																																																CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_					
PCR_neg_16S_B1	PCR_neg_16S_B1	plate_1	G12	AGGGTACTAGGGA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACTAGGG	ACAGTG	CTRL																																																																																																																CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_					
KITOM_P_Biofilm	KITOM_P_Biofilm	plate_1	H12	AGGGTATAGCCGA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ATAGCCG	ACAGTG	CTRL																																																																																																																CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_					
P53_CZ78_I_A	IS_P53_CZ78_I_A	plate_2	A1	AAAGCACCTTCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACCTTCC	GCCAAT	P53	patient	41	F	CD_F	160	76	29.69	overweight	smoker	CD_smoker	CD	IFX	Remsima	2	39	no	none	perial_disease	no	none	A2	B3	L1	non-L4	CD	no	none	yes	fistula_draige	CD_Start	IFX_Start	CD_IFX_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	28/08/2019	IV	5	no	none	no	none	yes	Budesonid	yes	Omeprazol	2.4	low	13.3	243	10.15	136	117	slightly_increased	0	negative	3	3	CD		3	inactive	remission	baseline	baseline	Base	A	Dr	no	none	BT_A	IFX_A	IFX_Dr	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_Dr	CD_IFX_no	CD_IFX_none	CD_IFX_BT_A	CD_A	CD_no	CD_A_no	CD_Dr	CD_Dr_no	CD_none	CD_none	CD_BT_A	CD_visit_1	CD_visit_1	CD_IFX_visit_1	CD_IFX_visit_1	CD_IFX_no_no	P53_visit_1_no	P53_visit_1_no	P53_visit_1_A_no	P53_visit_1_A_no	P53_visit_1_none	P53_visit_1_none	P53_visit_1_none	P53_visit_1_none	CD_Base	CD_IFX_Base	CD_no_Base	CD_A_no_Base	CD_Dr_no_Base
P53_CZ78_I_D	IS_P53_CZ78_I_D	plate_2	B1	AAAGCAGCCACCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGCCACC	GCCAAT	P53	patient	41	F	CD_F	160	76	29.69	overweight	smoker	CD_smoker	CD	IFX	Remsima	2	39	no	none	perial_disease	no	none	A2	B3	L1	non-L4	CD	no	none	yes	fistula_draige	CD_Start	IFX_Start	CD_IFX_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	28/08/2019	IV	5	no	none	no	none	yes	Budesonid	yes	Omeprazol	2.4	low	13.3	243	10.15	136	117	slightly_increased	0	negative	3	3	CD		3	inactive	remission	baseline	baseline	Base	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_1	CD_visit_1	CD_IFX_visit_1	CD_IFX_visit_1	CD_IFX_no_no	P53_visit_1_no	P53_visit_1_no	P53_visit_1_D_no	P53_visit_1_D_no	P53_visit_1_none	P53_visit_1_none	P53_visit_1_none	P53_visit_1_none	CD_Base	CD_IFX_Base	CD_no_Base	CD_D_no_Base	CD_SeT_no_Base
P53_CZ78_II_A	IS_P53_CZ78_II_A	plate_2	C1	AAAGCAACAGCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AACAGCC	GCCAAT	P53	patient	41	F	CD_F	160	75	29.3	overweight	smoker	CD_smoker	CD	IFX	Remsima	2	39	no	none	perial_disease	no	none	A2	B3	L1	non-L4	CD	no	none	yes	fistula_draige	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	11/09/2019	IV	5	no	none	no	none	yes	Budesonid	yes	Omeprazol	5.8	low	8.3	216	11.89	134	122	slightly_increased	19.7	positive	3	3	CD		3	inactive	remission	response	partial_response	Part	A	Dr	no	none	BT_A	IFX_A	IFX_Dr	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_Dr	CD_IFX_no	CD_IFX_none	CD_IFX_BT_A	CD_A	CD_no	CD_A_no	CD_Dr	CD_Dr_no	CD_none	CD_none	CD_BT_A	CD_visit_2	CD_visit_2	CD_IFX_visit_2	CD_IFX_visit_2	CD_IFX_no_no	P53_visit_2_no	P53_visit_2_no	P53_visit_2_A_no	P53_visit_2_A_no	P53_visit_2_none	P53_visit_2_none	P53_visit_2_none	P53_visit_2_none	CD_Part	CD_IFX_Part	CD_no_Part	CD_A_no_Part	CD_Dr_no_Part
P53_CZ78_II_D	IS_P53_CZ78_II_D	plate_2	D1	AAAGCACGGCCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACGGCCC	GCCAAT	P53	patient	41	F	CD_F	160	75	29.3	overweight	smoker	CD_smoker	CD	IFX	Remsima	2	39	no	none	perial_disease	no	none	A2	B3	L1	non-L4	CD	no	none	yes	fistula_draige	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	11/09/2019	IV	5	no	none	no	none	yes	Budesonid	yes	Omeprazol	5.8	low	8.3	216	11.89	134	122	slightly_increased	19.7	positive	3	3	CD		3	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_2	CD_visit_2	CD_IFX_visit_2	CD_IFX_visit_2	CD_IFX_no_no	P53_visit_2_no	P53_visit_2_no	P53_visit_2_D_no	P53_visit_2_D_no	P53_visit_2_none	P53_visit_2_none	P53_visit_2_none	P53_visit_2_none	CD_Part	CD_IFX_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P53_CZ78_III_A	IS_P53_CZ78_III_A	plate_2	E1	AAAGCACTGGCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACTGGCC	GCCAAT	P53	patient	41	F	CD_F	160	75	29.3	overweight	smoker	CD_smoker	CD	IFX	Remsima	2	39	no	none	perial_disease	no	none	A2	B3	L1	non-L4	CD	no	none	yes	fistula_draige	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_6	week_6	6	08/10/2019	IV	5	no	none	no	none	yes	Budesonid	yes	Omeprazol_Caltrate	3	low	10.7	255	7.3	130	81	slightly_increased	2.9	positive	7	7	CD		7	inactive	mild	no_response	no_response	NoRe	A	Dr	no	none	BT_A	IFX_A	IFX_Dr	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_Dr	CD_IFX_no	CD_IFX_none	CD_IFX_BT_A	CD_A	CD_no	CD_A_no	CD_Dr	CD_Dr_no	CD_none	CD_none	CD_BT_A	CD_visit_3	CD_visit_3	CD_IFX_visit_3	CD_IFX_visit_3	CD_IFX_no_no	P53_visit_3_no	P53_visit_3_no	P53_visit_3_A_no	P53_visit_3_A_no	P53_visit_3_none	P53_visit_3_none	P53_visit_3_none	P53_visit_3_none	CD_NoRe	CD_IFX_NoRe	CD_no_NoRe	CD_A_no_NoRe	CD_Dr_no_NoRe
P53_CZ78_III_D	IS_P53_CZ78_III_D	plate_2	F1	AAAGCAAGGACCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AAGGACC	GCCAAT	P53	patient	41	F	CD_F	160	75	29.3	overweight	smoker	CD_smoker	CD	IFX	Remsima	2	39	no	none	perial_disease	no	none	A2	B3	L1	non-L4	CD	no	none	yes	fistula_draige	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_6	week_6	6	08/10/2019	IV	5	no	none	no	none	yes	Budesonid	yes	Omeprazol_Caltrate	3	low	10.7	255	7.3	130	81	slightly_increased	2.9	positive	7	7	CD		7	inactive	mild	no_response	no_response	NoRe	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_3	CD_visit_3	CD_IFX_visit_3	CD_IFX_visit_3	CD_IFX_no_no	P53_visit_3_no	P53_visit_3_no	P53_visit_3_D_no	P53_visit_3_D_no	P53_visit_3_none	P53_visit_3_none	P53_visit_3_none	P53_visit_3_none	CD_NoRe	CD_IFX_NoRe	CD_no_NoRe	CD_D_no_NoRe	CD_SeT_no_NoRe
P53_CZ78_IV_A	IS_P53_CZ78_IV_A	plate_2	G1	AAAGCACGCTCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACGCTCC	GCCAAT	P53	patient	41	F	CD_F	160	75	29.3	overweight	smoker	CD_smoker	CD	IFX	Remsima	2	39	no	none	perial_disease	no	none	A2	B3	L1	non-L4	CD	no	none	yes	fistula_draige	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	04/12/2019	IV	5	no	none	no	none	no	none	yes	Omeprazol_Caltrate	1.3	low	10.2	241	9.45	132	177	slightly_increased	1.6	positive	6	6	CD		6	inactive	mild	response	partial_response	Part	A	Dr	yes	"A,D,F"	SAE_A	SAE.IFX_A	SAE.IFX_Dr	A	Dr	A	none	none	none	none	none	none	none	eczema	none	none	none	CD_IFX	CD_IFX_Dr	CD_IFX_yes	CD_IFX_Dr	CD_IFX_SAE_A	CD_A	CD_yes	CD_A_yes	CD_Dr	CD_Dr_yes	CD_A	CD_Dr	CD_SAE_A	CD_visit_4	CD_visit_4	CD_IFX_visit_4	CD_IFX_visit_4	CD_IFX_yes_no	P53_visit_4_yes	P53_visit_4_yes	P53_visit_4_A_yes	P53_visit_4_A_yes	P53_visit_4_A	P53_visit_4_A	P53_visit_4_Dr	P53_visit_4_Dr	CD_Part	CD_IFX_Part	CD_yes_Part	CD_A_yes_Part	CD_Dr_yes_Part
P53_CZ78_IV_D	IS_P53_CZ78_IV_D	plate_2	H1	AAAGCAGCGCCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGCGCCC	GCCAAT	P53	patient	41	F	CD_F	160	75	29.3	overweight	smoker	CD_smoker	CD	IFX	Remsima	2	39	no	none	perial_disease	no	none	A2	B3	L1	non-L4	CD	no	none	yes	fistula_draige	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	04/12/2019	IV	5	no	none	no	none	no	none	yes	Omeprazol_Caltrate	1.3	low	10.2	241	9.45	132	177	slightly_increased	1.6	positive	6	6	CD		6	inactive	mild	response	partial_response	Part	D	SeT	yes	"A,D,F"	SAE_D	SAE.IFX_D	SAE.IFX_SeD	D	SeT	none	none	none	D	none	none	none	none	eczema	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_yes	CD_IFX_SeT	CD_IFX_SAE_D	CD_D	CD_yes	CD_D_yes	CD_SeT	CD_SeT_yes	CD_D	CD_SeT	CD_SAE_D	CD_visit_4	CD_visit_4	CD_IFX_visit_4	CD_IFX_visit_4	CD_IFX_yes_no	P53_visit_4_yes	P53_visit_4_yes	P53_visit_4_D_yes	P53_visit_4_D_yes	P53_visit_4_D	P53_visit_4_D	P53_visit_4_SeT	P53_visit_4_SeT	CD_Part	CD_IFX_Part	CD_yes_Part	CD_D_yes_Part	CD_SeT_yes_Part
P53_CZ78_V_A	IS_P53_CZ78_V_A	plate_2	A2	AAAGCAATTAGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AATTAGC	GCCAAT	P53	patient	41	F	CD_F	160	75	29.3	overweight	smoker	CD_smoker	CD	IFX	Remsima	2	39	no	none	perial_disease	no	none	A2	B3	L1	non-L4	CD	no	none	yes	fistula_draige	CD_Finish	IFX_Finish	CD_IFX_Finish	Finish	Finish	Finish.22	Finish.22	visit_5	visit_5	week_22	week_22	22	20/02/2020	IV	5	no	none	no	none	no	none	yes	Omeprazol_Caltrate	5	low	8.9	242	10.41	131	82	slightly_increased	0.1	negative	4	4	CD		4	inactive	remission	response	partial_response	Part	A	Dr	yes	"A,D,F"	SAE_A	SAE.IFX_A	SAE.IFX_Dr	A	Dr	A	none	none	none	none	none	none	none	eczema	none	none	none	CD_IFX	CD_IFX_Dr	CD_IFX_yes	CD_IFX_Dr	CD_IFX_SAE_A	CD_A	CD_yes	CD_A_yes	CD_Dr	CD_Dr_yes	CD_A	CD_Dr	CD_SAE_A	CD_visit_5	CD_visit_5	CD_IFX_visit_5	CD_IFX_visit_5	CD_IFX_yes_no	P53_visit_5_yes	P53_visit_5_yes	P53_visit_5_A_yes	P53_visit_5_A_yes	P53_visit_5_A	P53_visit_5_A	P53_visit_5_Dr	P53_visit_5_Dr	CD_Part	CD_IFX_Part	CD_yes_Part	CD_A_yes_Part	CD_Dr_yes_Part
P53_CZ78_V_D	IS_P53_CZ78_V_D	plate_2	B2	AAAGCATCCTCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ATCCTCC	GCCAAT	P53	patient	41	F	CD_F	160	75	29.3	overweight	smoker	CD_smoker	CD	IFX	Remsima	2	39	no	none	perial_disease	no	none	A2	B3	L1	non-L4	CD	no	none	yes	fistula_draige	CD_Finish	IFX_Finish	CD_IFX_Finish	Finish	Finish	Finish.22	Finish.22	visit_5	visit_5	week_22	week_22	22	20/02/2020	IV	5	no	none	no	none	no	none	yes	Omeprazol_Caltrate	5	low	8.9	242	10.41	131	82	slightly_increased	0.1	negative	4	4	CD		4	inactive	remission	response	partial_response	Part	D	SeT	yes	"A,D,F"	SAE_D	SAE.IFX_D	SAE.IFX_SeT	D	SeT	none	none	none	D	none	none	none	none	eczema	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_yes	CD_IFX_SeT	CD_IFX_SAE_D	CD_D	CD_yes	CD_D_yes	CD_SeT	CD_SeT_yes	CD_D	CD_SeT	CD_SAE_D	CD_visit_5	CD_visit_5	CD_IFX_visit_5	CD_IFX_visit_5	CD_IFX_yes_no	P53_visit_5_yes	P53_visit_5_yes	P53_visit_5_D_yes	P53_visit_5_D_yes	P53_visit_5_D	P53_visit_5_D	P53_visit_5_SeT	P53_visit_5_SeT	CD_Part	CD_IFX_Part	CD_yes_Part	CD_D_yes_Part	CD_SeT_yes_Part
P53_CZ78_V_F	IS_P53_CZ78_V_F	plate_2	C2	AAAGCAACCCGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AACCCGC	GCCAAT	P53	patient	41	F	CD_F	160	75	29.3	overweight	smoker	CD_smoker	CD	IFX	Remsima	2	39	no	none	perial_disease	no	none	A2	B3	L1	non-L4	CD	no	none	yes	fistula_draige	CD_Finish	IFX_Finish	CD_IFX_Finish	Finish	Finish	Finish.22	Finish.22	visit_5	visit_5	week_22	week_22	22	20/02/2020	IV	5	no	none	no	none	no	none	yes	Omeprazol_Caltrate	5	low	8.9	242	10.41	131	82	slightly_increased	0.1	negative	4	4	CD		4	inactive	remission	response	partial_response	Part	F	Mo	yes	"A,D,F"	SAE_F	SAE.IFX_F	SAE.IFX_Mo	F	Mo	none	none	none	none	none	F	none	none	eczema	none	none	none	CD_IFX	CD_IFX_Mo	CD_IFX_yes	CD_IFX_Mo	CD_IFX_SAE_F	CD_F	CD_yes	CD_F_yes	CD_Mo	CD_Mo_yes	CD_F	CD_Mo	CD_SAE_F	CD_visit_5	CD_visit_5	CD_IFX_visit_5	CD_IFX_visit_5	CD_IFX_yes_no	P53_visit_5_yes	P53_visit_5_yes	P53_visit_5_F_yes	P53_visit_5_F_yes	P53_visit_5_F	P53_visit_5_F	P53_visit_5_Mo	P53_visit_5_Mo	CD_Part	CD_IFX_Part	CD_yes_Part	CD_F_yes_Part	CD_Mo_yes_Part
P76_RJ88_I_A	IS_P76_RJ88_I_A	plate_2	D2	AAAGCATCCCTCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ATCCCTC	GCCAAT	P76	patient	31	F	CD_F	176	68	21.95	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	9	22	no	none	switch_from_IFX_for_adverse_events	no	none	A2	B1	L1	non-L4	CD	no	none	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_extra	visit_extra	week_X	week_X		13/11/2019	SC	40	no	none	no	none	no	none	yes	Globifer	2.6	low	6.3	262	9.71	123	235	significantly_increased	6.1	negative	0	0	CD		0	inactive	remission	response	full_response	Full	A	Dr	yes	"A,E"	SAE_A	SAE.ADA_A	SAE.ADA_Dr	A	Dr	A	none	none	none	none	none	none	none	acneiform_exanthema	none	none	"new_redness_appeared_on_HK_and_DK,_without_papules,_slight_itching,_does_not_burn,_the_deposits_gradually_increase"	CD_ADA	CD_ADA_Dr	CD_ADA_yes	CD_ADA_Dr	CD_ADA_SAE_A	CD_A	CD_yes	CD_A_yes	CD_Dr	CD_Dr_yes	CD_A	CD_Dr	CD_SAE_A	CD_visit_extra	CD_visit_extra	CD_ADA_visit_extra	CD_ADA_visit_extra	CD_ADA_yes_no	P76_visit_extra_yes	P76_visit_extra_yes	P76_visit_extra_A_yes	P76_visit_extra_A_yes	P76_visit_extra_A	P76_visit_extra_A	P76_visit_extra_Dr	P76_visit_extra_Dr	CD_Full	CD_ADA_Full	CD_yes_Full	CD_A_yes_Full	CD_Dr_yes_Full
P76_RJ88_I_E	IS_P76_RJ88_I_E	plate_2	E2	AAAGCACTCGCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACTCGCC	GCCAAT	P76	patient	31	F	CD_F	176	68	21.95	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	9	22	no	none	switch_from_IFX_for_adverse_events	no	none	A2	B1	L1	non-L4	CD	no	none	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_extra	visit_extra	week_X	week_X		13/11/2019	SC	40	no	none	no	none	no	none	yes	Globifer	2.6	low	6.3	262	9.71	123	235	significantly_increased	6.1	negative	0	0	CD		0	inactive	remission	response	full_response	Full	E	Mo	yes	"A,E"	SAE_E	SAE.ADA_E	SAE.ADA_Mo	E	Mo	none	none	none	none	E	none	none	none	acneiform_exanthema	none	none	"new_redness_appeared_on_HK_and_DK,_without_papules,_slight_itching,_does_not_burn,_the_deposits_gradually_increase"	CD_ADA	CD_ADA_Mo	CD_ADA_yes	CD_ADA_Mo	CD_ADA_SAE_E	CD_E	CD_yes	CD_E_yes	CD_Mo	CD_Mo_yes	CD_E	CD_Mo	CD_SAE_E	CD_visit_extra	CD_visit_extra	CD_ADA_visit_extra	CD_ADA_visit_extra	CD_ADA_yes_no	P76_visit_extra_yes	P76_visit_extra_yes	P76_visit_extra_E_yes	P76_visit_extra_E_yes	P76_visit_extra_E	P76_visit_extra_E	P76_visit_extra_Mo	P76_visit_extra_Mo	CD_Full	CD_ADA_Full	CD_yes_Full	CD_E_yes_Full	CD_Mo_yes_Full
P84_MM84_I_A	IS_P84_MM84_I_A	plate_2	F2	AAAGCAGGCCTCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGGCCTC	GCCAAT	P84	patient	35	F	CD_F	160	75	29.29	overweight	smoker	CD_smoker	CD	IFX	Remsima	12	23	yes	mutation_FV_Leiden	parenteral_disability	no	none	A2	B1	L3	non-L4	CD	yes	joints;eye	no	none	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_extra	visit_extra	week_X	week_X		16/01/2020	IV	5	no	none	yes	none	no	none	yes	"před_infuzí_Dithiaden,_po_infuzi_Aerius"			2.1	274	24.91	146	30	normal	9.4	negative	2	2	CD		2	inactive	remission	response	full_response	Full	A	Dr	yes	"A,B"	SAE_A	SAE.IFX_A	SAE.IFX_Dr	A	Dr	A	none	none	none	none	none	none	none	paradoxical_psoriasis	none	none	"lession_on_PDK,_LHK,_belly,_elbow,_palms-paraxocical_psoriasis"	CD_IFX	CD_IFX_Dr	CD_IFX_yes	CD_IFX_Dr	CD_IFX_SAE_A	CD_A	CD_yes	CD_A_yes	CD_Dr	CD_Dr_yes	CD_A	CD_Dr	CD_SAE_A	CD_visit_extra	CD_visit_extra	CD_IFX_visit_extra	CD_IFX_visit_extra	CD_IFX_yes_yes	P84_visit_extra_yes	P84_visit_extra_yes	P84_visit_extra_A_yes	P84_visit_extra_A_yes	P84_visit_extra_A	P84_visit_extra_A	P84_visit_extra_Dr	P84_visit_extra_Dr	CD_Full	CD_IFX_Full	CD_yes_Full	CD_A_yes_Full	CD_Dr_yes_Full
P84_MM84_I_B	IS_P84_MM84_I_B	plate_2	G2	AAAGCACCCAGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACCCAGC	GCCAAT	P84	patient	35	F	CD_F	160	75	29.29	overweight	smoker	CD_smoker	CD	IFX	Remsima	12	23	yes	mutation_FV_Leiden	parenteral_disability	no	none	A2	B1	L3	non-L4	CD	yes	joints;eye	no	none	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_extra	visit_extra	week_X	week_X		16/01/2020	IV	5	no	none	yes	none	no	none	yes	"před_infuzí_Dithiaden,_po_infuzi_Aerius"			2.1	274	24.91	146	30	normal	9.4	negative	2	2	CD		2	inactive	remission	response	full_response	Full	B	Dr	yes	"A,B"	SAE_B	SAE.IFX_B	SAE.IFX_Dr	B	Dr	none	B	none	none	none	none	none	none	paradoxical_psoriasis	none	none	"lession_on_PDK,_LHK,_belly,_elbow,_palms-paraxocical_psoriasis"	CD_IFX	CD_IFX_Dr	CD_IFX_yes	CD_IFX_Dr	CD_IFX_SAE_B	CD_B	CD_yes	CD_B_yes	CD_Dr	CD_Dr_yes	CD_B	CD_Dr	CD_SAE_B	CD_visit_extra	CD_visit_extra	CD_IFX_visit_extra	CD_IFX_visit_extra	CD_IFX_yes_yes	P84_visit_extra_yes	P84_visit_extra_yes	P84_visit_extra_B_yes	P84_visit_extra_B_yes	P84_visit_extra_B	P84_visit_extra_B	P84_visit_extra_Dr	P84_visit_extra_Dr	CD_Full	CD_IFX_Full	CD_yes_Full	CD_B_yes_Full	CD_Dr_yes_Full
P2_ZM87_I_D	IS_P2_ZM87_I_D	plate_2	H2	AAAGCAAAGAGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AAAGAGC	GCCAAT	P2	patient	31	M	CD_M	178	62	19.57	normal	non-smoker	CD_non-smoker	CD	UST	Stelara	11	22	no	none	biological_therapy_ineffectiveness_IFX_switch_without_washout	yes	IFX	A2	B1	L3	non-L4	CD	no	none	no	none	CD_Start	UST_Start	CD_UST_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	06/11/2018	IV	390	no	none	yes	AZA	no	none	no	none	13.5	high	8.5	426	57.95	153	1278	significantly_increased	0	negative	0	0	CD		0	inactive	remission	baseline	baseline	Base	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_1	CD_visit_1	CD_UST_visit_1	CD_UST_visit_1	CD_UST_no_yes	P2_visit_1_no	P2_visit_1_no	P2_visit_1_D_no	P2_visit_1_D_no	P2_visit_1_none	P2_visit_1_none	P2_visit_1_none	P2_visit_1_none	CD_Base	CD_UST_Base	CD_no_Base	CD_D_no_Base	CD_SeT_no_Base
P2_ZM87_II_D	IS_P2_ZM87_II_D	plate_2	A3	AAAGCACGGCTCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACGGCTC	GCCAAT	P2	patient	32	M	CD_M	178	62	19.57	normal	non-smoker	CD_non-smoker	CD	UST	Stelara	11	22	no	none	biological_therapy_ineffectiveness_IFX_switch_without_washout	yes	IFX	A3	B2	L4	non-L4	CD	no	none	no	none	CD_	UST_	CD_UST_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_8	week_8	8	25/01/2019	SC	90	no	none	yes	AZA	no	none	no	none	6.9	low	7.3	348	24.54	149	631	significantly_increased	14.6	negative	0	0	CD		0	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_2	CD_visit_2	CD_UST_visit_2	CD_UST_visit_2	CD_UST_no_yes	P2_visit_2_no	P2_visit_2_no	P2_visit_2_D_no	P2_visit_2_D_no	P2_visit_2_none	P2_visit_2_none	P2_visit_2_none	P2_visit_2_none	CD_Part	CD_UST_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P2_ZM87_III_D	IS_P2_ZM87_III_D	plate_2	B3	AAAGCACGACATA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACGACAT	GCCAAT	P2	patient	33	M	CD_M	178	62	19.57	normal	non-smoker	CD_non-smoker	CD	UST	Stelara	11	22	no	none	biological_therapy_ineffectiveness_IFX_switch_without_washout	yes	IFX	A4	B3	L5	non-L4	CD	no	none	no	none	CD_	UST_	CD_UST_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_16	week_16	16	20/03/2019	SC	90	no	none	yes	AZA	no	none	no	none	5	low	6.7	375	13.17	150	505	significantly_increased	5.6	negative	0	0	CD		0	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	antibiotics_transiently_from_06-01	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_3	CD_visit_3	CD_UST_visit_3	CD_UST_visit_3	CD_UST_no_yes	P2_visit_3_no	P2_visit_3_no	P2_visit_3_D_no	P2_visit_3_D_no	P2_visit_3_none	P2_visit_3_none	P2_visit_3_none	P2_visit_3_none	CD_Part	CD_UST_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P2_ZM87_IV_D	IS_P2_ZM87_IV_D	plate_2	C3	AAAGCATCCCGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ATCCCGC	GCCAAT	P2	patient	34	M	CD_M	178	65	20.52	normal	non-smoker	CD_non-smoker	CD	UST	Stelara	11	22	no	none	biological_therapy_ineffectiveness_IFX_switch_without_washout	yes	IFX	A5	B4	L6	non-L4	CD	no	none	no	none	CD_	UST_	CD_UST_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_24	week_24	24	15/05/2019	SC	90	no	none	yes	AZA	no	none	no	none	4.1	low	7.1	371	20.47	149	799	significantly_increased	5.2	negative	1	1	CD		1	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_4	CD_visit_4	CD_UST_visit_4	CD_UST_visit_4	CD_UST_no_yes	P2_visit_4_no	P2_visit_4_no	P2_visit_4_D_no	P2_visit_4_D_no	P2_visit_4_none	P2_visit_4_none	P2_visit_4_none	P2_visit_4_none	CD_Part	CD_UST_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P2_ZM87_V_D	IS_P2_ZM87_V_D	plate_2	D3	AAAGCAGTGCGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGTGCGC	GCCAAT	P2	patient	35	M	CD_M	178	67	21.15	normal	non-smoker	CD_non-smoker	CD	UST	Stelara	11	22	no	none	biological_therapy_ineffectiveness_IFX_switch_without_washout	yes	IFX	A6	B5	L7	non-L4	CD	no	none	no	none	CD_	UST_	CD_UST_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_32	week_32	32	10/07/2019	SC	90	no	none	yes	AZA	no	none	no	none	3.5	low	7.2	301	21.41	145	419	significantly_increased	5.1	negative	1	1	CD		1	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_5	CD_visit_5	CD_UST_visit_5	CD_UST_visit_5	CD_UST_no_yes	P2_visit_5_no	P2_visit_5_no	P2_visit_5_D_no	P2_visit_5_D_no	P2_visit_5_none	P2_visit_5_none	P2_visit_5_none	P2_visit_5_none	CD_Part	CD_UST_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P2_ZM87_VI_D	IS_P2_ZM87_VI_D	plate_2	E3	AAAGCAGACTCTA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGACTCT	GCCAAT	P2	patient	36	M	CD_M	178	67	21.15	normal	non-smoker	CD_non-smoker	CD	UST	Stelara	11	22	no	none	biological_therapy_ineffectiveness_IFX_switch_without_washout	yes	IFX	A7	B6	L8	non-L4	CD	no	none	no	none	CD_Finish	UST_Finish	CD_UST_Finish	Finish	Finish	Finish.40	Finish.40	visit_6	visit_6	week_40	week_40	40	03/09/2019	SC	90	no	none	yes	AZA	no	none	no	none	2.3	low	6.5	350	41.45	156	469	significantly_increased	4.7	negative	1	1	CD		1	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_6	CD_visit_6	CD_UST_visit_6	CD_UST_visit_6	CD_UST_no_yes	P2_visit_6_no	P2_visit_6_no	P2_visit_6_D_no	P2_visit_6_D_no	P2_visit_6_none	P2_visit_6_none	P2_visit_6_none	P2_visit_6_none	CD_Part	CD_UST_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P8_LV78_I_D	IS_P8_LV78_I_D	plate_2	F3	AAAGCAGGGGTTA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGGGGTT	GCCAAT	P8	patient	40	F	CD_F	162	70	26.67	overweight	non-smoker	CD_non-smoker	CD	UST	Stelara	10	32	no	none	conventiol_therapy_ineffectiveness	yes	IFX	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_Start	UST_Start	CD_UST_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	16/11/2018	IV	390	no	none	no	none	yes	Medrol	yes	Caltrate_Kalnormin_Nolpaza_B12_Subcuvia_Vasosan_Zoloft	15.3	high	9.1	140	15.04	115	380	significantly_increased	0	negative	7	7	CD		7	inactive	mild	baseline	baseline	Base	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_1	CD_visit_1	CD_UST_visit_1	CD_UST_visit_1	CD_UST_no_no	P8_visit_1_no	P8_visit_1_no	P8_visit_1_D_no	P8_visit_1_D_no	P8_visit_1_none	P8_visit_1_none	P8_visit_1_none	P8_visit_1_none	CD_Base	CD_UST_Base	CD_no_Base	CD_D_no_Base	CD_SeT_no_Base
P8_LV78_II_D	IS_P8_LV78_II_D	plate_2	G3	AAAGCACTAGGGA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACTAGGG	GCCAAT	P8	patient	40	F	CD_F	162	70	26.67	overweight	non-smoker	CD_non-smoker	CD	UST	Stelara	10	32	no	none	conventiol_therapy_ineffectiveness	yes	IFX	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_	UST_	CD_UST_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_8	week_8	8	10/01/2019	SC	90	no	none	no	none	no	none	yes	Vasosan_B13									30	negative	4	4	CD		4	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_2	CD_visit_2	CD_UST_visit_2	CD_UST_visit_2	CD_UST_no_no	P8_visit_2_no	P8_visit_2_no	P8_visit_2_D_no	P8_visit_2_D_no	P8_visit_2_none	P8_visit_2_none	P8_visit_2_none	P8_visit_2_none	CD_Part	CD_UST_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P8_LV78_III_D	IS_P8_LV78_III_D	plate_2	H3	AAAGCATAGCCGA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ATAGCCG	GCCAAT	P8	patient	40	F	CD_F	162	69	26.29	overweight	non-smoker	CD_non-smoker	CD	UST	Stelara	10	32	no	none	conventiol_therapy_ineffectiveness	yes	IFX	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_	UST_	CD_UST_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_16	week_16	16	18/04/2019	SC	90	no	none	no	none	no	none	yes	Vasosan_B12_Gammanorm	2.9	low	7.6	144	8.89	125	4	normal	8.4	negative	9	9	CD		9	active	moderate	response	partial_response	Part	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_3	CD_visit_3	CD_UST_visit_3	CD_UST_visit_3	CD_UST_no_no	P8_visit_3_no	P8_visit_3_no	P8_visit_3_D_no	P8_visit_3_D_no	P8_visit_3_none	P8_visit_3_none	P8_visit_3_none	P8_visit_3_none	CD_Part	CD_UST_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P8_LV78_IV_D	IS_P8_LV78_IV_D	plate_2	A4	ACGAAACCTTCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACCTTCC	GCCAAT	P8	patient	40	F	CD_F	162	70	26.67	overweight	non-smoker	CD_non-smoker	CD	UST	Stelara	10	32	no	none	conventiol_therapy_ineffectiveness	yes	IFX	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_	UST_	CD_UST_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_24	week_24	24	10/06/2019	SC	90	no	none	no	none	no	none	yes	Vasosan_B12_Gammanorm	6.6	low	8.5	163	6.19	118	47	normal	12.6	negative	3	3	CD		3	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_4	CD_visit_4	CD_UST_visit_4	CD_UST_visit_4	CD_UST_no_no	P8_visit_4_no	P8_visit_4_no	P8_visit_4_D_no	P8_visit_4_D_no	P8_visit_4_none	P8_visit_4_none	P8_visit_4_none	P8_visit_4_none	CD_Full	CD_UST_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P8_LV78_V_D	IS_P8_LV78_V_D	plate_2	B4	ACGAAAGCCACCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGCCACC	GCCAAT	P8	patient	40	F	CD_F	162	70	26.67	overweight	non-smoker	CD_non-smoker	CD	UST	Stelara	10	32	no	none	conventiol_therapy_ineffectiveness	yes	IFX	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_Finish	UST_Finish	CD_UST_Finish	Finish	Finish	Finish.32	Finish.32	visit_5	visit_5	week_32	week_32	32	09/08/2019	SC	90	no	none	no	none	no	none	yes	Vasosan_B12_Gammanorm	3	low	9	164	4.43	119	103	slightly_increased	12.6	negative	3	3	CD		3	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_5	CD_visit_5	CD_UST_visit_5	CD_UST_visit_5	CD_UST_no_no	P8_visit_5_no	P8_visit_5_no	P8_visit_5_D_no	P8_visit_5_D_no	P8_visit_5_none	P8_visit_5_none	P8_visit_5_none	P8_visit_5_none	CD_Full	CD_UST_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P11_GT85_I_D	IS_P11_GT85_I_D	plate_2	C4	ACGAAAACAGCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AACAGCC	GCCAAT	P11	patient	33	F	UC_F	170	50	17.3	underweight	non-smoker	UC_non-smoker	UC	UST	Stelara	10	25	no	none	biological_therapy_ineffectiveness_IFX_VEDO_switch_with_washout	yes	IFX_VEDO	A2	UC	UC	UC	E2	no	none	no	none	UC_Start	UST_Start	UC_UST_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	26/11/2018	IV	260	yes	Asacol	no	none	yes	Prednison	yes	Kalnormin_Caltrate_Helicid_Mutaflor_metro+před_supp	0.7	low	17.3	374	23.53	125	2658	significantly_increased	0	negative	UC		9	9	9	active	severe	baseline	baseline	Base	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	herpes_labialis_08-01-2019	UC_UST	UC_UST_SeT	UC_UST_no	UC_UST_none	UC_UST_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_1	UC_visit_1	UC_UST_visit_1	UC_UST_visit_1	UC_UST_no_no	P11_visit_1_no	P11_visit_1_no	P11_visit_1_D_no	P11_visit_1_D_no	P11_visit_1_none	P11_visit_1_none	P11_visit_1_none	P11_visit_1_none	UC_Base	UC_UST_Base	UC_no_Base	UC_D_no_Base	UC_SeT_no_Base
P11_GT85_II_D	IS_P11_GT85_II_D	plate_2	D4	ACGAAACGGCCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACGGCCC	GCCAAT	P11	patient	33	F	UC_F	170	52	17.99	underweight	non-smoker	UC_non-smoker	UC	UST	Stelara	10	25	no	none	biological_therapy_ineffectiveness_IFX_VEDO_switch_with_washout	yes	IFX_VEDO	A2	UC	UC	UC	E2	no	none	no	none	UC_	UST_	UC_UST_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_8	week_8	8	21/01/2019	SC	90	yes	Asacol	no	none	yes	Prednison_Budesonid_MMX	yes	Kalnormin_Caltrate_Helicid_Mutaflor_metro+před_supp	0.6	low	12.8	375	32.67	141	40	normal	14.4	negative	UC		1	1	1	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_UST	UC_UST_SeT	UC_UST_no	UC_UST_none	UC_UST_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_2	UC_visit_2	UC_UST_visit_2	UC_UST_visit_2	UC_UST_no_no	P11_visit_2_no	P11_visit_2_no	P11_visit_2_D_no	P11_visit_2_D_no	P11_visit_2_none	P11_visit_2_none	P11_visit_2_none	P11_visit_2_none	UC_Full	UC_UST_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
P11_GT85_III_D	IS_P11_GT85_III_D	plate_2	E4	ACGAAACTGGCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACTGGCC	GCCAAT	P11	patient	33	F	UC_F	170	54	18.69	normal	non-smoker	UC_non-smoker	UC	UST	Stelara	10	25	no	none	biological_therapy_ineffectiveness_IFX_VEDO_switch_with_washout	yes	IFX_VEDO	A2	UC	UC	UC	E2	no	none	no	none	UC_	UST_	UC_UST_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_16	week_16	16	18/03/2019	SC	90	yes	Asacol	no	none	yes	Prednison_Budesonid_MMX	yes	Kalnormin_Caltrate_Helicid_Mutaflor_metro+před_supp	0.5	low	11.8	451	15.62	126	86	slightly_increased	12.9	negative	UC		4	4	4	inactive	mild	response	full_response	Full	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_UST	UC_UST_SeT	UC_UST_no	UC_UST_none	UC_UST_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_3	UC_visit_3	UC_UST_visit_3	UC_UST_visit_3	UC_UST_no_no	P11_visit_3_no	P11_visit_3_no	P11_visit_3_D_no	P11_visit_3_D_no	P11_visit_3_none	P11_visit_3_none	P11_visit_3_none	P11_visit_3_none	UC_Full	UC_UST_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
P11_GT85_IV_D	IS_P11_GT85_IV_D	plate_2	F4	ACGAAAAGGACCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AAGGACC	GCCAAT	P11	patient	33	F	UC_F	170	54	18.69	normal	non-smoker	UC_non-smoker	UC	UST	Stelara	10	25	no	none	biological_therapy_ineffectiveness_IFX_VEDO_switch_with_washout	yes	IFX_VEDO	A2	UC	UC	UC	E2	no	none	no	none	UC_	UST_	UC_UST_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_24	week_24	24	13/05/2019	SC	90	yes	Asacol	no	none	no	none	no	none	0.3	low	8.9	393	12.16	122	270	significantly_increased	12.9	negative	UC		3	3	3	inactive	mild	response	full_response	Full	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_UST	UC_UST_SeT	UC_UST_no	UC_UST_none	UC_UST_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_4	UC_visit_4	UC_UST_visit_4	UC_UST_visit_4	UC_UST_no_no	P11_visit_4_no	P11_visit_4_no	P11_visit_4_D_no	P11_visit_4_D_no	P11_visit_4_none	P11_visit_4_none	P11_visit_4_none	P11_visit_4_none	UC_Full	UC_UST_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
P11_GT85_V_D	IS_P11_GT85_V_D	plate_2	G4	ACGAAACGCTCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACGCTCC	GCCAAT	P11	patient	33	F	UC_F	170	52	17.99	underweight	non-smoker	UC_non-smoker	UC	UST	Stelara	10	25	no	none	biological_therapy_ineffectiveness_IFX_VEDO_switch_with_washout	yes	IFX_VEDO	A2	UC	UC	UC	E2	no	none	no	none	UC_	UST_	UC_UST_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_32	week_32	32	02/07/2019	SC	90	yes	Asacol	no	none	yes	Budesonid_MMX	yes	Budenofalk	2	low	8	383	11.76	119	3065	significantly_increased	17.9	negative	UC		5	5	5	active	moderate	response	partial_response	Part	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_UST	UC_UST_SeT	UC_UST_no	UC_UST_none	UC_UST_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_5	UC_visit_5	UC_UST_visit_5	UC_UST_visit_5	UC_UST_no_no	P11_visit_5_no	P11_visit_5_no	P11_visit_5_D_no	P11_visit_5_D_no	P11_visit_5_none	P11_visit_5_none	P11_visit_5_none	P11_visit_5_none	UC_Part	UC_UST_Part	UC_no_Part	UC_D_no_Part	UC_SeT_no_Part
P11_GT85_VI_D	IS_P11_GT85_VI_D	plate_2	H4	ACGAAAGCGCCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGCGCCC	GCCAAT	P11	patient	33	F	UC_F	170	49	16.96	underweight	non-smoker	UC_non-smoker	UC	UST	Stelara	10	25	no	none	biological_therapy_ineffectiveness_IFX_VEDO_switch_with_washout	yes	IFX_VEDO	A2	UC	UC	UC	E2	no	none	no	none	UC_Finish	UST_Finish	UC_UST_Finish	Finish	Finish	Finish.40	Finish.40	visit_6	visit_6	week_40	week_40	40	12/08/2019	SC	90	yes	Asacol	no	none	yes	Budesonid_MMX	yes	Budenofalk	0.4	low	9.9	347	7.33	119	64	slightly_increased	20.5	negative	UC		2	2	2	inactive	mild	response	full_response	Full	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_UST	UC_UST_SeT	UC_UST_no	UC_UST_none	UC_UST_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_6	UC_visit_6	UC_UST_visit_6	UC_UST_visit_6	UC_UST_no_no	P11_visit_6_no	P11_visit_6_no	P11_visit_6_D_no	P11_visit_6_D_no	P11_visit_6_none	P11_visit_6_none	P11_visit_6_none	P11_visit_6_none	UC_Full	UC_UST_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
P17_BH58_I_D	IS_P17_BH58_I_D	plate_2	A5	ACGAAAATTAGCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AATTAGC	GCCAAT	P17	patient	60	F	CD_F	170	70	24.22	normal	non-smoker	CD_non-smoker	CD	UST	Stelara	24	37	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B2	L3	non-L4	CD	no	none	yes	ileocecal_astomosis_resection	CD_Start	UST_Start	CD_UST_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	13/12/2018	IV	390	no	none	yes	AZA	yes	Budesonid	yes	Helicid	3.8	low	5.4	402	33.16	126	335	significantly_increased	0	negative	8	8	CD		8	active	moderate	baseline	baseline	Base	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_1	CD_visit_1	CD_UST_visit_1	CD_UST_visit_1	CD_UST_no_yes	P17_visit_1_no	P17_visit_1_no	P17_visit_1_D_no	P17_visit_1_D_no	P17_visit_1_none	P17_visit_1_none	P17_visit_1_none	P17_visit_1_none	CD_Base	CD_UST_Base	CD_no_Base	CD_D_no_Base	CD_SeT_no_Base
P17_BH58_II_D	IS_P17_BH58_II_D	plate_2	B5	ACGAAATCCTCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ATCCTCC	GCCAAT	P17	patient	60	F	CD_F	170	74	25.61	overweight	non-smoker	CD_non-smoker	CD	UST	Stelara	24	37	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B2	L3	non-L4	CD	no	none	yes	ileocecal_astomosis_resection	CD_	UST_	CD_UST_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_8	week_8	8	07/02/2019	SC	90	no	none	yes	AZA	yes	Budesonid	yes	Helicid	2.1	low	6	318	20.05	118	152	slightly_increased	30	negative	2	2	CD		2	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_2	CD_visit_2	CD_UST_visit_2	CD_UST_visit_2	CD_UST_no_yes	P17_visit_2_no	P17_visit_2_no	P17_visit_2_D_no	P17_visit_2_D_no	P17_visit_2_none	P17_visit_2_none	P17_visit_2_none	P17_visit_2_none	CD_Part	CD_UST_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P17_BH58_III_D	IS_P17_BH58_III_D	plate_2	C5	ACGAAAACCCGCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AACCCGC	GCCAAT	P17	patient	60	F	CD_F	170	74	25.61	overweight	non-smoker	CD_non-smoker	CD	UST	Stelara	24	37	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B2	L3	non-L4	CD	no	none	yes	ileocecal_astomosis_resection	CD_	UST_	CD_UST_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_16	week_16	16	04/04/2019	SC	90	no	none	yes	AZA	no	none	yes	Helicid	2.5	low	5.9	266	26.51	132	57	slightly_increased	18.7	negative	3	3	CD		3	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_3	CD_visit_3	CD_UST_visit_3	CD_UST_visit_3	CD_UST_no_yes	P17_visit_3_no	P17_visit_3_no	P17_visit_3_D_no	P17_visit_3_D_no	P17_visit_3_none	P17_visit_3_none	P17_visit_3_none	P17_visit_3_none	CD_Full	CD_UST_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P17_BH58_IV_D	IS_P17_BH58_IV_D	plate_2	D5	ACGAAATCCCTCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ATCCCTC	GCCAAT	P17	patient	60	F	CD_F	170	74	25.61	overweight	non-smoker	CD_non-smoker	CD	UST	Stelara	24	37	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B2	L3	non-L4	CD	no	none	yes	ileocecal_astomosis_resection	CD_	UST_	CD_UST_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_24	week_24	24	04/05/2019	SC	90	no	none	yes	AZA	no	none	yes	Helicid_Tezefort_Ferrofolgama_Indapamid_Detralex	1.5	low	6.1	299	12.83	131	39	normal	20	negative	2	2	CD		2	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_4	CD_visit_4	CD_UST_visit_4	CD_UST_visit_4	CD_UST_no_yes	P17_visit_4_no	P17_visit_4_no	P17_visit_4_D_no	P17_visit_4_D_no	P17_visit_4_none	P17_visit_4_none	P17_visit_4_none	P17_visit_4_none	CD_Full	CD_UST_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P17_BH58_V_D	IS_P17_BH58_V_D	plate_2	E5	ACGAAACTCGCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACTCGCC	GCCAAT	P17	patient	60	F	CD_F	170	74	25.61	overweight	non-smoker	CD_non-smoker	CD	UST	Stelara	24	37	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B2	L3	non-L4	CD	no	none	yes	ileocecal_astomosis_resection	CD_	UST_	CD_UST_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_32	week_32	32	22/07/2019	SC	90	no	none	yes	AZA	no	none	yes	Helicid_Tezefort_Ferrofolgama_Indapamid_Detralex	2.2	low	5.8	309	30.42	130	109	slightly_increased	15.5	negative	3	3	CD		3	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_5	CD_visit_5	CD_UST_visit_5	CD_UST_visit_5	CD_UST_no_yes	P17_visit_5_no	P17_visit_5_no	P17_visit_5_D_no	P17_visit_5_D_no	P17_visit_5_none	P17_visit_5_none	P17_visit_5_none	P17_visit_5_none	CD_Full	CD_UST_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P17_BH58_VI_D	IS_P17_BH58_VI_D	plate_2	F5	ACGAAAGGCCTCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGGCCTC	GCCAAT	P17	patient	60	F	CD_F	170	73	25.26	overweight	non-smoker	CD_non-smoker	CD	UST	Stelara	24	37	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B2	L3	non-L4	CD	no	none	yes	ileocecal_astomosis_resection	CD_Finish	UST_Finish	CD_UST_Finish	Finish	Finish	Finish.40	Finish.40	visit_6	visit_6	week_40	week_40	40	22/07/2019	SC	90	no	none	yes	AZA	no	none	yes	Helicid_Tezefort_Ferrofolgama_Indapamid_Detralex	2	low	5.2	287	14.63	132	52	slightly_increased	16.6	negative	3	3	CD		3	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_6	CD_visit_6	CD_UST_visit_6	CD_UST_visit_6	CD_UST_no_yes	P17_visit_6_no	P17_visit_6_no	P17_visit_6_D_no	P17_visit_6_D_no	P17_visit_6_none	P17_visit_6_none	P17_visit_6_none	P17_visit_6_none	CD_Full	CD_UST_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P18_SJ75_I_D	IS_P18_SJ75_I_D	plate_2	G5	ACGAAACCCAGCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACCCAGC	GCCAAT	P18	patient	43	M	CD_M	176	86	27.76	overweight	non-smoker	CD_non-smoker	CD	UST	Stelara	1	43	yes	"chronic_limb_threatening_ischemia,_vasculitis"	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	no	none	CD_Start	UST_Start	CD_UST_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	07/01/2019	IV	520	no	none	no	none	no	none	yes	Trombex_Noclaud_Valsap_combi	5.8	low	7.8	469	191.51	152	220	significantly_increased	0	negative	3	3	CD		3	inactive	remission	baseline	baseline	Base	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_1	CD_visit_1	CD_UST_visit_1	CD_UST_visit_1	CD_UST_no_no	P18_visit_1_no	P18_visit_1_no	P18_visit_1_D_no	P18_visit_1_D_no	P18_visit_1_none	P18_visit_1_none	P18_visit_1_none	P18_visit_1_none	CD_Base	CD_UST_Base	CD_no_Base	CD_D_no_Base	CD_SeT_no_Base
P18_SJ75_II_D	IS_P18_SJ75_II_D	plate_2	H5	AAAGAGCACGAAA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AAAGAGC	GCCAAT	P18	patient	43	M	CD_M	176	94	30.35	obesity	non-smoker	CD_non-smoker	CD	UST	Stelara	1	43	yes	"chronic_limb_threatening_ischemia,_vasculitis"	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	no	none	CD_	UST_	CD_UST_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_8	week_8	8	13/03/2019	SC	90	no	none	no	none	no	none	yes	Trombex_Noclaud_Valsap_combi	5.1	low	7.4	492	150.36	148	75	slightly_increased	17.5	negative	1	1	CD		1	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_2	CD_visit_2	CD_UST_visit_2	CD_UST_visit_2	CD_UST_no_no	P18_visit_2_no	P18_visit_2_no	P18_visit_2_D_no	P18_visit_2_D_no	P18_visit_2_none	P18_visit_2_none	P18_visit_2_none	P18_visit_2_none	CD_Full	CD_UST_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P18_SJ75_III_D	IS_P18_SJ75_III_D	plate_2	A6	ACGAAACGGCTCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACGGCTC	GCCAAT	P18	patient	43	M	CD_M	176	94	30.35	obesity	non-smoker	CD_non-smoker	CD	UST	Stelara	1	43	yes	"chronic_limb_threatening_ischemia,_vasculitis"	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	no	none	CD_	UST_	CD_UST_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_16	week_16	16	06/05/2019	SC	90	no	none	no	none	no	none	yes	Trombex_Noclaud_Valsap_combi	2.2	low	6.9	448	169.41	159	47	normal	8.9	negative	0	0	CD		0	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_3	CD_visit_3	CD_UST_visit_3	CD_UST_visit_3	CD_UST_no_no	P18_visit_3_no	P18_visit_3_no	P18_visit_3_D_no	P18_visit_3_D_no	P18_visit_3_none	P18_visit_3_none	P18_visit_3_none	P18_visit_3_none	CD_Full	CD_UST_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P18_SJ75_IV_D	IS_P18_SJ75_IV_D	plate_2	B6	ACGAAACGACATA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACGACAT	GCCAAT	P18	patient	43	M	CD_M	176	94	30.35	obesity	non-smoker	CD_non-smoker	CD	UST	Stelara	1	43	yes	"chronic_limb_threatening_ischemia,_vasculitis"	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	no	none	CD_	UST_	CD_UST_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_24	week_24	24	01/07/2019	SC	90	no	none	no	none	no	none	yes	Trombex_Noclaud_Valsap_combi	3.5	low	7.4	423	157.21	152	193	slightly_increased	7.5	negative	1	1	CD		1	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_4	CD_visit_4	CD_UST_visit_4	CD_UST_visit_4	CD_UST_no_no	P18_visit_4_no	P18_visit_4_no	P18_visit_4_D_no	P18_visit_4_D_no	P18_visit_4_none	P18_visit_4_none	P18_visit_4_none	P18_visit_4_none	CD_Full	CD_UST_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P18_SJ75_V_D	IS_P18_SJ75_V_D	plate_2	C6	ACGAAATCCCGCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ATCCCGC	GCCAAT	P18	patient	43	M	CD_M	176	94	30.35	obesity	non-smoker	CD_non-smoker	CD	UST	Stelara	1	43	yes	"chronic_limb_threatening_ischemia,_vasculitis"	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	no	none	CD_Finish	UST_Finish	CD_UST_Finish	Finish	Finish	Finish.32	Finish.32	visit_5	visit_5	week_32	week_32	32	25/10/2019	SC	90	no	none	no	none	no	none	yes	Trombex_Noclaud_Valsap_combi	2.9	low	7.1	429	184.96	163	40	normal	6.3	negative	2	2	CD		2	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_5	CD_visit_5	CD_UST_visit_5	CD_UST_visit_5	CD_UST_no_no	P18_visit_5_no	P18_visit_5_no	P18_visit_5_D_no	P18_visit_5_D_no	P18_visit_5_none	P18_visit_5_none	P18_visit_5_none	P18_visit_5_none	CD_Full	CD_UST_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P30_KM73_I_D	IS_P30_KM73_I_D	plate_2	D6	ACGAAAGTGCGCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGTGCGC	GCCAAT	P30	patient	46	F	CD_F	168	77	27.28	overweight	smoker	CD_smoker	CD	UST	Stelara	8	39	no	none	EIM	yes	IFX	A2	B3	L1	non-L4	CD	yes	joints	no	none	CD_Start	UST_Start	CD_UST_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	08/04/2019	IV	390	no	none	yes	MTX	no	none	yes	folate	3.7	low	6.9	422	4.16	113	1678	significantly_increased	0	negative	8	8	CD		8	active	moderate	baseline	baseline	Base	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_1	CD_visit_1	CD_UST_visit_1	CD_UST_visit_1	CD_UST_no_yes	P30_visit_1_no	P30_visit_1_no	P30_visit_1_D_no	P30_visit_1_D_no	P30_visit_1_none	P30_visit_1_none	P30_visit_1_none	P30_visit_1_none	CD_Base	CD_UST_Base	CD_no_Base	CD_D_no_Base	CD_SeT_no_Base
P30_KM73_II_D	IS_P30_KM73_II_D	plate_2	E6	ACGAAAGACTCTA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGACTCT	GCCAAT	P30	patient	46	F	CD_F	168	77	27.28	overweight	smoker	CD_smoker	CD	UST	Stelara	8	39	no	none	EIM	yes	IFX	A2	B3	L1	non-L4	CD	yes	joints	no	none	CD_	UST_	CD_UST_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_8	week_8	8	03/06/2019	SC	90	no	none	yes	MTX	no	none	yes	folate	14.6	high	7.5	365	5.41	102	2291	significantly_increased	24.1	positive	3	3	CD		3	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_2	CD_visit_2	CD_UST_visit_2	CD_UST_visit_2	CD_UST_no_yes	P30_visit_2_no	P30_visit_2_no	P30_visit_2_D_no	P30_visit_2_D_no	P30_visit_2_none	P30_visit_2_none	P30_visit_2_none	P30_visit_2_none	CD_Part	CD_UST_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P30_KM73_III_D	IS_P30_KM73_III_D	plate_2	F6	ACGAAAGGGGTTA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGGGGTT	GCCAAT	P30	patient	46	F	CD_F	168	77	27.28	overweight	smoker	CD_smoker	CD	UST	Stelara	8	39	no	none	EIM	yes	IFX	A2	B3	L1	non-L4	CD	yes	joints	no	none	CD_	UST_	CD_UST_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_16	week_16	16	29/07/2019	SC	90	no	none	no	none	no	none	yes	Maltofer_Sulfasalazin_D3_calcium	3.9	low	5.8	332	2.41	100	529	significantly_increased	6.5	negative	2	2	CD		2	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_3	CD_visit_3	CD_UST_visit_3	CD_UST_visit_3	CD_UST_no_no	P30_visit_3_no	P30_visit_3_no	P30_visit_3_D_no	P30_visit_3_D_no	P30_visit_3_none	P30_visit_3_none	P30_visit_3_none	P30_visit_3_none	CD_Full	CD_UST_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P30_KM73_IV_D	IS_P30_KM73_IV_D	plate_2	G6	ACGAAACTAGGGA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACTAGGG	GCCAAT	P30	patient	46	F	CD_F	168	77	27.28	overweight	smoker	CD_smoker	CD	UST	Stelara	8	39	no	none	EIM	yes	IFX	A2	B3	L1	non-L4	CD	yes	joints	no	none	CD_	UST_	CD_UST_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_24	week_24	24	23/09/2019	SC	90	no	none	no	none	no	none	yes	Maltofer_Sulfasalazin_D3_calcium	4.1	low	7.2	318	8.67	114	143	slightly_increased	8.6	negative	2	2	CD		2	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_4	CD_visit_4	CD_UST_visit_4	CD_UST_visit_4	CD_UST_no_no	P30_visit_4_no	P30_visit_4_no	P30_visit_4_D_no	P30_visit_4_D_no	P30_visit_4_none	P30_visit_4_none	P30_visit_4_none	P30_visit_4_none	CD_Full	CD_UST_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P30_KM73_V_D	IS_P30_KM73_V_D	plate_2	H6	ACGAAATAGCCGA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ATAGCCG	GCCAAT	P30	patient	46	F	CD_F	168	77	27.28	overweight	smoker	CD_smoker	CD	UST	Stelara	8	39	no	none	EIM	yes	IFX	A2	B3	L1	non-L4	CD	yes	joints	no	none	CD_	UST_	CD_UST_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_32	week_32	32	18/11/2019	SC	90	no	none	no	none	no	none	yes	Maltofer_Sulfasalazin_D3_calcium	6	low	6.6	304	9.58	121	1407	significantly_increased	8.8	negative	2	2	CD		2	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_5	CD_visit_5	CD_UST_visit_5	CD_UST_visit_5	CD_UST_no_no	P30_visit_5_no	P30_visit_5_no	P30_visit_5_D_no	P30_visit_5_D_no	P30_visit_5_none	P30_visit_5_none	P30_visit_5_none	P30_visit_5_none	CD_Part	CD_UST_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P30_KM73_VI_D	IS_P30_KM73_VI_D	plate_2	A7	ATAATACCTTCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACCTTCC	GCCAAT	P30	patient	46	F	CD_F	168	77	27.28	overweight	smoker	CD_smoker	CD	UST	Stelara	8	39	no	none	EIM	yes	IFX	A2	B3	L1	non-L4	CD	yes	joints	no	none	CD_Finish	UST_Finish	CD_UST_Finish	Finish	Finish	Finish.40	Finish.40	visit_6	visit_6	week_40	week_40	40	13/01/2020	SC	90	no	none	no	none	no	none	yes	Maltofer_Sulfasalazin_D3_calcium	4	low	7	294	6.35	122	528	significantly_increased	7.9	negative	3	3	CD		3	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_6	CD_visit_6	CD_UST_visit_6	CD_UST_visit_6	CD_UST_no_no	P30_visit_6_no	P30_visit_6_no	P30_visit_6_D_no	P30_visit_6_D_no	P30_visit_6_none	P30_visit_6_none	P30_visit_6_none	P30_visit_6_none	CD_Part	CD_UST_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P36_KJ78_I_D	IS_P36_KJ78_I_D	plate_2	B7	ATAATAGCCACCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGCCACC	GCCAAT	P36	patient	40	M	CD_M	188	97	27.44	overweight	non-smoker	CD_non-smoker	CD	UST	Stelara	14	27	no	none	conventiol_therapy_ineffectiveness	yes	IFX_ADA	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_Start	UST_Start	CD_UST_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	02/05/2019	IV	520	no	none	yes	AZA	yes	Budesonid	yes	Vasosan_B12_Calcichew	6.4	low	7.6	492	20.47	134	894	significantly_increased	0	negative	5	5	CD		5	inactive	mild	baseline	baseline	Base	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_1	CD_visit_1	CD_UST_visit_1	CD_UST_visit_1	CD_UST_no_yes	P36_visit_1_no	P36_visit_1_no	P36_visit_1_D_no	P36_visit_1_D_no	P36_visit_1_none	P36_visit_1_none	P36_visit_1_none	P36_visit_1_none	CD_Base	CD_UST_Base	CD_no_Base	CD_D_no_Base	CD_SeT_no_Base
P36_KJ78_III_D	IS_P36_KJ78_III_D	plate_2	C7	ATAATAACAGCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AACAGCC	GCCAAT	P36	patient	40	M	CD_M	188	104	29.43	overweight	non-smoker	CD_non-smoker	CD	UST	Stelara	14	27	no	none	conventiol_therapy_ineffectiveness	yes	IFX_ADA	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_	UST_	CD_UST_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_16	week_16	16	23/08/2019	SC	90	no	none	yes	AZA	no	none	yes	Vasosan_B12_Calcichew	3.6	low	6.1	455	4.69	125	750	significantly_increased	5.8	positive	0	0	CD		0	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_3	CD_visit_3	CD_UST_visit_3	CD_UST_visit_3	CD_UST_no_yes	P36_visit_3_no	P36_visit_3_no	P36_visit_3_D_no	P36_visit_3_D_no	P36_visit_3_none	P36_visit_3_none	P36_visit_3_none	P36_visit_3_none	CD_Part	CD_UST_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P36_KJ78_IV_D	IS_P36_KJ78_IV_D	plate_2	D7	ATAATACGGCCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACGGCCC	GCCAAT	P36	patient	40	M	CD_M	188	104	29.43	overweight	non-smoker	CD_non-smoker	CD	UST	Stelara	14	27	no	none	conventiol_therapy_ineffectiveness	yes	IFX_ADA	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_	UST_	CD_UST_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_24	week_24	24	14/10/2019	SC	90	no	none	yes	AZA	no	none	yes	Vasosan_B12_Calcichew	4.2	low	5.3	401	10.68	119	756	significantly_increased	5.5	negative	3	3	CD		3	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_4	CD_visit_4	CD_UST_visit_4	CD_UST_visit_4	CD_UST_no_yes	P36_visit_4_no	P36_visit_4_no	P36_visit_4_D_no	P36_visit_4_D_no	P36_visit_4_none	P36_visit_4_none	P36_visit_4_none	P36_visit_4_none	CD_Part	CD_UST_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P36_KJ78_V_D	IS_P36_KJ78_V_D	plate_2	E7	ATAATACTGGCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACTGGCC	GCCAAT	P36	patient	40	M	CD_M	188	102	28.86	overweight	non-smoker	CD_non-smoker	CD	UST	Stelara	14	27	no	none	conventiol_therapy_ineffectiveness	yes	IFX_ADA	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_	UST_	CD_UST_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_32	week_32	32	09/12/2019	SC	90	no	none	yes	AZA	no	none	yes	Vasosan_B12_Calcichew	3.5	low	5.3	493	1.98	103	792	significantly_increased	2.9	negative	2	2	CD		2	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_5	CD_visit_5	CD_UST_visit_5	CD_UST_visit_5	CD_UST_no_yes	P36_visit_5_no	P36_visit_5_no	P36_visit_5_D_no	P36_visit_5_D_no	P36_visit_5_none	P36_visit_5_none	P36_visit_5_none	P36_visit_5_none	CD_Part	CD_UST_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P36_KJ78_VI_D	IS_P36_KJ78_VI_D	plate_2	F7	ATAATAAGGACCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AAGGACC	GCCAAT	P36	patient	40	M	CD_M	188	102	28.86	overweight	non-smoker	CD_non-smoker	CD	UST	Stelara	14	27	no	none	conventiol_therapy_ineffectiveness	yes	IFX_ADA	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_resection	CD_Finish	UST_Finish	CD_UST_Finish	Finish	Finish	Finish.40	Finish.40	visit_6	visit_6	week_40	week_40	40	03/02/2020	SC	90	no	none	yes	AZA	no	none	yes	Vasosan_B12_Calcichew	5	low	7	586	1.98	125	1974	significantly_increased	3.6	negative	5	5	CD		5	inactive	mild	no_response	no_response	NoRe	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_6	CD_visit_6	CD_UST_visit_6	CD_UST_visit_6	CD_UST_no_yes	P36_visit_6_no	P36_visit_6_no	P36_visit_6_D_no	P36_visit_6_D_no	P36_visit_6_none	P36_visit_6_none	P36_visit_6_none	P36_visit_6_none	CD_NoRe	CD_UST_NoRe	CD_no_NoRe	CD_D_no_NoRe	CD_SeT_no_NoRe
P37_SJ55_I_D	IS_P37_SJ55_I_D	plate_2	G7	ATAATACGCTCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACGCTCC	GCCAAT	P37	patient	63	M	CD_M	182	84	25.36	overweight	non-smoker	UC_non-smoker	UC	UST	Stelara	15	49	yes	"corory_artery_disease,_hypothyroidism,_hyperuricemia"	"conventiol_therapy_ineffectiveness,_allergic_reaction_VEDO_switch_without_wash_out"	yes	VEDO	A2	UC	UC	UC	E3	no	none	no	none	UC_Start	UST_Start	UC_UST_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	02/05/2019	IV	390	yes	Pentasa	no	none	yes	Prednison	yes	Vigantol_Helicid_Trombex_Rosucard_Cordarone_Tritace_Atram_Furon	10.3	high	13.6	382	13.84	107	1426	significantly_increased	0	negative	UC		4	4	4	inactive	mild	baseline	baseline	Base	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_UST	UC_UST_SeT	UC_UST_no	UC_UST_none	UC_UST_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_1	UC_visit_1	UC_UST_visit_1	UC_UST_visit_1	UC_UST_no_no	P37_visit_1_no	P37_visit_1_no	P37_visit_1_D_no	P37_visit_1_D_no	P37_visit_1_none	P37_visit_1_none	P37_visit_1_none	P37_visit_1_none	UC_Base	UC_UST_Base	UC_no_Base	UC_D_no_Base	UC_SeT_no_Base
P37_SJ55_II_D	IS_P37_SJ55_II_D	plate_2	H7	ATAATAGCGCCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGCGCCC	GCCAAT	P37	patient	63	M	CD_M	182	82	24.76	normal	non-smoker	UC_non-smoker	UC	UST	Stelara	15	49	yes	"corory_artery_disease,_hypothyroidism,_hyperuricemia"	"conventiol_therapy_ineffectiveness,_allergic_reaction_VEDO_switch_without_wash_out"	yes	VEDO	A2	UC	UC	UC	E3	no	none	no	none	UC_	UST_	UC_UST_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_8	week_8	8	27/06/2019	SC	90	no	none	no	none	yes	Prednison	yes	Vigantol_Helicid_Rosucard_Cordarone_Tritace_Atram_Warfarin	2.9	low	7.1	182	16.17	128	229	significantly_increased	16.1	negative	UC		1	1	1	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_UST	UC_UST_SeT	UC_UST_no	UC_UST_none	UC_UST_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_2	UC_visit_2	UC_UST_visit_2	UC_UST_visit_2	UC_UST_no_no	P37_visit_2_no	P37_visit_2_no	P37_visit_2_D_no	P37_visit_2_D_no	P37_visit_2_none	P37_visit_2_none	P37_visit_2_none	P37_visit_2_none	UC_Full	UC_UST_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
P37_SJ55_III_D	IS_P37_SJ55_III_D	plate_2	A8	ATAATAATTAGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AATTAGC	GCCAAT	P37	patient	63	M	CD_M	182	84	25.36	overweight	non-smoker	UC_non-smoker	UC	UST	Stelara	15	49	yes	"corory_artery_disease,_hypothyroidism,_hyperuricemia"	"conventiol_therapy_ineffectiveness,_allergic_reaction_VEDO_switch_without_wash_out"	yes	VEDO	A2	UC	UC	UC	E3	no	none	no	none	UC_	UST_	UC_UST_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_16	week_16	16	26/08/2019	SC	90	no	none	no	none	no	none	yes	Vigantol_Helicid_Rosucard_Cordarone_Tritace_Atram_Warfarin	4.6	low	6.8	189	18.04	141	230	significantly_increased	6.9	negative	UC		1	1	1	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_UST	UC_UST_SeT	UC_UST_no	UC_UST_none	UC_UST_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_3	UC_visit_3	UC_UST_visit_3	UC_UST_visit_3	UC_UST_no_no	P37_visit_3_no	P37_visit_3_no	P37_visit_3_D_no	P37_visit_3_D_no	P37_visit_3_none	P37_visit_3_none	P37_visit_3_none	P37_visit_3_none	UC_Full	UC_UST_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
P37_SJ55_IV_D	IS_P37_SJ55_IV_D	plate_2	B8	ATAATATCCTCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ATCCTCC	GCCAAT	P37	patient	63	M	CD_M	182	84	25.36	overweight	non-smoker	UC_non-smoker	UC	UST	Stelara	15	49	yes	"corory_artery_disease,_hypothyroidism,_hyperuricemia"	"conventiol_therapy_ineffectiveness,_allergic_reaction_VEDO_switch_without_wash_out"	yes	VEDO	A2	UC	UC	UC	E3	no	none	no	none	UC_	UST_	UC_UST_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_24	week_24	24	17/10/2019	SC	90	no	none	no	none	no	none	yes	Warfarin_Rosucard_Tritace_Atram	2.9	low	6.1	158	24.14	146	433	significantly_increased	9.3	negative	UC		1	1	1	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_UST	UC_UST_SeT	UC_UST_no	UC_UST_none	UC_UST_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_4	UC_visit_4	UC_UST_visit_4	UC_UST_visit_4	UC_UST_no_no	P37_visit_4_no	P37_visit_4_no	P37_visit_4_D_no	P37_visit_4_D_no	P37_visit_4_none	P37_visit_4_none	P37_visit_4_none	P37_visit_4_none	UC_Part	UC_UST_Part	UC_no_Part	UC_D_no_Part	UC_SeT_no_Part
P37_SJ55_V_D	IS_P37_SJ55_V_D	plate_2	C8	ATAATAACCCGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AACCCGC	GCCAAT	P37	patient	63	M	CD_M	182	84	25.36	overweight	non-smoker	UC_non-smoker	UC	UST	Stelara	15	49	yes	"corory_artery_disease,_hypothyroidism,_hyperuricemia"	"conventiol_therapy_ineffectiveness,_allergic_reaction_VEDO_switch_without_wash_out"	yes	VEDO	A2	UC	UC	UC	E3	no	none	no	none	UC_	UST_	UC_UST_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_32	week_32	32	12/12/2019	SC	90	no	none	no	none	no	none	yes	Warfarin_Rosucard_Tritace_Atram	2.7	low	7.1	163	24.13	155	132	slightly_increased	7.5	negative	UC		0	0	0	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_UST	UC_UST_SeT	UC_UST_no	UC_UST_none	UC_UST_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_5	UC_visit_5	UC_UST_visit_5	UC_UST_visit_5	UC_UST_no_no	P37_visit_5_no	P37_visit_5_no	P37_visit_5_D_no	P37_visit_5_D_no	P37_visit_5_none	P37_visit_5_none	P37_visit_5_none	P37_visit_5_none	UC_Full	UC_UST_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
P37_SJ55_VI_D	IS_P37_SJ55_VI_D	plate_2	D8	ATAATATCCCTCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ATCCCTC	GCCAAT	P37	patient	63	M	CD_M	182	85	25.66	overweight	non-smoker	UC_non-smoker	UC	UST	Stelara	15	49	yes	"corory_artery_disease,_hypothyroidism,_hyperuricemia"	"conventiol_therapy_ineffectiveness,_allergic_reaction_VEDO_switch_without_wash_out"	yes	VEDO	A2	UC	UC	UC	E3	no	none	no	none	UC_Finish	UST_Finish	UC_UST_Finish	Finish	Finish	Finish.40	Finish.40	visit_6	visit_6	week_40	week_40	40	06/02/2020	SC	90	no	none	no	none	no	none	yes	Warfarin_Rosucard_Tritace_Atram	2.3	low	7.5	179	36.39	156	289	significantly_increased	7.2	negative	UC		1	1	1	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_UST	UC_UST_SeT	UC_UST_no	UC_UST_none	UC_UST_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_6	UC_visit_6	UC_UST_visit_6	UC_UST_visit_6	UC_UST_no_no	P37_visit_6_no	P37_visit_6_no	P37_visit_6_D_no	P37_visit_6_D_no	P37_visit_6_none	P37_visit_6_none	P37_visit_6_none	P37_visit_6_none	UC_Full	UC_UST_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
P43_BR63_I_D	IS_P43_BR63_I_D	plate_2	E8	ATAATACTCGCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACTCGCC	GCCAAT	P43	patient	55	F	CD_F	170	80	27.68	overweight	non-smoker	CD_non-smoker	CD	UST	Stelara	1	55	yes	ovarian_cancer	conventiol_therapy_ineffectiveness	no	none	A2	B1	L1	non-L4	CD	no	none	no	none	CD_Start	UST_Start	CD_UST_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	27/05/2019	IV	390	no	none	no	none	yes	Budesonid	no	none	8.8	low	5.4	319	91.45	135	1248	significantly_increased	0	negative	4	4	CD		4	inactive	remission	baseline	baseline	Base	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_1	CD_visit_1	CD_UST_visit_1	CD_UST_visit_1	CD_UST_no_no	P43_visit_1_no	P43_visit_1_no	P43_visit_1_D_no	P43_visit_1_D_no	P43_visit_1_none	P43_visit_1_none	P43_visit_1_none	P43_visit_1_none	CD_Base	CD_UST_Base	CD_no_Base	CD_D_no_Base	CD_SeT_no_Base
P43_BR63_II_D	IS_P43_BR63_II_D	plate_2	F8	ATAATAGGCCTCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGGCCTC	GCCAAT	P43	patient	55	F	CD_F	170	80	27.68	overweight	non-smoker	CD_non-smoker	CD	UST	Stelara	1	55	yes	ovarian_cancer	conventiol_therapy_ineffectiveness	no	none	A2	B1	L1	non-L4	CD	no	none	no	none	CD_	UST_	CD_UST_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_8	week_8	8	23/07/2019	SC	90	no	none	no	none	no	none	no	none	5.1	low	6.2	312	64.67	144	667	significantly_increased	28.7	negative	2	2	CD		2	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	UST_D	UST_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	recurrent_infections_did_not_come_for_more_applications	CD_UST	CD_UST_SeT	CD_UST_no	CD_UST_none	CD_UST_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_2	CD_visit_2	CD_UST_visit_2	CD_UST_visit_2	CD_UST_no_no	P43_visit_2_no	P43_visit_2_no	P43_visit_2_D_no	P43_visit_2_D_no	P43_visit_2_none	P43_visit_2_none	P43_visit_2_none	P43_visit_2_none	CD_Part	CD_UST_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P43_BR63_III_D	IS_P43_BR63_III_D	plate_2	G8	ATAATACCCAGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACCCAGC	GCCAAT	P43	patient	55	F	CD_F	170				non-smoker	CD_non-smoker	CD	UST	Stelara	1	55	yes	ovarian_cancer	conventiol_therapy_ineffectiveness	no	none	A2	B1	L1	non-L4	CD	no	none	no	none	CD_Finish	UST_Finish	CD_UST_Finish	Finish	Finish	Finish.16	Finish.16	visit_3	visit_3	week_16	week_16	16																																D	SeT				UST_D	UST_SeT									none	none					CD_UST	CD_UST_SeT	CD_UST_	CD_UST_	CD_UST_	CD_D	CD_	CD_D_	CD_SeT	CD_SeT_	CD_	CD_	CD_	CD_visit_3	CD_visit_3	CD_UST_visit_3	CD_UST_visit_3	CD_UST_	P43_visit_3_	P43_visit_3_	P43_visit_3_D_	P43_visit_3_D_	P43_visit_3_	P43_visit_3_	P43_visit_3_	P43_visit_3_	CD_	CD_UST	CD_	CD_D_	CD_SeT_
PCR_neg_16S_B2_I	PCR_neg_16S_B2_I	plate_2	H8	ATAATAAAGAGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AAAGAGC	GCCAAT	CTRL																																																																																								none	none																							CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_					
P1_BA93_I_C	IS_P1_BA93_I_C	plate_2	A9	ATAATACGGCTCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACGGCTC	GCCAAT	P1	patient	25	F	CD_F	170	77	26.64	overweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	yes	IFX	A2	B2	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_Start	ADA_Start	CD_ADA_Start	Start	Start_switch_ADA	Start.0	Start.0_switch_ADA	visit_1	visit_1_switch_ADA	week_0	week_0_switch_ADA	0	02/11/2018	SC	160	no	none	yes	AZA	no	none	yes	Euthyrox	1.4	low	7	350	25.56	130			0	negative	6	6	CD		6	inactive	mild	baseline	baseline	Base	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_1	CD_visit_1_switch_ADA	CD_ADA_visit_1	CD_ADA_visit_1_switch_ADA	CD_ADA_no_yes	P1_visit_1_no	P1_visit_1_switch_ADA_no	P1_visit_1_C_no	P1_visit_1_switch_ADA_C_no	P1_visit_1_none	P1_visit_1_switch_ADA_none	P1_visit_1_none	P1_visit_1_switch_ADA_none	CD_Base	CD_ADA_Base	CD_no_Base	CD_C_no_Base	CD_SeS_no_Base
P1_BA93_I_E	IS_P1_BA93_I_E	plate_2	B9	ATAATACGACATA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACGACAT	GCCAAT	P1	patient	25	F	CD_F	170	77	26.64	overweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	yes	IFX	A2	B2	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_Start	ADA_Start	CD_ADA_Start	Start	Start_switch_ADA	Start.0	Start.0_switch_ADA	visit_1	visit_1_switch_ADA	week_0	week_0_switch_ADA	0	02/11/2018	SC	160	no	none	yes	AZA	no	none	yes	Euthyrox	1.4	low	7	350	25.56	130			0	negative	6	6	CD		6	inactive	mild	baseline	baseline	Base	E	Mo	no	none	BT_E	ADA_E	ADA_Mo	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_Mo	CD_ADA_no	CD_ADA_none	CD_ADA_BT_E	CD_E	CD_no	CD_E_no	CD_Mo	CD_Mo_no	CD_none	CD_none	CD_BT_E	CD_visit_1	CD_visit_1_switch_ADA	CD_ADA_visit_1	CD_ADA_visit_1_switch_ADA	CD_ADA_no_yes	P1_visit_1_no	P1_visit_1_switch_ADA_no	P1_visit_1_E_no	P1_visit_1_switch_ADA_E_no	P1_visit_1_none	P1_visit_1_switch_ADA_none	P1_visit_1_none	P1_visit_1_switch_ADA_none	CD_Base	CD_ADA_Base	CD_no_Base	CD_E_no_Base	CD_Mo_no_Base
P1_BA93_II_C	IS_P1_BA93_II_C	plate_2	C9	ATAATATCCCGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ATCCCGC	GCCAAT	P1	patient	25	F	CD_F	170	77	26.64	overweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	yes	IFX	A2	B2	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	16/11/2018	SC	80	no	none	yes	AZA	no	none	yes	Euthyrox	0.8	low	9.9	304	27.2	136	83	slightly_increased	20	negative	1	1	CD		1	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_2	CD_visit_2	CD_ADA_visit_2	CD_ADA_visit_2	CD_ADA_no_yes	P1_visit_2_no	P1_visit_2_no	P1_visit_2_C_no	P1_visit_2_C_no	P1_visit_2_none	P1_visit_2_none	P1_visit_2_none	P1_visit_2_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
P1_BA93_II_E	IS_P1_BA93_II_E	plate_2	D9	ATAATAGTGCGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGTGCGC	GCCAAT	P1	patient	25	F	CD_F	170	77	26.64	overweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	yes	IFX	A2	B2	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	16/11/2018	SC	80	no	none	yes	AZA	no	none	yes	Euthyrox	0.8	low	9.9	304	27.2	136	83	slightly_increased	20	negative	1	1	CD		1	inactive	remission	response	full_response	Full	E	Mo	no	none	BT_E	ADA_E	ADA_Mo	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_Mo	CD_ADA_no	CD_ADA_none	CD_ADA_BT_E	CD_E	CD_no	CD_E_no	CD_Mo	CD_Mo_no	CD_none	CD_none	CD_BT_E	CD_visit_2	CD_visit_2	CD_ADA_visit_2	CD_ADA_visit_2	CD_ADA_no_yes	P1_visit_2_no	P1_visit_2_no	P1_visit_2_E_no	P1_visit_2_E_no	P1_visit_2_none	P1_visit_2_none	P1_visit_2_none	P1_visit_2_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_E_no_Full	CD_Mo_no_Full
P1_BA93_III_C	IS_P1_BA93_III_C	plate_2	E9	ATAATAGACTCTA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGACTCT	GCCAAT	P1	patient	25	F	CD_F	170	78	26.99	overweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	yes	IFX	A2	B2	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	27/12/2018	SC	40	no	none	yes	AZA	no	none	yes	Euthyrox	0.9	low	6.8	297	26.45	131	43	normal	11.7	negative	1	1	CD		1	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_3	CD_visit_3	CD_ADA_visit_3	CD_ADA_visit_3	CD_ADA_no_yes	P1_visit_3_no	P1_visit_3_no	P1_visit_3_C_no	P1_visit_3_C_no	P1_visit_3_none	P1_visit_3_none	P1_visit_3_none	P1_visit_3_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
P1_BA93_III_E	IS_P1_BA93_III_E	plate_2	F9	ATAATAGGGGTTA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGGGGTT	GCCAAT	P1	patient	25	F	CD_F	170	78	26.99	overweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	yes	IFX	A2	B2	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	27/12/2018	SC	40	no	none	yes	AZA	no	none	yes	Euthyrox	0.9	low	6.8	297	26.45	131	43	normal	11.7	negative	1	1	CD		1	inactive	remission	response	full_response	Full	E	Mo	no	none	BT_E	ADA_E	ADA_Mo	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_Mo	CD_ADA_no	CD_ADA_none	CD_ADA_BT_E	CD_E	CD_no	CD_E_no	CD_Mo	CD_Mo_no	CD_none	CD_none	CD_BT_E	CD_visit_3	CD_visit_3	CD_ADA_visit_3	CD_ADA_visit_3	CD_ADA_no_yes	P1_visit_3_no	P1_visit_3_no	P1_visit_3_E_no	P1_visit_3_E_no	P1_visit_3_none	P1_visit_3_none	P1_visit_3_none	P1_visit_3_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_E_no_Full	CD_Mo_no_Full
P1_BA93_IV_C	IS_P1_BA93_IV_C	plate_2	G9	ATAATACTAGGGA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACTAGGG	GCCAAT	P1	patient	25	F	CD_F	170	79	27.34	overweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	yes	IFX	A2	B2	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	07/02/2019	SC	40	no	none	yes	AZA	no	none	yes	Euthyrox	0.7	low	7.7	334	32.98	137	115	slightly_increased	9.9	negative	1	1	CD		1	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_4	CD_visit_4	CD_ADA_visit_4	CD_ADA_visit_4	CD_ADA_no_yes	P1_visit_4_no	P1_visit_4_no	P1_visit_4_C_no	P1_visit_4_C_no	P1_visit_4_none	P1_visit_4_none	P1_visit_4_none	P1_visit_4_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
P1_BA93_IV_E	IS_P1_BA93_IV_E	plate_2	H9	ATAATATAGCCGA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ATAGCCG	GCCAAT	P1	patient	25	F	CD_F	170	79	27.34	overweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	yes	IFX	A2	B2	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	07/02/2019	SC	40	no	none	yes	AZA	no	none	yes	Euthyrox	0.7	low	7.7	334	32.98	137	115	slightly_increased	9.9	negative	1	1	CD		1	inactive	remission	response	full_response	Full	E	Mo	no	none	BT_E	ADA_E	ADA_Mo	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_Mo	CD_ADA_no	CD_ADA_none	CD_ADA_BT_E	CD_E	CD_no	CD_E_no	CD_Mo	CD_Mo_no	CD_none	CD_none	CD_BT_E	CD_visit_4	CD_visit_4	CD_ADA_visit_4	CD_ADA_visit_4	CD_ADA_no_yes	P1_visit_4_no	P1_visit_4_no	P1_visit_4_E_no	P1_visit_4_E_no	P1_visit_4_none	P1_visit_4_none	P1_visit_4_none	P1_visit_4_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_E_no_Full	CD_Mo_no_Full
P1_BA93_V_C	IS_P1_BA93_V_C	plate_2	A10	AGGGTACCTTCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACCTTCC	GCCAAT	P1	patient	25	F	CD_F	170	80	27.68	overweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	yes	IFX	A2	B2	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_22	week_22	22	21/03/2019	SC	40	no	none	yes	AZA	no	none	yes	Euthyrox	1.2	low	6.4	315	37	139	56	slightly_increased	7.9	negative	1	1	CD		1	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_5	CD_visit_5	CD_ADA_visit_5	CD_ADA_visit_5	CD_ADA_no_yes	P1_visit_5_no	P1_visit_5_no	P1_visit_5_C_no	P1_visit_5_C_no	P1_visit_5_none	P1_visit_5_none	P1_visit_5_none	P1_visit_5_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
P1_BA93_V_E	IS_P1_BA93_V_E	plate_2	B10	AGGGTAGCCACCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGCCACC	GCCAAT	P1	patient	25	F	CD_F	170	80	27.68	overweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	yes	IFX	A2	B2	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_22	week_22	22	21/03/2019	SC	40	no	none	yes	AZA	no	none	yes	Euthyrox	1.2	low	6.4	315	37	139	56	slightly_increased	7.9	negative	1	1	CD		1	inactive	remission	response	full_response	Full	E	Mo	no	none	BT_E	ADA_E	ADA_Mo	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_Mo	CD_ADA_no	CD_ADA_none	CD_ADA_BT_E	CD_E	CD_no	CD_E_no	CD_Mo	CD_Mo_no	CD_none	CD_none	CD_BT_E	CD_visit_5	CD_visit_5	CD_ADA_visit_5	CD_ADA_visit_5	CD_ADA_no_yes	P1_visit_5_no	P1_visit_5_no	P1_visit_5_E_no	P1_visit_5_E_no	P1_visit_5_none	P1_visit_5_none	P1_visit_5_none	P1_visit_5_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_E_no_Full	CD_Mo_no_Full
P1_BA93_VI_C	IS_P1_BA93_VI_C	plate_2	C10	AGGGTAACAGCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AACAGCC	GCCAAT	P1	patient	25	F	CD_F	170	81	28.03	overweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	yes	IFX	A2	B2	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_6	visit_6	week_26	week_26	26	23/05/2019	SC	40	no	none	yes	AZA	no	none	yes	Euthyrox	1.7	low	9.7	321	33.9	133	528	significantly_increased	0.2	negative	4	4	CD		4	inactive	remission	response	partial_response	Part	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_6	CD_visit_6	CD_ADA_visit_6	CD_ADA_visit_6	CD_ADA_no_yes	P1_visit_6_no	P1_visit_6_no	P1_visit_6_C_no	P1_visit_6_C_no	P1_visit_6_none	P1_visit_6_none	P1_visit_6_none	P1_visit_6_none	CD_Part	CD_ADA_Part	CD_no_Part	CD_C_no_Part	CD_SeS_no_Part
P1_BA93_VI_E	IS_P1_BA93_VI_E	plate_2	D10	AGGGTACGGCCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACGGCCC	GCCAAT	P1	patient	25	F	CD_F	170	81	28.03	overweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	yes	IFX	A2	B2	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_6	visit_6	week_26	week_26	26	23/05/2019	SC	40	no	none	yes	AZA	no	none	yes	Euthyrox	1.7	low	9.7	321	33.9	133	528	significantly_increased	0.2	negative	4	4	CD		4	inactive	remission	response	partial_response	Part	E	Mo	no	none	BT_E	ADA_E	ADA_Mo	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_Mo	CD_ADA_no	CD_ADA_none	CD_ADA_BT_E	CD_E	CD_no	CD_E_no	CD_Mo	CD_Mo_no	CD_none	CD_none	CD_BT_E	CD_visit_6	CD_visit_6	CD_ADA_visit_6	CD_ADA_visit_6	CD_ADA_no_yes	P1_visit_6_no	P1_visit_6_no	P1_visit_6_E_no	P1_visit_6_E_no	P1_visit_6_none	P1_visit_6_none	P1_visit_6_none	P1_visit_6_none	CD_Part	CD_ADA_Part	CD_no_Part	CD_E_no_Part	CD_Mo_no_Part
P1_BA93_VII_C	IS_P1_BA93_VII_C	plate_2	E10	AGGGTACTGGCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACTGGCC	GCCAAT	P1	patient	25	F	CD_F	170	81	28.03	overweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	yes	IFX	A2	B2	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_7	visit_7	week_32	week_32	32	18/07/2019	SC	40	no	none	yes	AZA	no	none	yes	Euthyrox	5.5	low	7.6	373	41.25	137	459	significantly_increased	0.1	negative	5	5	CD		5	inactive	mild	no_response	no_response	NoRe	C	SeS	yes	none	SAE_C	SAE.ADA_C	SAE.ADA_SeS	none	none	none	none	C	none	none	none	none	none	herpes	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_yes	CD_ADA_none	CD_ADA_SAE_C	CD_C	CD_yes	CD_C_yes	CD_SeS	CD_SeS_yes	CD_none	CD_none	CD_SAE_C	CD_visit_7	CD_visit_7	CD_ADA_visit_7	CD_ADA_visit_7	CD_ADA_yes_yes	P1_visit_7_yes	P1_visit_7_yes	P1_visit_7_C_yes	P1_visit_7_C_yes	P1_visit_7_none	P1_visit_7_none	P1_visit_7_none	P1_visit_7_none	CD_NoRe	CD_ADA_NoRe	CD_yes_NoRe	CD_C_yes_NoRe	CD_SeS_yes_NoRe
P1_BA93_VII_E	IS_P1_BA93_VII_E	plate_2	F10	AGGGTAAGGACCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AAGGACC	GCCAAT	P1	patient	25	F	CD_F	170	81	28.03	overweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	yes	IFX	A2	B2	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_7	visit_7	week_32	week_32	32	18/07/2019	SC	40	no	none	yes	AZA	no	none	yes	Euthyrox	5.5	low	7.6	373	41.25	137	459	significantly_increased	0.1	negative	5	5	CD		5	inactive	mild	no_response	no_response	NoRe	E	Mo	yes	none	SAE_E	SAE.ADA_E	SAE.ADA_Mo	none	none	none	none	none	none	E	none	none	none	herpes	none	none	none	CD_ADA	CD_ADA_Mo	CD_ADA_yes	CD_ADA_none	CD_ADA_SAE_E	CD_E	CD_yes	CD_E_yes	CD_Mo	CD_Mo_yes	CD_none	CD_none	CD_SAE_E	CD_visit_7	CD_visit_7	CD_ADA_visit_7	CD_ADA_visit_7	CD_ADA_yes_yes	P1_visit_7_yes	P1_visit_7_yes	P1_visit_7_E_yes	P1_visit_7_E_yes	P1_visit_7_none	P1_visit_7_none	P1_visit_7_none	P1_visit_7_none	CD_NoRe	CD_ADA_NoRe	CD_yes_NoRe	CD_E_yes_NoRe	CD_Mo_yes_NoRe
P1_BA93_VIII_C	IS_P1_BA93_VIII_C	plate_2	G10	AGGGTACGCTCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACGCTCC	GCCAAT	P1	patient	25	F	CD_F	170	81	28.03	overweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	yes	IFX	A2	B2	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_Finish	ADA_Finish	CD_ADA_Finish	Finish	Finish	Finish.38	Finish.38	visit_8	visit_8	week_38	week_38	38	13/09/2019	SC	40	no	none	yes	AZA	no	none	yes	Euthyrox	2.4	low	7.3	363	30.87	143	764	significantly_increased	0.8	negative	6	6	CD		6	inactive	mild	no_response	no_response	NoRe	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	"perially_2_drains,_intermittent_purulent_secretions,_joint_pain_and_stiffness"	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_8	CD_visit_8	CD_ADA_visit_8	CD_ADA_visit_8	CD_ADA_no_yes	P1_visit_8_no	P1_visit_8_no	P1_visit_8_C_no	P1_visit_8_C_no	P1_visit_8_none	P1_visit_8_none	P1_visit_8_none	P1_visit_8_none	CD_NoRe	CD_ADA_NoRe	CD_no_NoRe	CD_C_no_NoRe	CD_SeS_no_NoRe
P1_BA93_VIII_E	IS_P1_BA93_VIII_E	plate_2	H10	AGGGTAGCGCCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGCGCCC	GCCAAT	P1	patient	25	F	CD_F	170	81	28.03	overweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	23	yes	hypothyroidism	allergic_reaction_to_IFX_switch_without_washout	yes	IFX	A2	B2	L3	non-L4	CD	no	none	yes	ileocecal_resection	CD_Finish	ADA_Finish	CD_ADA_Finish	Finish	Finish	Finish.38	Finish.38	visit_8	visit_8	week_38	week_38	38	13/09/2019	SC	40	no	none	yes	AZA	no	none	yes	Euthyrox	2.4	low	7.3	363	30.87	143	764	significantly_increased	0.8	negative	6	6	CD		6	inactive	mild	no_response	no_response	NoRe	E	Mo	no	none	BT_E	ADA_E	ADA_Mo	none	none	none	none	none	none	none	none	none	none	none	none	none	"perially_2_drains,_intermittent_purulent_secretions,_joint_pain_and_stiffness"	CD_ADA	CD_ADA_Mo	CD_ADA_no	CD_ADA_none	CD_ADA_BT_E	CD_E	CD_no	CD_E_no	CD_Mo	CD_Mo_no	CD_none	CD_none	CD_BT_E	CD_visit_8	CD_visit_8	CD_ADA_visit_8	CD_ADA_visit_8	CD_ADA_no_yes	P1_visit_8_no	P1_visit_8_no	P1_visit_8_E_no	P1_visit_8_E_no	P1_visit_8_none	P1_visit_8_none	P1_visit_8_none	P1_visit_8_none	CD_NoRe	CD_ADA_NoRe	CD_no_NoRe	CD_E_no_NoRe	CD_Mo_no_NoRe
P9_AM78_I_D	IS_P9_AM78_I_D	plate_2	A11	AGGGTAATTAGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AATTAGC	GCCAAT	P9	patient	40	M	UC_M	183	75	22.4	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	3	37	no	none	EIM	no	none	A2	UC	UC	UC	E1	yes	uveitis_sakroiliitis	no	none	UC_Start	ADA_Start	UC_ADA_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	22/11/2018	SC	160	yes	Pentasa	yes	AZA	no	none	no	none	0.9	low	5.1	207	152.54	136	51	slightly_increased	0	negative	UC		4	4	4	inactive	mild	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_1	UC_visit_1	UC_ADA_visit_1	UC_ADA_visit_1	UC_ADA_no_yes	P9_visit_1_no	P9_visit_1_no	P9_visit_1_D_no	P9_visit_1_D_no	P9_visit_1_none	P9_visit_1_none	P9_visit_1_none	P9_visit_1_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
P9_AM78_II_D	IS_P9_AM78_II_D	plate_2	B11	AGGGTATCCTCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ATCCTCC	GCCAAT	P9	patient	40	M	UC_M	183	75	22.4	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	3	37	no	none	EIM	no	none	A2	UC	UC	UC	E1	yes	uveitis_sakroiliitis	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	11/12/2018	SC	80	yes	Pentasa	yes	AZA	no	none	yes	Maltofer	7.1	low	6.1	281	141.7	132	42	normal	11.2	negative	UC		3	3	3	inactive	mild	response	partial_response	Part	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	upper_respiratory_tract_infection	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_2	UC_visit_2	UC_ADA_visit_2	UC_ADA_visit_2	UC_ADA_no_yes	P9_visit_2_no	P9_visit_2_no	P9_visit_2_D_no	P9_visit_2_D_no	P9_visit_2_none	P9_visit_2_none	P9_visit_2_none	P9_visit_2_none	UC_Part	UC_ADA_Part	UC_no_Part	UC_D_no_Part	UC_SeT_no_Part
P9_AM78_III_D	IS_P9_AM78_III_D	plate_2	C11	AGGGTAACCCGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AACCCGC	GCCAAT	P9	patient	40	M	UC_M	183	75	22.4	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	3	37	no	none	EIM	no	none	A2	UC	UC	UC	E1	yes	uveitis_sakroiliitis	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	29/01/2019	SC	40	yes	Pentasa	yes	AZA	no	none	yes	Maltofer	8.3	low	3.6	231	304.83	119	23	normal	14.3	negative	UC		3	3	3	inactive	mild	response	partial_response	Part	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_3	UC_visit_3	UC_ADA_visit_3	UC_ADA_visit_3	UC_ADA_no_yes	P9_visit_3_no	P9_visit_3_no	P9_visit_3_D_no	P9_visit_3_D_no	P9_visit_3_none	P9_visit_3_none	P9_visit_3_none	P9_visit_3_none	UC_Part	UC_ADA_Part	UC_no_Part	UC_D_no_Part	UC_SeT_no_Part
P9_AM78_IV_D	IS_P9_AM78_IV_D	plate_2	D11	AGGGTATCCCTCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ATCCCTC	GCCAAT	P9	patient	40	M	UC_M	183	75	22.4	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	3	37	no	none	EIM	no	none	A2	UC	UC	UC	E1	yes	uveitis_sakroiliitis	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	14/03/2019	SC	40	yes	Pentasa	yes	AZA	no	none	yes	Maltofer	0.5	low	3.7	281	403.74	123	60	slightly_increased	16.3	negative	UC		2	2	2	inactive	mild	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_4	UC_visit_4	UC_ADA_visit_4	UC_ADA_visit_4	UC_ADA_no_yes	P9_visit_4_no	P9_visit_4_no	P9_visit_4_D_no	P9_visit_4_D_no	P9_visit_4_none	P9_visit_4_none	P9_visit_4_none	P9_visit_4_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
P9_AM78_V_D	IS_P9_AM78_V_D	plate_2	E11	AGGGTACTCGCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACTCGCC	GCCAAT	P9	patient	40	M	UC_M	183	75	22.4	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	3	37	no	none	EIM	no	none	A2	UC	UC	UC	E1	yes	uveitis_sakroiliitis	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_22	week_22	22	25/04/2019	SC	40	yes	Pentasa	yes	AZA	no	none	yes	Sorbifer	2.7	low	4	198	171.73	135	7	normal	20	negative	UC		1	1	1	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	virosis	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_5	UC_visit_5	UC_ADA_visit_5	UC_ADA_visit_5	UC_ADA_no_yes	P9_visit_5_no	P9_visit_5_no	P9_visit_5_D_no	P9_visit_5_D_no	P9_visit_5_none	P9_visit_5_none	P9_visit_5_none	P9_visit_5_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
P9_AM78_VI_D	IS_P9_AM78_VI_D	plate_2	F11	AGGGTAGGCCTCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGGCCTC	GCCAAT	P9	patient	40	M	UC_M	183	75	22.4	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	3	37	no	none	EIM	no	none	A2	UC	UC	UC	E1	yes	uveitis_sakroiliitis	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_6	visit_6	week_26	week_26	26	11/06/2019	SC	40	yes	Pentasa	yes	AZA	no	none	yes	Sorbifer	1	low	5.8	243	131.69	139	24	normal	18.1	negative	UC		1	1	1	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_6	UC_visit_6	UC_ADA_visit_6	UC_ADA_visit_6	UC_ADA_no_yes	P9_visit_6_no	P9_visit_6_no	P9_visit_6_D_no	P9_visit_6_D_no	P9_visit_6_none	P9_visit_6_none	P9_visit_6_none	P9_visit_6_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
P9_AM78_VII_D	IS_P9_AM78_VII_D	plate_2	G11	AGGGTACCCAGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACCCAGC	GCCAAT	P9	patient	40	M	UC_M	183	75	22.4	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	3	37	no	none	EIM	no	none	A2	UC	UC	UC	E1	yes	uveitis_sakroiliitis	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_7	visit_7	week_32	week_32	32	25/07/2019	SC	40	yes	Pentasa	yes	AZA	no	none	yes	Sorbifer_	0.8	low	5.5	199	124.73	143	36	normal	16.6	negative	UC		1	1	1	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_7	UC_visit_7	UC_ADA_visit_7	UC_ADA_visit_7	UC_ADA_no_yes	P9_visit_7_no	P9_visit_7_no	P9_visit_7_D_no	P9_visit_7_D_no	P9_visit_7_none	P9_visit_7_none	P9_visit_7_none	P9_visit_7_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
P9_AM78_VIII_D	IS_P9_AM78_VIII_D	plate_2	H11	AGGGTAAAGAGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AAAGAGC	GCCAAT	P9	patient	40	M	UC_M	183	75	22.4	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	3	37	no	none	EIM	no	none	A2	UC	UC	UC	E1	yes	uveitis_sakroiliitis	no	none	UC_Finish	ADA_Finish	UC_ADA_Finish	Finish	Finish	Finish.38	Finish.38	visit_8	visit_8	week_38	week_38	38	05/09/2019	SC	40	yes	Pentasa	yes	AZA	no	none	yes	Sorbifer_	5.5	low	4.8	206	152.98	135	253	significantly_increased	10.5	negative	UC		2	2	2	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_8	UC_visit_8	UC_ADA_visit_8	UC_ADA_visit_8	UC_ADA_no_yes	P9_visit_8_no	P9_visit_8_no	P9_visit_8_D_no	P9_visit_8_D_no	P9_visit_8_none	P9_visit_8_none	P9_visit_8_none	P9_visit_8_none	UC_Part	UC_ADA_Part	UC_no_Part	UC_D_no_Part	UC_SeT_no_Part
P10_VM73_I_D	IS_P10_VM73_I_D	plate_2	A12	AGGGTACGGCTCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACGGCTC	GCCAAT	P10	patient	45	F	CD_F	158	77	30.84	obesity	smoker	CD_smoker	CD	IFX	Flixabi	1	43	yes	"asthma,_Barretts_esophagus"	conventiol_therapy_ineffectiveness	no	none	A2	B1	L3	non-L4	CD	yes	joints	no	none	CD_Start	IFX_Start	CD_IFX_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	23/11/2018	IV	5	no	none	no	none	yes	Budesonid	yes	Nolpaza_Famosan_Caltrate_Viganti_B12_Symbicort_Aerius	4.3	low	8	415	27.56	135	1737	significantly_increased	0	negative	6	6	CD		6	inactive	mild	baseline	baseline	Base	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_1	CD_visit_1	CD_IFX_visit_1	CD_IFX_visit_1	CD_IFX_no_no	P10_visit_1_no	P10_visit_1_no	P10_visit_1_D_no	P10_visit_1_D_no	P10_visit_1_none	P10_visit_1_none	P10_visit_1_none	P10_visit_1_none	CD_Base	CD_IFX_Base	CD_no_Base	CD_D_no_Base	CD_SeT_no_Base
P10_VM73_II_D	IS_P10_VM73_II_D	plate_2	B12	AGGGTACGACATA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACGACAT	GCCAAT	P10	patient	45	F	CD_F	158	77	30.84	obesity	smoker	CD_smoker	CD	IFX	Flixabi	1	43	yes	"asthma,_Barretts_esophagus"	conventiol_therapy_ineffectiveness	no	none	A2	B1	L3	non-L4	CD	yes	joints	no	none	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	07/12/2018	IV	5	no	none	no	none	yes	Budesonid	yes	Nolpaza_Famosan_Caltrate_Viganti_B12_Symbicort_Aerius	1.4	low	7.6	407	29.68	137	90	slightly_increased	20	negative	6	6	CD		6	inactive	mild	response	partial_response	Part	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_2	CD_visit_2	CD_IFX_visit_2	CD_IFX_visit_2	CD_IFX_no_no	P10_visit_2_no	P10_visit_2_no	P10_visit_2_D_no	P10_visit_2_D_no	P10_visit_2_none	P10_visit_2_none	P10_visit_2_none	P10_visit_2_none	CD_Part	CD_IFX_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P10_VM73_III_D	IS_P10_VM73_III_D	plate_2	C12	AGGGTATCCCGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ATCCCGC	GCCAAT	P10	patient	45	F	CD_F	158	79	31.65	obesity	smoker	CD_smoker	CD	IFX	Flixabi	1	43	yes	"asthma,_Barretts_esophagus"	conventiol_therapy_ineffectiveness	no	none	A2	B1	L3	non-L4	CD	yes	joints	no	none	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	04/01/2019	IV	5	no	none	no	none	yes	Budesonid	yes	Nolpaza_Famosan_Caltrate_Viganti_B12_Symbicort_Aerius	0.9	low	6.2	321	21.5	132	59	slightly_increased	20	negative	3	3	CD		3	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_3	CD_visit_3	CD_IFX_visit_3	CD_IFX_visit_3	CD_IFX_no_no	P10_visit_3_no	P10_visit_3_no	P10_visit_3_D_no	P10_visit_3_D_no	P10_visit_3_none	P10_visit_3_none	P10_visit_3_none	P10_visit_3_none	CD_Full	CD_IFX_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P10_VM73_IV_D	IS_P10_VM73_IV_D	plate_2	D12	AGGGTAGTGCGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGTGCGC	GCCAAT	P10	patient	45	F	CD_F	158	79	31.65	obesity	smoker	CD_smoker	CD	IFX	Flixabi	1	43	yes	"asthma,_Barretts_esophagus"	conventiol_therapy_ineffectiveness	no	none	A2	B1	L3	non-L4	CD	yes	joints	no	none	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	01/03/2019	IV	5	no	none	no	none	no	none	yes	Nolpaza_Famosan_Caltrate_Viganti_B12_Symbicort_Aerius	1.2	low	5.6	378	28.09	133	226	significantly_increased	2.6	negative	7	7	CD		7	inactive	mild	no_response	no_response	NoRe	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_4	CD_visit_4	CD_IFX_visit_4	CD_IFX_visit_4	CD_IFX_no_no	P10_visit_4_no	P10_visit_4_no	P10_visit_4_D_no	P10_visit_4_D_no	P10_visit_4_none	P10_visit_4_none	P10_visit_4_none	P10_visit_4_none	CD_NoRe	CD_IFX_NoRe	CD_no_NoRe	CD_D_no_NoRe	CD_SeT_no_NoRe
P10_VM73_V_D	IS_P10_VM73_V_D	plate_2	E12	AGGGTAGACTCTA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGACTCT	GCCAAT	P10	patient	45	F	CD_F	158	80	32.05	obesity	smoker	CD_smoker	CD	IFX	Flixabi	1	43	yes	"asthma,_Barretts_esophagus"	conventiol_therapy_ineffectiveness	no	none	A2	B1	L3	non-L4	CD	yes	joints	no	none	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_22	week_22	22	26/04/2019	IV	5	no	none	no	none	no	none	yes	Nolpaza_Famosan_Caltrate_Viganti_B12_Symbicort_Aerius	3.9	low	7.4	376	19.26	137	333	significantly_increased	1.5	positive	6	6	CD		6	inactive	mild	response	partial_response	Part	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_5	CD_visit_5	CD_IFX_visit_5	CD_IFX_visit_5	CD_IFX_no_no	P10_visit_5_no	P10_visit_5_no	P10_visit_5_D_no	P10_visit_5_D_no	P10_visit_5_none	P10_visit_5_none	P10_visit_5_none	P10_visit_5_none	CD_Part	CD_IFX_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P10_VM73_VI_D	IS_P10_VM73_VI_D	plate_2	F12	AGGGTAGGGGTTA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGGGGTT	GCCAAT	P10	patient	45	F	CD_F	158	80	32.05	obesity	smoker	CD_smoker	CD	IFX	Flixabi	1	43	yes	"asthma,_Barretts_esophagus"	conventiol_therapy_ineffectiveness	no	none	A2	B1	L3	non-L4	CD	yes	joints	no	none	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_6	visit_6	week_32	week_32	32	01/07/2019	IV	5	no	none	no	none	no	none	yes	Nolpaza_Famosan_Caltrate_Viganti_B12_Symbicort_Aerius	7.5	low	7.6	413	17.91	139	125	slightly_increased	0.2	positive	6	6	CD		6	inactive	mild	no_response	no_response	NoRe	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_6	CD_visit_6	CD_IFX_visit_6	CD_IFX_visit_6	CD_IFX_no_no	P10_visit_6_no	P10_visit_6_no	P10_visit_6_D_no	P10_visit_6_D_no	P10_visit_6_none	P10_visit_6_none	P10_visit_6_none	P10_visit_6_none	CD_NoRe	CD_IFX_NoRe	CD_no_NoRe	CD_D_no_NoRe	CD_SeT_no_NoRe
P10_VM73_VII_D	IS_P10_VM73_VII_D	plate_2	G12	AGGGTACTAGGGA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACTAGGG	GCCAAT	P10	patient	45	F	CD_F	158	80	32.05	obesity	smoker	CD_smoker	CD	IFX	Flixabi	1	43	yes	"asthma,_Barretts_esophagus"	conventiol_therapy_ineffectiveness	no	none	A2	B1	L3	non-L4	CD	yes	joints	no	none	CD_Finish	IFX_Finish	CD_IFX_Finish	Finish	Finish	Finish.38	Finish.38	visit_7	visit_7	week_38	week_38	38	30/08/2019	IV	5	no	none	no	none	no	none	yes	Nolpaza_Famosan_Caltrate_Viganti_B12_Symbicort_Aerius	4.3	low	8.2	435	17.2	134	279	significantly_increased	37.3	positive	6	6	CD		6	inactive	mild	no_response	no_response	NoRe	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_7	CD_visit_7	CD_IFX_visit_7	CD_IFX_visit_7	CD_IFX_no_no	P10_visit_7_no	P10_visit_7_no	P10_visit_7_D_no	P10_visit_7_D_no	P10_visit_7_none	P10_visit_7_none	P10_visit_7_none	P10_visit_7_none	CD_NoRe	CD_IFX_NoRe	CD_no_NoRe	CD_D_no_NoRe	CD_SeT_no_NoRe
PCR_neg_16S_B2_II	PCR_neg_16S_B2_II	plate_2	H12	AGGGTATAGCCGA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ATAGCCG	GCCAAT	CTRL																																																																																								none	none																							CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_					
P4_HJ94_I_D	IS_P4_HJ94_I_D	plate_3	A1	AAAGCACCTTCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACCTTCC	CTTGTA	P4	patient	24	M	CD_M	183	66	19.71	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	18	6	no	none	biological_therapy_ineffectiveness_IFX_switch_without_washout	yes	IFX	A1	B3	L3	non-L4	CD	yes	joints	yes	hemicolectomy_and_ileocecal_resection	CD_Start	ADA_Start	CD_ADA_Start	Start	Start_switch_ADA	Start.0	Start.0_switch_ADA	visit_1	visit_1_switch_ADA	week_0	week_0_switch_ADA	0	09/11/2018	SC	160	no	none	no	AZA	no	none	no	none	25.5	high	8.9	232	78.79	147			0	negative	1	1	CD		1	inactive	remission	baseline	baseline	Base	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_1	CD_visit_1_switch_ADA	CD_ADA_visit_1	CD_ADA_visit_1_switch_ADA	CD_ADA_no_no	P4_visit_1_no	P4_visit_1_switch_ADA_no	P4_visit_1_D_no	P4_visit_1_switch_ADA_D_no	P4_visit_1_none	P4_visit_1_switch_ADA_none	P4_visit_1_none	P4_visit_1_switch_ADA_none	CD_Base	CD_ADA_Base	CD_no_Base	CD_D_no_Base	CD_SeT_no_Base
P4_HJ94_II_D	IS_P4_HJ94_II_D	plate_3	B1	AAAGCAGCCACCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGCCACC	CTTGTA	P4	patient	24	M	CD_M	183	67	20.01	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	18	6	no	none	biological_therapy_ineffectiveness_IFX_switch_without_washout	yes	IFX	A1	B3	L3	non-L4	CD	yes	joints	yes	hemicolectomy_and_ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	23/11/2018	SC	80	no	none	no	AZA	no	none	no	none	5.1	low	7.2	218	78.27	144	364	significantly_increased	17.2	negative	0	0	CD		0	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_2	CD_visit_2	CD_ADA_visit_2	CD_ADA_visit_2	CD_ADA_no_no	P4_visit_2_no	P4_visit_2_no	P4_visit_2_D_no	P4_visit_2_D_no	P4_visit_2_none	P4_visit_2_none	P4_visit_2_none	P4_visit_2_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P4_HJ94_III_D	IS_P4_HJ94_III_D	plate_3	C1	AAAGCAACAGCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AACAGCC	CTTGTA	P4	patient	24	M	CD_M	183	65	19.41	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	18	6	no	none	biological_therapy_ineffectiveness_IFX_switch_without_washout	yes	IFX	A1	B3	L3	non-L4	CD	yes	joints	yes	hemicolectomy_and_ileocecal_resection	CD_Finish	ADA_Finish	CD_ADA_Finish	Finish	Finish	Finish.8	Finish.8	visit_3	visit_3	week_8	week_8	8	17/01/2019	SC	40	no	none	no	AZA	no	none	no	none	4.2	low	6.5	225	45.54	151			12	negative	0	0	CD		0	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_3	CD_visit_3	CD_ADA_visit_3	CD_ADA_visit_3	CD_ADA_no_no	P4_visit_3_no	P4_visit_3_no	P4_visit_3_D_no	P4_visit_3_D_no	P4_visit_3_none	P4_visit_3_none	P4_visit_3_none	P4_visit_3_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P12_SK91_I_D	IS_P12_SK91_I_D	plate_3	D1	AAAGCACGGCCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACGGCCC	CTTGTA	P12	patient	27	F	UC_F	168	56	19.84	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	10	17	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_Start	ADA_Start	UC_ADA_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	26/11/2018	SC	160	yes	Asacol	no	none	yes	Cortiment	no	none	2.6	low	6.7	373	16.4	128	5019	significantly_increased	0	negative	UC		6	6	6	active	moderate	baseline	baseline	Base	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_1	UC_visit_1	UC_ADA_visit_1	UC_ADA_visit_1	UC_ADA_no_no	P12_visit_1_no	P12_visit_1_no	P12_visit_1_D_no	P12_visit_1_D_no	P12_visit_1_none	P12_visit_1_none	P12_visit_1_none	P12_visit_1_none	UC_Base	UC_ADA_Base	UC_no_Base	UC_D_no_Base	UC_SeT_no_Base
P12_SK91_II_D	IS_P12_SK91_II_D	plate_3	E1	AAAGCACTGGCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACTGGCC	CTTGTA	P12	patient	27	F	UC_F	168	56	19.84	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	10	17	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	10/12/2018	SC	80	yes	Asacol	no	none	yes	Cortiment	no	none	0.9	low	7.1	366	18.37	126	5413	significantly_increased	20	negative	UC		4	4	4	inactive	mild	response	partial_response	Part	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_2	UC_visit_2	UC_ADA_visit_2	UC_ADA_visit_2	UC_ADA_no_no	P12_visit_2_no	P12_visit_2_no	P12_visit_2_D_no	P12_visit_2_D_no	P12_visit_2_none	P12_visit_2_none	P12_visit_2_none	P12_visit_2_none	UC_Part	UC_ADA_Part	UC_no_Part	UC_D_no_Part	UC_SeT_no_Part
P12_SK91_III_D	IS_P12_SK91_III_D	plate_3	F1	AAAGCAAGGACCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AAGGACC	CTTGTA	P12	patient	27	F	UC_F	168	56	19.84	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	10	17	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	21/01/2019	SC	40	yes	Asacol	no	none	yes	Cortiment	no	none	2.5	low	7.5	405	10.28	131	146	slightly_increased	20	negative	UC		3	3	3	inactive	mild	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_3	UC_visit_3	UC_ADA_visit_3	UC_ADA_visit_3	UC_ADA_no_no	P12_visit_3_no	P12_visit_3_no	P12_visit_3_D_no	P12_visit_3_D_no	P12_visit_3_none	P12_visit_3_none	P12_visit_3_none	P12_visit_3_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
P12_SK91_IV_D	IS_P12_SK91_IV_D	plate_3	G1	AAAGCACGCTCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACGCTCC	CTTGTA	P12	patient	27	F	UC_F	168	56	19.84	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	10	17	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	04/03/2019	SC	40	yes	Asacol	no	none	no	none	no	none	6.6	low	6	430	8.23	119	360	significantly_increased	17.7	negative	UC		5	5	5	active	moderate	response	partial_response	Part	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_4	UC_visit_4	UC_ADA_visit_4	UC_ADA_visit_4	UC_ADA_no_no	P12_visit_4_no	P12_visit_4_no	P12_visit_4_D_no	P12_visit_4_D_no	P12_visit_4_none	P12_visit_4_none	P12_visit_4_none	P12_visit_4_none	UC_Part	UC_ADA_Part	UC_no_Part	UC_D_no_Part	UC_SeT_no_Part
P12_SK91_V_D	IS_P12_SK91_V_D	plate_3	H1	AAAGCAGCGCCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGCGCCC	CTTGTA	P12	patient	27	F	UC_F	168	56	19.84	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	10	17	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_22	week_22	22	15/04/2019	SC	40	yes	Asacol	no	none	no	none	no	none	6.6	low	7.9	445	5.93	111	623	significantly_increased	5.5	negative	UC		6	6	6	active	moderate	no_response	no_response	NoRe	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_5	UC_visit_5	UC_ADA_visit_5	UC_ADA_visit_5	UC_ADA_no_no	P12_visit_5_no	P12_visit_5_no	P12_visit_5_D_no	P12_visit_5_D_no	P12_visit_5_none	P12_visit_5_none	P12_visit_5_none	P12_visit_5_none	UC_NoRe	UC_ADA_NoRe	UC_no_NoRe	UC_D_no_NoRe	UC_SeT_no_NoRe
P12_SK91_VI_D	IS_P12_SK91_VI_D	plate_3	A2	AAAGCAATTAGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AATTAGC	CTTGTA	P12	patient	27	F	UC_F	168	56	19.84	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	10	17	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_6	visit_6	week_26	week_26	26	27/05/2019	SC	40	yes	Asacol	no	none	no	none	no	none	12.8	high	7.7	455	5.9	106			12.4	negative	UC		6	6	6	active	moderate	no_response	no_response	NoRe	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_6	UC_visit_6	UC_ADA_visit_6	UC_ADA_visit_6	UC_ADA_no_no	P12_visit_6_no	P12_visit_6_no	P12_visit_6_D_no	P12_visit_6_D_no	P12_visit_6_none	P12_visit_6_none	P12_visit_6_none	P12_visit_6_none	UC_NoRe	UC_ADA_NoRe	UC_no_NoRe	UC_D_no_NoRe	UC_SeT_no_NoRe
P12_SK91_VII_D	IS_P12_SK91_VII_D	plate_3	B2	AAAGCATCCTCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ATCCTCC	CTTGTA	P12	patient	27	F	UC_F	168	55	19.49	normal	non-smoker	UC_non-smoker	UC	ADA	Imraldi	10	17	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_Finish	ADA_Finish	UC_ADA_Finish	Finish	Finish	Finish.32	Finish.32	visit_7	visit_7	week_32	week_32	32	08/07/2019	SC	40	yes	Asacol	no	none	no	none	no	none	14.9	high	8.5	430	5.86	110	75	slightly_increased	13.8	negative	UC		2	2	2	inactive	mild	response	partial_response	Part	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_7	UC_visit_7	UC_ADA_visit_7	UC_ADA_visit_7	UC_ADA_no_no	P12_visit_7_no	P12_visit_7_no	P12_visit_7_D_no	P12_visit_7_D_no	P12_visit_7_none	P12_visit_7_none	P12_visit_7_none	P12_visit_7_none	UC_Part	UC_ADA_Part	UC_no_Part	UC_D_no_Part	UC_SeT_no_Part
P13_SI74_I_C	IS_P13_SI74_I_C	plate_3	C2	AAAGCAACCCGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AACCCGC	CTTGTA	P13	patient	44	F	CD_F	160	47	18.36	underweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	42	no	none	EIM	no	none	A3	B2	L3	L4	CD	yes	joints	yes	ileocecal_resection	CD_Start	ADA_Start	CD_ADA_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	03/12/2018	SC	160	no	none	yes	AZA	yes	Hydrokortizon	yes	Vasosan_Caltrate	2.2	low	6.9	343	9.89	112	756	significantly_increased	0	negative	6	6	CD		6	inactive	mild	baseline	baseline	Base	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_1	CD_visit_1	CD_ADA_visit_1	CD_ADA_visit_1	CD_ADA_no_yes	P13_visit_1_no	P13_visit_1_no	P13_visit_1_C_no	P13_visit_1_C_no	P13_visit_1_none	P13_visit_1_none	P13_visit_1_none	P13_visit_1_none	CD_Base	CD_ADA_Base	CD_no_Base	CD_C_no_Base	CD_SeS_no_Base
P13_SI74_I_D	IS_P13_SI74_I_D	plate_3	D2	AAAGCATCCCTCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ATCCCTC	CTTGTA	P13	patient	44	F	CD_F	160	47	18.36	underweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	42	no	none	EIM	no	none	A3	B2	L3	L4	CD	yes	joints	yes	ileocecal_resection	CD_Start	ADA_Start	CD_ADA_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	03/12/2018	SC	160	no	none	yes	AZA	yes	Hydrokortizon	yes	Vasosan_Caltrate	2.2	low	6.9	343	9.89	112	756	significantly_increased	0	negative	6	6	CD		6	inactive	mild	baseline	baseline	Base	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_1	CD_visit_1	CD_ADA_visit_1	CD_ADA_visit_1	CD_ADA_no_yes	P13_visit_1_no	P13_visit_1_no	P13_visit_1_D_no	P13_visit_1_D_no	P13_visit_1_none	P13_visit_1_none	P13_visit_1_none	P13_visit_1_none	CD_Base	CD_ADA_Base	CD_no_Base	CD_D_no_Base	CD_SeT_no_Base
P13_SI74_II_C	IS_P13_SI74_II_C	plate_3	E2	AAAGCACTCGCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACTCGCC	CTTGTA	P13	patient	44	F	CD_F	160	47	18.36	underweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	42	no	none	EIM	no	none	A3	B2	L3	L4	CD	yes	joints	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	17/12/2018	SC	80	no	none	yes	AZA	yes	Hydrokortizon	yes	Vasosan_Caltrate	0.5	low	5.3	314	9.04	115	196	slightly_increased	20	positive	5	5	CD		5	inactive	mild	response	partial_response	Part	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_2	CD_visit_2	CD_ADA_visit_2	CD_ADA_visit_2	CD_ADA_no_yes	P13_visit_2_no	P13_visit_2_no	P13_visit_2_C_no	P13_visit_2_C_no	P13_visit_2_none	P13_visit_2_none	P13_visit_2_none	P13_visit_2_none	CD_Part	CD_ADA_Part	CD_no_Part	CD_C_no_Part	CD_SeS_no_Part
P13_SI74_II_D	IS_P13_SI74_II_D	plate_3	F2	AAAGCAGGCCTCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGGCCTC	CTTGTA	P13	patient	44	F	CD_F	160	47	18.36	underweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	42	no	none	EIM	no	none	A3	B2	L3	L4	CD	yes	joints	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	17/12/2018	SC	80	no	none	yes	AZA	yes	Hydrokortizon	yes	Vasosan_Caltrate	0.5	low	5.3	314	9.04	115	196	slightly_increased	20	positive	5	5	CD		5	inactive	mild	response	partial_response	Part	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_2	CD_visit_2	CD_ADA_visit_2	CD_ADA_visit_2	CD_ADA_no_yes	P13_visit_2_no	P13_visit_2_no	P13_visit_2_D_no	P13_visit_2_D_no	P13_visit_2_none	P13_visit_2_none	P13_visit_2_none	P13_visit_2_none	CD_Part	CD_ADA_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P13_SI74_III_C	IS_P13_SI74_III_C	plate_3	G2	AAAGCACCCAGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACCCAGC	CTTGTA	P13	patient	44	F	CD_F	160	47	18.36	underweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	42	no	none	EIM	no	none	A3	B2	L3	L4	CD	yes	joints	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	25/01/2019	SC	40	no	none	yes	AZA	yes	Hydrokortizon	yes	Vasosan_Caltrate_Sorbifer	0.3	low	6.6	256	34.71	126	43	normal	20	negative	5	5	CD		5	inactive	mild	response	partial_response	Part	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_3	CD_visit_3	CD_ADA_visit_3	CD_ADA_visit_3	CD_ADA_no_yes	P13_visit_3_no	P13_visit_3_no	P13_visit_3_C_no	P13_visit_3_C_no	P13_visit_3_none	P13_visit_3_none	P13_visit_3_none	P13_visit_3_none	CD_Part	CD_ADA_Part	CD_no_Part	CD_C_no_Part	CD_SeS_no_Part
P13_SI74_III_D	IS_P13_SI74_III_D	plate_3	H2	AAAGCAAAGAGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AAAGAGC	CTTGTA	P13	patient	44	F	CD_F	160	47	18.36	underweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	42	no	none	EIM	no	none	A3	B2	L3	L4	CD	yes	joints	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	25/01/2019	SC	40	no	none	yes	AZA	yes	Hydrokortizon	yes	Vasosan_Caltrate_Sorbifer	0.3	low	6.6	256	34.71	126	43	normal	20	negative	5	5	CD		5	inactive	mild	response	partial_response	Part	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_3	CD_visit_3	CD_ADA_visit_3	CD_ADA_visit_3	CD_ADA_no_yes	P13_visit_3_no	P13_visit_3_no	P13_visit_3_D_no	P13_visit_3_D_no	P13_visit_3_none	P13_visit_3_none	P13_visit_3_none	P13_visit_3_none	CD_Part	CD_ADA_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P13_SI74_V_C	IS_P13_SI74_V_C	plate_3	A3	AAAGCACGGCTCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACGGCTC	CTTGTA	P13	patient	44	F	CD_F	160	48	18.75	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	42	no	none	EIM	no	none	A3	B2	L3	L4	CD	yes	joints	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_22	week_22	22	18/04/2019	SC	40	no	none	yes	AZA	yes	Hydrokortizon	yes	Vasosan_Caltarte_Sorbifer	0.3	low	4.8	269	31.12	132	49	normal	20	negative	2	2	CD		2	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_5	CD_visit_5	CD_ADA_visit_5	CD_ADA_visit_5	CD_ADA_no_yes	P13_visit_5_no	P13_visit_5_no	P13_visit_5_C_no	P13_visit_5_C_no	P13_visit_5_none	P13_visit_5_none	P13_visit_5_none	P13_visit_5_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
P13_SI74_V_D	IS_P13_SI74_V_D	plate_3	B3	AAAGCACGACATA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACGACAT	CTTGTA	P13	patient	44	F	CD_F	160	48	18.75	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	42	no	none	EIM	no	none	A3	B2	L3	L4	CD	yes	joints	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_22	week_22	22	18/04/2019	SC	40	no	none	yes	AZA	yes	Hydrokortizon	yes	Vasosan_Caltarte_Sorbifer	0.3	low	4.8	269	31.12	132	49	normal	20	negative	2	2	CD		2	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_5	CD_visit_5	CD_ADA_visit_5	CD_ADA_visit_5	CD_ADA_no_yes	P13_visit_5_no	P13_visit_5_no	P13_visit_5_D_no	P13_visit_5_D_no	P13_visit_5_none	P13_visit_5_none	P13_visit_5_none	P13_visit_5_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P13_SI74_VII_C	IS_P13_SI74_VII_C	plate_3	C3	AAAGCATCCCGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ATCCCGC	CTTGTA	P13	patient	44	F	CD_F	160	47	18.36	underweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	42	no	none	EIM	no	none	A3	B2	L3	L4	CD	yes	joints	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_7	visit_7	week_32	week_32	32	11/07/2019	SC	40	no	none	yes	AZA	no	none	yes	Vasosan_Caltrate	0.4	low	5.9	290	17	130	130	slightly_increased	20	negative	3	3	CD		3	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_7	CD_visit_7	CD_ADA_visit_7	CD_ADA_visit_7	CD_ADA_no_yes	P13_visit_7_no	P13_visit_7_no	P13_visit_7_C_no	P13_visit_7_C_no	P13_visit_7_none	P13_visit_7_none	P13_visit_7_none	P13_visit_7_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
P13_SI74_VII_D	IS_P13_SI74_VII_D	plate_3	D3	AAAGCAGTGCGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGTGCGC	CTTGTA	P13	patient	44	F	CD_F	160	47	18.36	underweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	42	no	none	EIM	no	none	A3	B2	L3	L4	CD	yes	joints	yes	ileocecal_resection	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_7	visit_7	week_32	week_32	32	11/07/2019	SC	40	no	none	yes	AZA	no	none	yes	Vasosan_Caltrate	0.4	low	5.9	290	17	130	130	slightly_increased	20	negative	3	3	CD		3	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_7	CD_visit_7	CD_ADA_visit_7	CD_ADA_visit_7	CD_ADA_no_yes	P13_visit_7_no	P13_visit_7_no	P13_visit_7_D_no	P13_visit_7_D_no	P13_visit_7_none	P13_visit_7_none	P13_visit_7_none	P13_visit_7_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P13_SI74_VIII_C	IS_P13_SI74_VIII_C	plate_3	E3	AAAGCAGACTCTA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGACTCT	CTTGTA	P13	patient	44	F	CD_F	160	47	18.36	underweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	42	no	none	EIM	no	none	A3	B2	L3	L4	CD	yes	joints	yes	ileocecal_resection	CD_Finish	ADA_Finish	CD_ADA_Finish	Finish	Finish	Finish.38	Finish.38	visit_8	visit_8	week_38	week_38	38	22/08/2019	SC	40	no	none	no	AZA	no	none	yes	Caltrate	0.7	low	5.2	233	12.47	125	70	slightly_increased	15.1	negative	2	2	CD		2	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_8	CD_visit_8	CD_ADA_visit_8	CD_ADA_visit_8	CD_ADA_no_no	P13_visit_8_no	P13_visit_8_no	P13_visit_8_C_no	P13_visit_8_C_no	P13_visit_8_none	P13_visit_8_none	P13_visit_8_none	P13_visit_8_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
P13_SI74_VIII_D	IS_P13_SI74_VIII_D	plate_3	F3	AAAGCAGGGGTTA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGGGGTT	CTTGTA	P13	patient	44	F	CD_F	160	47	18.36	underweight	non-smoker	CD_non-smoker	CD	ADA	Imraldi	2	42	no	none	EIM	no	none	A3	B2	L3	L4	CD	yes	joints	yes	ileocecal_resection	CD_Finish	ADA_Finish	CD_ADA_Finish	Finish	Finish	Finish.38	Finish.38	visit_8	visit_8	week_38	week_38	38	22/08/2019	SC	40	no	none	no	AZA	no	none	yes	Caltrate	0.7	low	5.2	233	12.47	125	70	slightly_increased	15.1	negative	2	2	CD		2	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_8	CD_visit_8	CD_ADA_visit_8	CD_ADA_visit_8	CD_ADA_no_no	P13_visit_8_no	P13_visit_8_no	P13_visit_8_D_no	P13_visit_8_D_no	P13_visit_8_none	P13_visit_8_none	P13_visit_8_none	P13_visit_8_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P14_MM78_I_C	IS_P14_MM78_I_C	plate_3	G3	AAAGCACTAGGGA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACTAGGG	CTTGTA	P14	patient	40	F	CD_F	162	54	20.58	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	1	39	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B1	L2	non-L4	CD	yes	joints_eyes	no	none	CD_Start	ADA_Start	CD_ADA_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	05/12/2018	SC	160	yes	Asacol	no	none	yes	Cortiment	no	none	0.6	low	9.4	185	8	128	39	normal	0	negative	0	0	CD		0	inactive	remission	baseline	baseline	Base	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_1	CD_visit_1	CD_ADA_visit_1	CD_ADA_visit_1	CD_ADA_no_no	P14_visit_1_no	P14_visit_1_no	P14_visit_1_C_no	P14_visit_1_C_no	P14_visit_1_none	P14_visit_1_none	P14_visit_1_none	P14_visit_1_none	CD_Base	CD_ADA_Base	CD_no_Base	CD_C_no_Base	CD_SeS_no_Base
P14_MM78_I_D	IS_P14_MM78_I_D	plate_3	H3	AAAGCATAGCCGA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ATAGCCG	CTTGTA	P14	patient	40	F	CD_F	162	54	20.58	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	1	39	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B1	L2	non-L4	CD	yes	joints_eyes	no	none	CD_Start	ADA_Start	CD_ADA_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	05/12/2018	SC	160	yes	Asacol	no	none	yes	Cortiment	no	none	0.6	low	9.4	185	8	128	39	normal	0	negative	0	0	CD		0	inactive	remission	baseline	baseline	Base	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_1	CD_visit_1	CD_ADA_visit_1	CD_ADA_visit_1	CD_ADA_no_no	P14_visit_1_no	P14_visit_1_no	P14_visit_1_D_no	P14_visit_1_D_no	P14_visit_1_none	P14_visit_1_none	P14_visit_1_none	P14_visit_1_none	CD_Base	CD_ADA_Base	CD_no_Base	CD_D_no_Base	CD_SeT_no_Base
P14_MM78_II_C	IS_P14_MM78_II_C	plate_3	A4	ACGAAACCTTCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACCTTCC	CTTGTA	P14	patient	40	F	CD_F	162	54	20.58	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	1	39	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B1	L2	non-L4	CD	yes	joints_eyes	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	18/12/2018	SC	80	yes	Asacol	no	none	yes	Cortiment	no	none	0.2	low	6.3	200	8.41	120	25	normal	20	negative	0	0	CD		0	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_2	CD_visit_2	CD_ADA_visit_2	CD_ADA_visit_2	CD_ADA_no_no	P14_visit_2_no	P14_visit_2_no	P14_visit_2_C_no	P14_visit_2_C_no	P14_visit_2_none	P14_visit_2_none	P14_visit_2_none	P14_visit_2_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
P14_MM78_II_D	IS_P14_MM78_II_D	plate_3	B4	ACGAAAGCCACCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGCCACC	CTTGTA	P14	patient	40	F	CD_F	162	54	20.58	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	1	39	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B1	L2	non-L4	CD	yes	joints_eyes	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	18/12/2018	SC	80	yes	Asacol	no	none	yes	Cortiment	no	none	0.2	low	6.3	200	8.41	120	25	normal	20	negative	0	0	CD		0	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_2	CD_visit_2	CD_ADA_visit_2	CD_ADA_visit_2	CD_ADA_no_no	P14_visit_2_no	P14_visit_2_no	P14_visit_2_D_no	P14_visit_2_D_no	P14_visit_2_none	P14_visit_2_none	P14_visit_2_none	P14_visit_2_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P14_MM78_III_C	IS_P14_MM78_III_C	plate_3	C4	ACGAAAACAGCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AACAGCC	CTTGTA	P14	patient	40	F	CD_F	162	56	21.34	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	1	39	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B1	L2	non-L4	CD	yes	joints_eyes	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	18/02/2019	SC	40	yes	Asacol	no	none	no	none	yes	Globifer	1.3	low	8.5	169	7.6	117	9	normal	13.7	negative	1	1	CD		1	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_3	CD_visit_3	CD_ADA_visit_3	CD_ADA_visit_3	CD_ADA_no_no	P14_visit_3_no	P14_visit_3_no	P14_visit_3_C_no	P14_visit_3_C_no	P14_visit_3_none	P14_visit_3_none	P14_visit_3_none	P14_visit_3_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
P14_MM78_III_D	IS_P14_MM78_III_D	plate_3	D4	ACGAAACGGCCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACGGCCC	CTTGTA	P14	patient	40	F	CD_F	162	56	21.34	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	1	39	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B1	L2	non-L4	CD	yes	joints_eyes	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	18/02/2019	SC	40	yes	Asacol	no	none	no	none	yes	Globifer	1.3	low	8.5	169	7.6	117	9	normal	13.7	negative	1	1	CD		1	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_3	CD_visit_3	CD_ADA_visit_3	CD_ADA_visit_3	CD_ADA_no_no	P14_visit_3_no	P14_visit_3_no	P14_visit_3_D_no	P14_visit_3_D_no	P14_visit_3_none	P14_visit_3_none	P14_visit_3_none	P14_visit_3_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P14_MM78_IV_C	IS_P14_MM78_IV_C	plate_3	E4	ACGAAACTGGCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACTGGCC	CTTGTA	P14	patient	40	F	CD_F	162	56	21.34	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	1	39	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B1	L2	non-L4	CD	yes	joints_eyes	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	09/04/2019	SC	40	yes	Asacol	no	none	no	none	yes	Globifer	0.4	low	7.1	169	8.68	123	6	normal	6.7	negative	2	2	CD		2	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_4	CD_visit_4	CD_ADA_visit_4	CD_ADA_visit_4	CD_ADA_no_no	P14_visit_4_no	P14_visit_4_no	P14_visit_4_C_no	P14_visit_4_C_no	P14_visit_4_none	P14_visit_4_none	P14_visit_4_none	P14_visit_4_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
P14_MM78_IV_D	IS_P14_MM78_IV_D	plate_3	F4	ACGAAAAGGACCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AAGGACC	CTTGTA	P14	patient	40	F	CD_F	162	56	21.34	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	1	39	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B1	L2	non-L4	CD	yes	joints_eyes	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	09/04/2019	SC	40	yes	Asacol	no	none	no	none	yes	Globifer	0.4	low	7.1	169	8.68	123	6	normal	6.7	negative	2	2	CD		2	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_4	CD_visit_4	CD_ADA_visit_4	CD_ADA_visit_4	CD_ADA_no_no	P14_visit_4_no	P14_visit_4_no	P14_visit_4_D_no	P14_visit_4_D_no	P14_visit_4_none	P14_visit_4_none	P14_visit_4_none	P14_visit_4_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P14_MM78_V_C	IS_P14_MM78_V_C	plate_3	G4	ACGAAACGCTCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACGCTCC	CTTGTA	P14	patient	40	F	CD_F	162	56	21.34	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	1	39	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B1	L2	non-L4	CD	yes	joints_eyes	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_22	week_22	22	21/05/2019	SC	40	yes	Asacol	no	none	no	none	no	none	0.8	low	6.1	167	9.34	122	7	normal	14.2	negative	1	1	CD		1	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_5	CD_visit_5	CD_ADA_visit_5	CD_ADA_visit_5	CD_ADA_no_no	P14_visit_5_no	P14_visit_5_no	P14_visit_5_C_no	P14_visit_5_C_no	P14_visit_5_none	P14_visit_5_none	P14_visit_5_none	P14_visit_5_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
P14_MM78_V_D	IS_P14_MM78_V_D	plate_3	H4	ACGAAAGCGCCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGCGCCC	CTTGTA	P14	patient	40	F	CD_F	162	56	21.34	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	1	39	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B1	L2	non-L4	CD	yes	joints_eyes	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_22	week_22	22	21/05/2019	SC	40	yes	Asacol	no	none	no	none	no	none	0.8	low	6.1	167	9.34	122	7	normal	14.2	negative	1	1	CD		1	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_5	CD_visit_5	CD_ADA_visit_5	CD_ADA_visit_5	CD_ADA_no_no	P14_visit_5_no	P14_visit_5_no	P14_visit_5_D_no	P14_visit_5_D_no	P14_visit_5_none	P14_visit_5_none	P14_visit_5_none	P14_visit_5_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P14_MM78_VI_C	IS_P14_MM78_VI_C	plate_3	A5	ACGAAAATTAGCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AATTAGC	CTTGTA	P14	patient	40	F	CD_F	162	56	21.34	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	1	39	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B1	L2	non-L4	CD	yes	joints_eyes	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_7	visit_7	week_32	week_32	32	13/08/2019	SC	40	no	none	no	none	no	none	no	none	0.5	low	5.6	167	13.3	125	5	normal	20	negative	1	1	CD		1	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_7	CD_visit_7	CD_ADA_visit_7	CD_ADA_visit_7	CD_ADA_no_no	P14_visit_7_no	P14_visit_7_no	P14_visit_7_C_no	P14_visit_7_C_no	P14_visit_7_none	P14_visit_7_none	P14_visit_7_none	P14_visit_7_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
P14_MM78_VI_D	IS_P14_MM78_VI_D	plate_3	B5	ACGAAATCCTCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ATCCTCC	CTTGTA	P14	patient	40	F	CD_F	162	56	21.34	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	1	39	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B1	L2	non-L4	CD	yes	joints_eyes	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_7	visit_7	week_32	week_32	32	13/08/2019	SC	40	no	none	no	none	no	none	no	none	0.5	low	5.6	167	13.3	125	5	normal	20	negative	1	1	CD		1	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_7	CD_visit_7	CD_ADA_visit_7	CD_ADA_visit_7	CD_ADA_no_no	P14_visit_7_no	P14_visit_7_no	P14_visit_7_D_no	P14_visit_7_D_no	P14_visit_7_none	P14_visit_7_none	P14_visit_7_none	P14_visit_7_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P14_MM78_VIII_C	IS_P14_MM78_VIII_C	plate_3	C5	ACGAAAACCCGCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AACCCGC	CTTGTA	P14	patient	40	F	CD_F	162	56	21.34	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	1	39	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B1	L2	non-L4	CD	yes	joints_eyes	no	none	CD_Finish	ADA_Finish	CD_ADA_Finish	Finish	Finish	Finish.38	Finish.38	visit_8	visit_8	week_38	week_38	38	24/09/2019	SC	40	no	none	no	none	no	none	no	none	0.4	low	5	189	6.85	132	10	normal	20	negative	1	1	CD		1	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_8	CD_visit_8	CD_ADA_visit_8	CD_ADA_visit_8	CD_ADA_no_no	P14_visit_8_no	P14_visit_8_no	P14_visit_8_C_no	P14_visit_8_C_no	P14_visit_8_none	P14_visit_8_none	P14_visit_8_none	P14_visit_8_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
P14_MM78_VIII_D	IS_P14_MM78_VIII_D	plate_3	D5	ACGAAATCCCTCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ATCCCTC	CTTGTA	P14	patient	40	F	CD_F	162	56	21.34	normal	non-smoker	CD_non-smoker	CD	ADA	Imraldi	1	39	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B1	L2	non-L4	CD	yes	joints_eyes	no	none	CD_Finish	ADA_Finish	CD_ADA_Finish	Finish	Finish	Finish.38	Finish.38	visit_8	visit_8	week_38	week_38	38	24/09/2019	SC	40	no	none	no	none	no	none	no	none	0.4	low	5	189	6.85	132	10	normal	20	negative	1	1	CD		1	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_8	CD_visit_8	CD_ADA_visit_8	CD_ADA_visit_8	CD_ADA_no_no	P14_visit_8_no	P14_visit_8_no	P14_visit_8_D_no	P14_visit_8_D_no	P14_visit_8_none	P14_visit_8_none	P14_visit_8_none	P14_visit_8_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P19_DS90_I_C	IS_P19_DS90_I_C	plate_3	E5	ACGAAACTCGCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACTCGCC	CTTGTA	P19	patient	28	F	CD_F	173	80	26.73	overweight	non-smoker	CD_non-smoker	CD	IFX	Remsima	8	21	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_astomosis_resection	CD_Start	IFX_Start	CD_IFX_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	09/01/2019	IV	5	no	none	yes	AZA	no	none	yes	Vigantol	8.5	low	8.2	326	14	130	274	significantly_increased	0	negative	1	1	CD		1	inactive	remission	baseline	baseline	Base	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeS	CD_IFX_no	CD_IFX_none	CD_IFX_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_1	CD_visit_1	CD_IFX_visit_1	CD_IFX_visit_1	CD_IFX_no_yes	P19_visit_1_no	P19_visit_1_no	P19_visit_1_C_no	P19_visit_1_C_no	P19_visit_1_none	P19_visit_1_none	P19_visit_1_none	P19_visit_1_none	CD_Base	CD_IFX_Base	CD_no_Base	CD_C_no_Base	CD_SeS_no_Base
P19_DS90_I_D	IS_P19_DS90_I_D	plate_3	F5	ACGAAAGGCCTCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGGCCTC	CTTGTA	P19	patient	28	F	CD_F	173	80	26.73	overweight	non-smoker	CD_non-smoker	CD	IFX	Remsima	8	21	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_astomosis_resection	CD_Start	IFX_Start	CD_IFX_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	09/01/2019	IV	5	no	none	yes	AZA	no	none	yes	Vigantol	8.5	low	8.2	326	14	130	274	significantly_increased	0	negative	1	1	CD		1	inactive	remission	baseline	baseline	Base	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_1	CD_visit_1	CD_IFX_visit_1	CD_IFX_visit_1	CD_IFX_no_yes	P19_visit_1_no	P19_visit_1_no	P19_visit_1_D_no	P19_visit_1_D_no	P19_visit_1_none	P19_visit_1_none	P19_visit_1_none	P19_visit_1_none	CD_Base	CD_IFX_Base	CD_no_Base	CD_D_no_Base	CD_SeT_no_Base
P19_DS90_II_C	IS_P19_DS90_II_C	plate_3	G5	ACGAAACCCAGCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACCCAGC	CTTGTA	P19	patient	28	F	CD_F	173	87	29.07	overweight	non-smoker	CD_non-smoker	CD	IFX	Remsima	8	21	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_astomosis_resection	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	24/01/2019	IV	5	no	none	yes	AZA	no	none	yes	Vigantol	4.2	low	8.1	281	16.48	135	10	normal	20	negative	4	4	CD		4	inactive	remission	response	partial_response	Part	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeS	CD_IFX_no	CD_IFX_none	CD_IFX_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_2	CD_visit_2	CD_IFX_visit_2	CD_IFX_visit_2	CD_IFX_no_yes	P19_visit_2_no	P19_visit_2_no	P19_visit_2_C_no	P19_visit_2_C_no	P19_visit_2_none	P19_visit_2_none	P19_visit_2_none	P19_visit_2_none	CD_Part	CD_IFX_Part	CD_no_Part	CD_C_no_Part	CD_SeS_no_Part
P19_DS90_II_D	IS_P19_DS90_II_D	plate_3	H5	AAAGAGCACGAAA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AAAGAGC	CTTGTA	P19	patient	28	F	CD_F	173	87	29.07	overweight	non-smoker	CD_non-smoker	CD	IFX	Remsima	8	21	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_astomosis_resection	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	24/01/2019	IV	5	no	none	yes	AZA	no	none	yes	Vigantol	4.2	low	8.1	281	16.48	135	10	normal	20	negative	4	4	CD		4	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_2	CD_visit_2	CD_IFX_visit_2	CD_IFX_visit_2	CD_IFX_no_yes	P19_visit_2_no	P19_visit_2_no	P19_visit_2_D_no	P19_visit_2_D_no	P19_visit_2_none	P19_visit_2_none	P19_visit_2_none	P19_visit_2_none	CD_Part	CD_IFX_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P19_DS90_III_C	IS_P19_DS90_III_C	plate_3	A6	ACGAAACGGCTCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACGGCTC	CTTGTA	P19	patient	28	F	CD_F	173	87	29.07	overweight	non-smoker	CD_non-smoker	CD	IFX	Remsima	8	21	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_astomosis_resection	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	16/05/2019	IV	5	no	none	yes	AZA	no	none	yes	Vigantol	9.5	low	9.8	297	17.96	131	113	slightly_increased	1.7	negative	5	5	CD		5	inactive	mild	response	partial_response	Part	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeS	CD_IFX_no	CD_IFX_none	CD_IFX_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_4	CD_visit_4	CD_IFX_visit_4	CD_IFX_visit_4	CD_IFX_no_yes	P19_visit_4_no	P19_visit_4_no	P19_visit_4_C_no	P19_visit_4_C_no	P19_visit_4_none	P19_visit_4_none	P19_visit_4_none	P19_visit_4_none	CD_Part	CD_IFX_Part	CD_no_Part	CD_C_no_Part	CD_SeS_no_Part
P19_DS90_III_D	IS_P19_DS90_III_D	plate_3	B6	ACGAAACGACATA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACGACAT	CTTGTA	P19	patient	28	F	CD_F	173	87	29.07	overweight	non-smoker	CD_non-smoker	CD	IFX	Remsima	8	21	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_astomosis_resection	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	16/05/2019	IV	5	no	none	yes	AZA	no	none	yes	Vigantol	9.5	low	9.8	297	17.96	131	113	slightly_increased	1.7	negative	5	5	CD		5	inactive	mild	response	partial_response	Part	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_4	CD_visit_4	CD_IFX_visit_4	CD_IFX_visit_4	CD_IFX_no_yes	P19_visit_4_no	P19_visit_4_no	P19_visit_4_D_no	P19_visit_4_D_no	P19_visit_4_none	P19_visit_4_none	P19_visit_4_none	P19_visit_4_none	CD_Part	CD_IFX_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P19_DS90_IV_C	IS_P19_DS90_IV_C	plate_3	C6	ACGAAATCCCGCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ATCCCGC	CTTGTA	P19	patient	28	F	CD_F	173	87	29.07	overweight	non-smoker	CD_non-smoker	CD	IFX	Remsima	8	21	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_astomosis_resection	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_6	visit_6	week_32	week_32	32	05/09/2019	IV	5	no	none	yes	AZA	no	none	yes	Vigantol	4.8	low	10.7	263	26.38	139	38	normal	1.3	negative	5	5	CD		5	inactive	mild	no_response	no_response	NoRe	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeS	CD_IFX_no	CD_IFX_none	CD_IFX_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_6	CD_visit_6	CD_IFX_visit_6	CD_IFX_visit_6	CD_IFX_no_yes	P19_visit_6_no	P19_visit_6_no	P19_visit_6_C_no	P19_visit_6_C_no	P19_visit_6_none	P19_visit_6_none	P19_visit_6_none	P19_visit_6_none	CD_NoRe	CD_IFX_NoRe	CD_no_NoRe	CD_C_no_NoRe	CD_SeS_no_NoRe
P19_DS90_IV_D	IS_P19_DS90_IV_D	plate_3	D6	ACGAAAGTGCGCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGTGCGC	CTTGTA	P19	patient	28	F	CD_F	173	87	29.07	overweight	non-smoker	CD_non-smoker	CD	IFX	Remsima	8	21	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_astomosis_resection	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_6	visit_6	week_32	week_32	32	05/09/2019	IV	5	no	none	yes	AZA	no	none	yes	Vigantol	4.8	low	10.7	263	26.38	139	38	normal	1.3	negative	5	5	CD		5	inactive	mild	no_response	no_response	NoRe	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_6	CD_visit_6	CD_IFX_visit_6	CD_IFX_visit_6	CD_IFX_no_yes	P19_visit_6_no	P19_visit_6_no	P19_visit_6_D_no	P19_visit_6_D_no	P19_visit_6_none	P19_visit_6_none	P19_visit_6_none	P19_visit_6_none	CD_NoRe	CD_IFX_NoRe	CD_no_NoRe	CD_D_no_NoRe	CD_SeT_no_NoRe
P19_DS90_V_C	IS_P19_DS90_V_C	plate_3	E6	ACGAAAGACTCTA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGACTCT	CTTGTA	P19	patient	28	F	CD_F	173	94	31.41	obesity	non-smoker	CD_non-smoker	CD	IFX	Remsima	8	21	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_astomosis_resection	CD_Finish	IFX_Finish	CD_IFX_Finish	Finish	Finish	Finish.38	Finish.38	visit_7	visit_7	week_38	week_38	38	31/10/2019	IV	5	no	none	no	none	no	none	yes	Vigantol	3.6	low	8.8	283	16.82	133	48	normal	1.2	negative	4	4	CD		4	inactive	remission	response	partial_response	Part	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeS	CD_IFX_no	CD_IFX_none	CD_IFX_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_7	CD_visit_7	CD_IFX_visit_7	CD_IFX_visit_7	CD_IFX_no_no	P19_visit_7_no	P19_visit_7_no	P19_visit_7_C_no	P19_visit_7_C_no	P19_visit_7_none	P19_visit_7_none	P19_visit_7_none	P19_visit_7_none	CD_Part	CD_IFX_Part	CD_no_Part	CD_C_no_Part	CD_SeS_no_Part
P19_DS90_V_D	IS_P19_DS90_V_D	plate_3	F6	ACGAAAGGGGTTA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGGGGTT	CTTGTA	P19	patient	28	F	CD_F	173	94	31.41	obesity	non-smoker	CD_non-smoker	CD	IFX	Remsima	8	21	no	none	conventiol_therapy_ineffectiveness	no	none	A2	B3	L1	non-L4	CD	no	none	yes	ileocecal_astomosis_resection	CD_Finish	IFX_Finish	CD_IFX_Finish	Finish	Finish	Finish.38	Finish.38	visit_7	visit_7	week_38	week_38	38	31/10/2019	IV	5	no	none	no	none	no	none	yes	Vigantol	3.6	low	8.8	283	16.82	133	48	normal	1.2	negative	4	4	CD		4	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_7	CD_visit_7	CD_IFX_visit_7	CD_IFX_visit_7	CD_IFX_no_no	P19_visit_7_no	P19_visit_7_no	P19_visit_7_D_no	P19_visit_7_D_no	P19_visit_7_none	P19_visit_7_none	P19_visit_7_none	P19_visit_7_none	CD_Part	CD_IFX_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P28_WL83_I_C	IS_P28_WL83_I_C	plate_3	G6	ACGAAACTAGGGA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACTAGGG	CTTGTA	P28_ADA	patient	35	F	CD_F	164	48	17.8	underweight	non-smoker	CD_non-smoker	CD	ADA	Hulio	7	28	no	none	EIM	no	none	A2	B1	L1	non-L4	CD	yes	joints	no	none	CD_Start	ADA_Start	CD_ADA_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	28/02/2019	SC	160	no	none	yes	MTX	yes	Hydrokortizon	no	none	0.6	low	6.8	384	36.58	117	452	significantly_increased	0	negative	7	7	CD		7	inactive	mild	baseline	baseline	Base	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_1	CD_visit_1	CD_ADA_visit_1	CD_ADA_visit_1	CD_ADA_no_yes	P28_visit_1_no	P28_visit_1_no	P28_visit_1_C_no	P28_visit_1_C_no	P28_visit_1_none	P28_visit_1_none	P28_visit_1_none	P28_visit_1_none	CD_Base	CD_ADA_Base	CD_no_Base	CD_C_no_Base	CD_SeS_no_Base
P28_WL83_II_C	IS_P28_WL83_II_C	plate_3	H6	ACGAAATAGCCGA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ATAGCCG	CTTGTA	P28_ADA	patient	35	F	CD_F	164	48	17.85	underweight	non-smoker	CD_non-smoker	CD	ADA	Hulio	7	28	no	none	EIM	no	none	A2	B1	L1	non-L4	CD	yes	joints	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	14/03/2019	SC	80	yes	Pentasa	yes	MTX	yes	Hydrokortizon	yes	Euthyrox_Calcichew_Omeprazol_Vigantol_Celecoxib_Doreta_folate	0.2	low	9.3	343	20.5	122	257	significantly_increased	20	negative	7	7	CD		7	inactive	mild	response	partial_response	Part	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_2	CD_visit_2	CD_ADA_visit_2	CD_ADA_visit_2	CD_ADA_no_yes	P28_visit_2_no	P28_visit_2_no	P28_visit_2_C_no	P28_visit_2_C_no	P28_visit_2_none	P28_visit_2_none	P28_visit_2_none	P28_visit_2_none	CD_Part	CD_ADA_Part	CD_no_Part	CD_C_no_Part	CD_SeS_no_Part
P28_WL83_III_C	IS_P28_WL83_III_C	plate_3	A7	ATAATACCTTCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACCTTCC	CTTGTA	P28_ADA	patient	35	F	CD_F	164	48	17.85	underweight	non-smoker	CD_non-smoker	CD	ADA	Hulio	7	28	no	none	EIM	no	none	A2	B1	L1	non-L4	CD	yes	joints	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	25/04/2019	SC	40	yes	Pentasa	yes	MTX	yes	Hydrokortizon	yes	Euthyrox_Calcichew_Omeprazol_Vigantol_Celecoxib_Doreta_folate	1	low	5.7	383	19.17	120	294	significantly_increased	20	negative	7	7	CD		7	inactive	mild	no_response	no_response	NoRe	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_3	CD_visit_3	CD_ADA_visit_3	CD_ADA_visit_3	CD_ADA_no_yes	P28_visit_3_no	P28_visit_3_no	P28_visit_3_C_no	P28_visit_3_C_no	P28_visit_3_none	P28_visit_3_none	P28_visit_3_none	P28_visit_3_none	CD_NoRe	CD_ADA_NoRe	CD_no_NoRe	CD_C_no_NoRe	CD_SeS_no_NoRe
P28_WL83_IV_C	IS_P28_WL83_IV_C	plate_3	B7	ATAATAGCCACCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGCCACC	CTTGTA	P28_ADA	patient	35	F	CD_F	164	48	17.85	underweight	non-smoker	CD_non-smoker	CD	ADA	Hulio	7	28	no	none	EIM	no	none	A2	B1	L1	non-L4	CD	yes	joints	no	none	CD_Finish	ADA_Finish	CD_ADA_Finish	Finish	Finish	Finish.14	Finish.14	visit_4	visit_4	week_14	week_14	14	06/06/2019	SC	40	yes	Pentasa	yes	MTX	yes	Hydrokortizon	yes	Euthyrox_Calcichew_Omeprazol_Vigantol_Celecoxib_Doreta_folate	0.3	low	6.2	388	15.5	121	557	significantly_increased	20	negative	7	7	CD		7	inactive	mild	no_response	no_response	NoRe	C	SeS	no	none	BT_C	ADA_C	ADA_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	"ADA_termited,_switch_to_IFX"	CD_ADA	CD_ADA_SeS	CD_ADA_no	CD_ADA_none	CD_ADA_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_4	CD_visit_4	CD_ADA_visit_4	CD_ADA_visit_4	CD_ADA_no_yes	P28_visit_4_no	P28_visit_4_no	P28_visit_4_C_no	P28_visit_4_C_no	P28_visit_4_none	P28_visit_4_none	P28_visit_4_none	P28_visit_4_none	CD_NoRe	CD_ADA_NoRe	CD_no_NoRe	CD_C_no_NoRe	CD_SeS_no_NoRe
P28_WL83_V_C	IS_P28_WL83_V_C	plate_3	C7	ATAATAACAGCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AACAGCC	CTTGTA	P28_IFX	patient	35	F	CD_F	162	48	18.29	underweight	non-smoker	CD_non-smoker	CD	IFX	Remsima	7	28	yes	seronegative_spondyloarthritis	EIM	yes	ADA	A2	B1	L1	non-L4	CD	yes	joints	no	none	CD_Start	IFX_Start	CD_IFX_Start	Start	Start_switch_IFX	Start.0	Start.0_switch_IFX	visit_1	visit_1_swich_IFX	week_0	week_0_switch_IFX	0	18/07/2019	IV	5	no	none	yes	MTX	yes	Hydrokortizon	yes	Omeprazol_Calcichew_folate_Vigantol_Euthyrox_Doreta_Ultarcod_Nutridrink_Mutaflor	0.4	low	12.4	416	13.47	118	300	significantly_increased	0	negative	7	7	CD		7	inactive	mild	baseline	baseline	Base	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeS	CD_IFX_no	CD_IFX_none	CD_IFX_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_1	CD_visit_1_switch_IFX	CD_IFX_visit_1	CD_IFX_visit_1_switch_IFX	CD_IFX_no_yes	P28_visit_1_no	P28_visit_1_switch_IFX_no	P28_visit_1_C_no	P28_visit_1_switch_IFX_C_no	P28_visit_1_none	P28_visit_1_switch_IFX_none	P28_visit_1_none	P28_visit_1_switch_IFX_none	CD_Base	CD_IFX_Base	CD_no_Base	CD_C_no_Base	CD_SeS_no_Base
P28_WL83_VI_C	IS_P28_WL83_VI_C	plate_3	D7	ATAATACGGCCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACGGCCC	CTTGTA	P28_IFX	patient	35	F	CD_F	162	48	18.29	underweight	non-smoker	CD_non-smoker	CD	IFX	Remsima	7	28	yes	seronegative_spondyloarthritis	EIM	yes	ADA	A2	B1	L1	non-L4	CD	yes	joints	no	none	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	02/08/2019	IV	5	no	none	yes	MTX	yes	Hydrokortizon	yes	Omeprazol_Calcichew_folate_Vigantol_Euthyrox_Doreta_Ultarcod_Nutridrink_Mutaflor	0.4	low	5.3	389	17.98	112	501	significantly_increased	20	negative	4	4	CD		4	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeS	CD_IFX_no	CD_IFX_none	CD_IFX_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_2	CD_visit_2	CD_IFX_visit_2	CD_IFX_visit_2	CD_IFX_no_yes	P28_visit_2_no	P28_visit_2_no	P28_visit_2_C_no	P28_visit_2_C_no	P28_visit_2_none	P28_visit_2_none	P28_visit_2_none	P28_visit_2_none	CD_Full	CD_IFX_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
P28_WL83_VII_C	IS_P28_WL83_VII_C	plate_3	E7	ATAATACTGGCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACTGGCC	CTTGTA	P28_IFX	patient	35	F	CD_F	162	48	18.29	underweight	non-smoker	CD_non-smoker	CD	IFX	Remsima	7	28	yes	seronegative_spondyloarthritis	EIM	yes	ADA	A2	B1	L1	non-L4	CD	yes	joints	no	none	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	30/08/2019	IV	5	no	none	yes	MTX	yes	Hydrokortizon	yes	Omeprazol_Calcichew_folate_Vigantol_Euthyrox_Doreta_Ultarcod_Nutridrink_Mutaflor	0.3	low	5.8	368	10.15	109	127	slightly_increased	19.8	negative	3	3	CD		3	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeS	CD_IFX_no	CD_IFX_none	CD_IFX_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_3	CD_visit_3	CD_IFX_visit_3	CD_IFX_visit_3	CD_IFX_no_yes	P28_visit_3_no	P28_visit_3_no	P28_visit_3_C_no	P28_visit_3_C_no	P28_visit_3_none	P28_visit_3_none	P28_visit_3_none	P28_visit_3_none	CD_Full	CD_IFX_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
P28_WL83_VIII_C	IS_P28_WL83_VIII_C	plate_3	F7	ATAATAAGGACCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AAGGACC	CTTGTA	P28_IFX	patient	35	F	CD_F	162	48	18.29	underweight	non-smoker	CD_non-smoker	CD	IFX	Remsima	7	28	yes	seronegative_spondyloarthritis	EIM	yes	ADA	A2	B1	L1	non-L4	CD	yes	joints	no	none	CD_Finish	IFX_Finish	CD_IFX_Finish	Finish	Finish	Finish.22	Finish.22	visit_5	visit_5	week_22	week_22	22	26/11/2019	IV	5	no	none	yes	MTX	yes	Hydrokortizon	yes	Omeprazol_Calcichew_folate_Vigantol_Euthyrox_Doreta_Ultarcod_Nutridrink_Mutaflor	0.3	low	5.8	368	10.15	109	127	slightly_increased	19.8	negative	3	3	CD		3	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeS	CD_IFX_no	CD_IFX_none	CD_IFX_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_5	CD_visit_5	CD_IFX_visit_5	CD_IFX_visit_5	CD_IFX_no_yes	P28_visit_5_no	P28_visit_5_no	P28_visit_5_C_no	P28_visit_5_C_no	P28_visit_5_none	P28_visit_5_none	P28_visit_5_none	P28_visit_5_none	CD_Full	CD_IFX_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
P29_MS81_I_C	IS_P29_MS81_I_C	plate_3	G7	ATAATACGCTCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACGCTCC	CTTGTA	P29	patient	38	F	CD_F	170	67	23.18	normal	smoker	CD_smoker	CD	IFX	Remsima	12	26	no	none	perial_disease	no	none	A2	B3	L2	non-L4	CD	no	none	yes	fistula_draige	CD_Start	IFX_Start	CD_IFX_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	01/04/2019	IV	5	no	none	yes	MTX	no	none	yes	folate	2.8	low	10.3	237	163.08	145	163	slightly_increased	0	negative	3	3	CD		3	inactive	remission	baseline	baseline	Base	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeS	CD_IFX_no	CD_IFX_none	CD_IFX_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_1	CD_visit_1	CD_IFX_visit_1	CD_IFX_visit_1	CD_IFX_no_yes	P29_visit_1_no	P29_visit_1_no	P29_visit_1_C_no	P29_visit_1_C_no	P29_visit_1_none	P29_visit_1_none	P29_visit_1_none	P29_visit_1_none	CD_Base	CD_IFX_Base	CD_no_Base	CD_C_no_Base	CD_SeS_no_Base
P29_MS81_I_D	IS_P29_MS81_I_D	plate_3	H7	ATAATAGCGCCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGCGCCC	CTTGTA	P29	patient	38	F	CD_F	170	67	23.18	normal	smoker	CD_smoker	CD	IFX	Remsima	12	26	no	none	perial_disease	no	none	A2	B3	L2	non-L4	CD	no	none	yes	fistula_draige	CD_Start	IFX_Start	CD_IFX_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	01/04/2019	IV	5	no	none	yes	MTX	no	none	yes	folate	2.8	low	10.3	237	163.08	145	163	slightly_increased	0	negative	3	3	CD		3	inactive	remission	baseline	baseline	Base	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_1	CD_visit_1	CD_IFX_visit_1	CD_IFX_visit_1	CD_IFX_no_yes	P29_visit_1_no	P29_visit_1_no	P29_visit_1_D_no	P29_visit_1_D_no	P29_visit_1_none	P29_visit_1_none	P29_visit_1_none	P29_visit_1_none	CD_Base	CD_IFX_Base	CD_no_Base	CD_D_no_Base	CD_SeT_no_Base
P29_MS81_II_C	IS_P29_MS81_II_C	plate_3	A8	ATAATAATTAGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AATTAGC	CTTGTA	P29	patient	38	F	CD_F	170	67	23.18	normal	smoker	CD_smoker	CD	IFX	Remsima	12	26	no	none	perial_disease	no	none	A2	B3	L2	non-L4	CD	no	none	yes	fistula_draige	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	15/04/2019	IV	5	no	none	yes	MTX	no	none	yes	folate	2.8	low	6.2	182	150.94	132	36	normal	20	negative	3	3	CD		3	inactive	remission	response	partial_response	Part	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeS	CD_IFX_no	CD_IFX_none	CD_IFX_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_2	CD_visit_2	CD_IFX_visit_2	CD_IFX_visit_2	CD_IFX_no_yes	P29_visit_2_no	P29_visit_2_no	P29_visit_2_C_no	P29_visit_2_C_no	P29_visit_2_none	P29_visit_2_none	P29_visit_2_none	P29_visit_2_none	CD_Part	CD_IFX_Part	CD_no_Part	CD_C_no_Part	CD_SeS_no_Part
P29_MS81_II_D	IS_P29_MS81_II_D	plate_3	B8	ATAATATCCTCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ATCCTCC	CTTGTA	P29	patient	38	F	CD_F	170	67	23.18	normal	smoker	CD_smoker	CD	IFX	Remsima	12	26	no	none	perial_disease	no	none	A2	B3	L2	non-L4	CD	no	none	yes	fistula_draige	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	15/04/2019	IV	5	no	none	yes	MTX	no	none	yes	folate	2.8	low	6.2	182	150.94	132	36	normal	20	negative	3	3	CD		3	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_2	CD_visit_2	CD_IFX_visit_2	CD_IFX_visit_2	CD_IFX_no_yes	P29_visit_2_no	P29_visit_2_no	P29_visit_2_D_no	P29_visit_2_D_no	P29_visit_2_none	P29_visit_2_none	P29_visit_2_none	P29_visit_2_none	CD_Part	CD_IFX_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P29_MS81_III_C	IS_P29_MS81_III_C	plate_3	C8	ATAATAACCCGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AACCCGC	CTTGTA	P29	patient	38	F	CD_F	170	67	23.18	normal	smoker	CD_smoker	CD	IFX	Remsima	12	26	no	none	perial_disease	no	none	A2	B3	L2	non-L4	CD	no	none	yes	fistula_draige	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_6	week_6	6	14/05/2019	IV	5	no	none	yes	MTX	no	none	yes	folate_Vigantol	2.3	low	43837	195	143.1	137	32	normal	20	negative	7	7	CD		7	inactive	mild	no_response	no_response	NoRe	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeS	CD_IFX_no	CD_IFX_none	CD_IFX_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_3	CD_visit_3	CD_IFX_visit_3	CD_IFX_visit_3	CD_IFX_no_yes	P29_visit_3_no	P29_visit_3_no	P29_visit_3_C_no	P29_visit_3_C_no	P29_visit_3_none	P29_visit_3_none	P29_visit_3_none	P29_visit_3_none	CD_NoRe	CD_IFX_NoRe	CD_no_NoRe	CD_C_no_NoRe	CD_SeS_no_NoRe
P29_MS81_III_D	IS_P29_MS81_III_D	plate_3	D8	ATAATATCCCTCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ATCCCTC	CTTGTA	P29	patient	38	F	CD_F	170	67	23.18	normal	smoker	CD_smoker	CD	IFX	Remsima	12	26	no	none	perial_disease	no	none	A2	B3	L2	non-L4	CD	no	none	yes	fistula_draige	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_6	week_6	6	14/05/2019	IV	5	no	none	yes	MTX	no	none	yes	folate_Vigantol	2.3	low	43837	195	143.1	137	32	normal	20	negative	7	7	CD		7	inactive	mild	no_response	no_response	NoRe	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_3	CD_visit_3	CD_IFX_visit_3	CD_IFX_visit_3	CD_IFX_no_yes	P29_visit_3_no	P29_visit_3_no	P29_visit_3_D_no	P29_visit_3_D_no	P29_visit_3_none	P29_visit_3_none	P29_visit_3_none	P29_visit_3_none	CD_NoRe	CD_IFX_NoRe	CD_no_NoRe	CD_D_no_NoRe	CD_SeT_no_NoRe
P29_MS81_IV_C	IS_P29_MS81_IV_C	plate_3	E8	ATAATACTCGCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACTCGCC	CTTGTA	P29	patient	38	F	CD_F	170	67	23.18	normal	smoker	CD_smoker	CD	IFX	Remsima	12	26	no	none	perial_disease	no	none	A2	B3	L2	non-L4	CD	no	none	yes	fistula_draige	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_22	week_22	22	29/08/2019	IV	5	no	none	yes	MTX	no	none	yes	folate_Vigantol	2.2	low	5.9	177	196.46	125	23	normal	8.4	negative	3	3	CD		3	inactive	remission	response	partial_response	Part	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeS	CD_IFX_no	CD_IFX_none	CD_IFX_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_5	CD_visit_5	CD_IFX_visit_5	CD_IFX_visit_5	CD_IFX_no_yes	P29_visit_5_no	P29_visit_5_no	P29_visit_5_C_no	P29_visit_5_C_no	P29_visit_5_none	P29_visit_5_none	P29_visit_5_none	P29_visit_5_none	CD_Part	CD_IFX_Part	CD_no_Part	CD_C_no_Part	CD_SeS_no_Part
P29_MS81_IV_D	IS_P29_MS81_IV_D	plate_3	F8	ATAATAGGCCTCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGGCCTC	CTTGTA	P29	patient	38	F	CD_F	170	67	23.18	normal	smoker	CD_smoker	CD	IFX	Remsima	12	26	no	none	perial_disease	no	none	A2	B3	L2	non-L4	CD	no	none	yes	fistula_draige	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_22	week_22	22	29/08/2019	IV	5	no	none	yes	MTX	no	none	yes	folate_Vigantol	2.2	low	5.9	177	196.46	125	23	normal	8.4	negative	3	3	CD		3	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_5	CD_visit_5	CD_IFX_visit_5	CD_IFX_visit_5	CD_IFX_no_yes	P29_visit_5_no	P29_visit_5_no	P29_visit_5_D_no	P29_visit_5_D_no	P29_visit_5_none	P29_visit_5_none	P29_visit_5_none	P29_visit_5_none	CD_Part	CD_IFX_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P29_MS81_CxE	IS_P29_MS81_CxE	plate_3	G8	ATAATACCCAGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACCCAGC	CTTGTA	P29	patient	38	F	CD_F	170	67	23.18	normal	smoker	CD_smoker	CD	IFX	Remsima	12	26	no	none	perial_disease	no	none	A2	B3	L2	non-L4	CD	no	none	yes	fistula_draige	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	04/07/2019	IV	5	no	none	yes	MTX	no	none	yes	folate_Vigantol	1.9	low	7	175	210.26	132	4	normal	20	negative	3	3	CD		3	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeS	CD_IFX_no	CD_IFX_none	CD_IFX_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_4	CD_visit_4	CD_IFX_visit_4	CD_IFX_visit_4	CD_IFX_no_yes	P29_visit_4_no	P29_visit_4_no	P29_visit_4_C_no	P29_visit_4_C_no	P29_visit_4_none	P29_visit_4_none	P29_visit_4_none	P29_visit_4_none	CD_Full	CD_IFX_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
P29_MS81_D	IS_P29_MS81_D	plate_3	H8	ATAATAAAGAGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AAAGAGC	CTTGTA	P29	patient	38	F	CD_F	170	67	23.18	normal	smoker	CD_smoker	CD	IFX	Remsima	12	26	no	none	perial_disease	no	none	A2	B3	L2	non-L4	CD	no	none	yes	fistula_draige	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	04/07/2019	IV	5	no	none	yes	MTX	no	none	yes	folate_Vigantol	1.9	low	7	175	210.26	132	4	normal	20	negative	3	3	CD		3	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_4	CD_visit_4	CD_IFX_visit_4	CD_IFX_visit_4	CD_IFX_no_yes	P29_visit_4_no	P29_visit_4_no	P29_visit_4_D_no	P29_visit_4_D_no	P29_visit_4_none	P29_visit_4_none	P29_visit_4_none	P29_visit_4_none	CD_Full	CD_IFX_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P29_MS81_V_C	IS_P29_MS81_V_C	plate_3	A9	ATAATACGGCTCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACGGCTC	CTTGTA	P29	patient	38	F	CD_F	170	67	23.18	normal	smoker	CD_smoker	CD	IFX	Remsima	12	26	no	none	perial_disease	no	none	A2	B3	L2	non-L4	CD	no	none	yes	fistula_draige	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_6	visit_6	week_30	week_30	30	24/10/2019	IV	5	no	none	yes	MTX	no	none	yes	folate_Vigantol	2.5	low	6.4	176	223.9	127	23	normal	10.4	negative	4	4	CD		4	inactive	remission	response	partial_response	Part	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeS	CD_IFX_no	CD_IFX_none	CD_IFX_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_6	CD_visit_6	CD_IFX_visit_6	CD_IFX_visit_6	CD_IFX_no_yes	P29_visit_6_no	P29_visit_6_no	P29_visit_6_C_no	P29_visit_6_C_no	P29_visit_6_none	P29_visit_6_none	P29_visit_6_none	P29_visit_6_none	CD_Part	CD_IFX_Part	CD_no_Part	CD_C_no_Part	CD_SeS_no_Part
P29_MS81_V_D	IS_P29_MS81_V_D	plate_3	B9	ATAATACGACATA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACGACAT	CTTGTA	P29	patient	38	F	CD_F	170	67	23.18	normal	smoker	CD_smoker	CD	IFX	Remsima	12	26	no	none	perial_disease	no	none	A2	B3	L2	non-L4	CD	no	none	yes	fistula_draige	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_6	visit_6	week_30	week_30	30	24/10/2019	IV	5	no	none	yes	MTX	no	none	yes	folate_Vigantol	2.5	low	6.4	176	223.9	127	23	normal	10.4	negative	4	4	CD		4	inactive	remission	response	partial_response	Part	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_6	CD_visit_6	CD_IFX_visit_6	CD_IFX_visit_6	CD_IFX_no_yes	P29_visit_6_no	P29_visit_6_no	P29_visit_6_D_no	P29_visit_6_D_no	P29_visit_6_none	P29_visit_6_none	P29_visit_6_none	P29_visit_6_none	CD_Part	CD_IFX_Part	CD_no_Part	CD_D_no_Part	CD_SeT_no_Part
P29_MS81_VI_C	IS_P29_MS81_VI_C	plate_3	C9	ATAATATCCCGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ATCCCGC	CTTGTA	P29	patient	38	F	CD_F	170	67	23.18	normal	smoker	CD_smoker	CD	IFX	Remsima	12	26	no	none	perial_disease	no	none	A2	B3	L2	non-L4	CD	no	none	yes	fistula_draige	CD_Finish	IFX_Finish	CD_IFX_Finish	Finish	Finish	Finish.38	Finish.38	visit_7	visit_7	week_38	week_38	38	12/12/2019	IV	5	no	none	yes	MTX	no	none	yes	folate_Vigantol	1.1	low	4.9	178	178.05	130	33	normal	6.7	negative	0	0	CD		0	inactive	remission	response	full_response	Full	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeS	CD_IFX_no	CD_IFX_none	CD_IFX_BT_C	CD_C	CD_no	CD_C_no	CD_SeS	CD_SeS_no	CD_none	CD_none	CD_BT_C	CD_visit_7	CD_visit_7	CD_IFX_visit_7	CD_IFX_visit_7	CD_IFX_no_yes	P29_visit_7_no	P29_visit_7_no	P29_visit_7_C_no	P29_visit_7_C_no	P29_visit_7_none	P29_visit_7_none	P29_visit_7_none	P29_visit_7_none	CD_Full	CD_IFX_Full	CD_no_Full	CD_C_no_Full	CD_SeS_no_Full
P29_MS81_VI_D	IS_P29_MS81_VI_D	plate_3	D9	ATAATAGTGCGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGTGCGC	CTTGTA	P29	patient	38	F	CD_F	170	67	23.18	normal	smoker	CD_smoker	CD	IFX	Remsima	12	26	no	none	perial_disease	no	none	A2	B3	L2	non-L4	CD	no	none	yes	fistula_draige	CD_Finish	IFX_Finish	CD_IFX_Finish	Finish	Finish	Finish.38	Finish.38	visit_7	visit_7	week_38	week_38	38	12/12/2019	IV	5	no	none	yes	MTX	no	none	yes	folate_Vigantol	1.1	low	4.9	178	178.05	130	33	normal	6.7	negative	0	0	CD		0	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_IFX	CD_IFX_SeT	CD_IFX_no	CD_IFX_none	CD_IFX_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_7	CD_visit_7	CD_IFX_visit_7	CD_IFX_visit_7	CD_IFX_no_yes	P29_visit_7_no	P29_visit_7_no	P29_visit_7_D_no	P29_visit_7_D_no	P29_visit_7_none	P29_visit_7_none	P29_visit_7_none	P29_visit_7_none	CD_Full	CD_IFX_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P29_MS81_VII_C	IS_P29_MS81_VII_C	plate_3	E9	ATAATAGACTCTA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGACTCT	CTTGTA	P29	patient	38	F	CD_F	170	67	23.18	normal	smoker	CD_smoker	CD	IFX	Remsima	12	26	no	none	perial_disease	no	none	A2	B3	L2	non-L4	CD	no	none	yes	fistula_draige	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_extra	visit_extra	week_X	week_X		03/02/2020																															C	SeS														none	none					CD_IFX	CD_IFX_SeS	CD_IFX_	CD_IFX_	CD_IFX_	CD_C	CD_	CD_C_	CD_SeS	CD_SeS_	CD_	CD_	CD_	CD_visit_extra	CD_visit_extra	CD_IFX_visit_extra	CD_IFX_visit_extra	CD_IFX_	P29_visit_extra_	P29_visit_extra_	P29_visit_extra_C_	P29_visit_extra_C_	P29_visit_extra_	P29_visit_extra_	P29_visit_extra_	P29_visit_extra_	CD_	CD_IFX_	CD_	CD_C_	CD_SeS_
P29_MS81_VII_D	IS_P29_MS81_VII_D	plate_3	F9	ATAATAGGGGTTA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGGGGTT	CTTGTA	P29	patient	38	F	CD_F	170	67	23.18	normal	smoker	CD_smoker	CD	IFX	Remsima	12	26	no	none	perial_disease	no	none	A2	B3	L2	non-L4	CD	no	none	yes	fistula_draige	CD_	IFX_	CD_IFX_	exclude	exclude	exclude	exclude	visit_extra	visit_extra	week_X	week_X		03/02/2020																															D	SeT														none	none					CD_IFX	CD_IFX_SeT	CD_IFX_	CD_IFX_	CD_IFX_	CD_D	CD_	CD_D_	CD_SeT	CD_SeT_	CD_	CD_	CD_	CD_visit_extra	CD_visit_extra	CD_IFX_visit_extra	CD_IFX_visit_extra	CD_IFX_	P29_visit_extra_	P29_visit_extra_	P29_visit_extra_D_	P29_visit_extra_D_	P29_visit_extra_	P29_visit_extra_	P29_visit_extra_	P29_visit_extra_	CD_	CD_IFX_	CD_	CD_D_	CD_SeT_
P31_RK85_I_A	IS_P31_RK85_I_A	plate_3	G9	ATAATACTAGGGA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACTAGGG	CTTGTA	P31	patient	33	F	UC_F	167	52	18.65	normal	non-smoker	UC_non-smoker	UC	ADA	Hulio	5	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_Start	ADA_Start	UC_ADA_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	27/03/2019	SC	160	yes	Pentasa	no	none	yes	Medrol	yes	Caltrate_Kalnormin	0.7	low	11.1	269	55.61	154	455	significantly_increased	0	negative	UC		8	8	8	active	severe	baseline	baseline	Base	A	Dr	no	none	BT_A	ADA_A	ADA_Dr	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_Dr	UC_ADA_no	UC_ADA_none	UC_ADA_BT_A	UC_A	UC_no	UC_A_no	UC_Dr	UC_Dr_no	UC_none	UC_none	UC_BT_A	UC_visit_1	UC_visit_1	UC_ADA_visit_1	UC_ADA_visit_1	UC_ADA_no_no	P31_visit_1_no	P31_visit_1_no	P31_visit_1_A_no	P31_visit_1_A_no	P31_visit_1_none	P31_visit_1_none	P31_visit_1_none	P31_visit_1_none	UC_Base	UC_ADA_Base	UC_no_Base	UC_A_no_Base	UC_Dr_no_Base
P31_RK85_I_D	IS_P31_RK85_I_D	plate_3	H9	ATAATATAGCCGA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ATAGCCG	CTTGTA	P31	patient	33	F	UC_F	167	52	18.65	normal	non-smoker	UC_non-smoker	UC	ADA	Hulio	5	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_Start	ADA_Start	UC_ADA_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	27/03/2019	SC	160	yes	Pentasa	no	none	yes	Medrol	yes	Caltrate_Kalnormin	0.7	low	11.1	269	55.61	154	455	significantly_increased	0	negative	UC		8	8	8	active	severe	baseline	baseline	Base	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_1	UC_visit_1	UC_ADA_visit_1	UC_ADA_visit_1	UC_ADA_no_no	P31_visit_1_no	P31_visit_1_no	P31_visit_1_D_no	P31_visit_1_D_no	P31_visit_1_none	P31_visit_1_none	P31_visit_1_none	P31_visit_1_none	UC_Base	UC_ADA_Base	UC_no_Base	UC_D_no_Base	UC_SeT_no_Base
P31_RK85_I_E	IS_P31_RK85_I_E	plate_3	A10	AGGGTACCTTCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACCTTCC	CTTGTA	P31	patient	33	F	UC_F	167	52	18.65	normal	non-smoker	UC_non-smoker	UC	ADA	Hulio	5	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_Start	ADA_Start	UC_ADA_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	27/03/2019	SC	160	yes	Pentasa	no	none	yes	Medrol	yes	Caltrate_Kalnormin	0.7	low	11.1	269	55.61	154	455	significantly_increased	0	negative	UC		8	8	8	active	severe	baseline	baseline	Base	E	Mo	no	none	BT_E	ADA_E	ADA_Mo	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_Mo	UC_ADA_no	UC_ADA_none	UC_ADA_BT_E	UC_E	UC_no	UC_E_no	UC_Mo	UC_Mo_no	UC_none	UC_none	UC_BT_E	UC_visit_1	UC_visit_1	UC_ADA_visit_1	UC_ADA_visit_1	UC_ADA_no_no	P31_visit_1_no	P31_visit_1_no	P31_visit_1_E_no	P31_visit_1_E_no	P31_visit_1_none	P31_visit_1_none	P31_visit_1_none	P31_visit_1_none	UC_Base	UC_ADA_Base	UC_no_Base	UC_E_no_Base	UC_Mo_no_Base
P31_RK85_II_A	IS_P31_RK85_II_A	plate_3	B10	AGGGTAGCCACCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGCCACC	CTTGTA	P31	patient	33	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	ADA	Hulio	5	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	11/04/2019	SC	80	yes	Pentasa	no	none	no	none	no	none	0.4	low	5.6	286	37.64	151	34	normal	18.9	negative	UC		1	1	1	inactive	remission	response	full_response	Full	A	Dr	no	none	BT_A	ADA_A	ADA_Dr	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_Dr	UC_ADA_no	UC_ADA_none	UC_ADA_BT_A	UC_A	UC_no	UC_A_no	UC_Dr	UC_Dr_no	UC_none	UC_none	UC_BT_A	UC_visit_2	UC_visit_2	UC_ADA_visit_2	UC_ADA_visit_2	UC_ADA_no_no	P31_visit_2_no	P31_visit_2_no	P31_visit_2_A_no	P31_visit_2_A_no	P31_visit_2_none	P31_visit_2_none	P31_visit_2_none	P31_visit_2_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_A_no_Full	UC_Dr_no_Full
P31_RK85_II_D	IS_P31_RK85_II_D	plate_3	C10	AGGGTAACAGCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AACAGCC	CTTGTA	P31	patient	33	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	ADA	Hulio	5	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	11/04/2019	SC	80	yes	Pentasa	no	none	no	none	no	none	0.4	low	5.6	286	37.64	151	34	normal	18.9	negative	UC		1	1	1	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_2	UC_visit_2	UC_ADA_visit_2	UC_ADA_visit_2	UC_ADA_no_no	P31_visit_2_no	P31_visit_2_no	P31_visit_2_D_no	P31_visit_2_D_no	P31_visit_2_none	P31_visit_2_none	P31_visit_2_none	P31_visit_2_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
P31_RK85_II_E	IS_P31_RK85_II_E	plate_3	D10	AGGGTACGGCCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACGGCCC	CTTGTA	P31	patient	33	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	ADA	Hulio	5	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	11/04/2019	SC	80	yes	Pentasa	no	none	no	none	no	none	0.4	low	5.6	286	37.64	151	34	normal	18.9	negative	UC		1	1	1	inactive	remission	response	full_response	Full	E	Mo	no	none	BT_E	ADA_E	ADA_Mo	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_Mo	UC_ADA_no	UC_ADA_none	UC_ADA_BT_E	UC_E	UC_no	UC_E_no	UC_Mo	UC_Mo_no	UC_none	UC_none	UC_BT_E	UC_visit_2	UC_visit_2	UC_ADA_visit_2	UC_ADA_visit_2	UC_ADA_no_no	P31_visit_2_no	P31_visit_2_no	P31_visit_2_E_no	P31_visit_2_E_no	P31_visit_2_none	P31_visit_2_none	P31_visit_2_none	P31_visit_2_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_E_no_Full	UC_Mo_no_Full
P31_RK85_III_A	IS_P31_RK85_III_A	plate_3	E10	AGGGTACTGGCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACTGGCC	CTTGTA	P31	patient	33	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	ADA	Hulio	5	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	22/05/2019	SC	40	yes	Pentasa	no	none	no	none	no	none	0.3	low	9	288	37.13	146	6	normal	20	negative	UC		0	0	0	inactive	remission	response	full_response	Full	A	Dr	no	none	BT_A	ADA_A	ADA_Dr	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_Dr	UC_ADA_no	UC_ADA_none	UC_ADA_BT_A	UC_A	UC_no	UC_A_no	UC_Dr	UC_Dr_no	UC_none	UC_none	UC_BT_A	UC_visit_3	UC_visit_3	UC_ADA_visit_3	UC_ADA_visit_3	UC_ADA_no_no	P31_visit_3_no	P31_visit_3_no	P31_visit_3_A_no	P31_visit_3_A_no	P31_visit_3_none	P31_visit_3_none	P31_visit_3_none	P31_visit_3_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_A_no_Full	UC_Dr_no_Full
P31_RK85_III_D	IS_P31_RK85_III_D	plate_3	F10	AGGGTAAGGACCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AAGGACC	CTTGTA	P31	patient	33	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	ADA	Hulio	5	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	22/05/2019	SC	40	yes	Pentasa	no	none	no	none	no	none	0.3	low	9	288	37.13	146	6	normal	20	negative	UC		0	0	0	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_3	UC_visit_3	UC_ADA_visit_3	UC_ADA_visit_3	UC_ADA_no_no	P31_visit_3_no	P31_visit_3_no	P31_visit_3_D_no	P31_visit_3_D_no	P31_visit_3_none	P31_visit_3_none	P31_visit_3_none	P31_visit_3_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
P31_RK85_III_E	IS_P31_RK85_III_E	plate_3	G10	AGGGTACGCTCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACGCTCC	CTTGTA	P31	patient	33	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	ADA	Hulio	5	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_8	week_8	8	22/05/2019	SC	40	yes	Pentasa	no	none	no	none	no	none	0.3	low	9	288	37.13	146	6	normal	20	negative	UC		0	0	0	inactive	remission	response	full_response	Full	E	Mo	no	none	BT_E	ADA_E	ADA_Mo	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_Mo	UC_ADA_no	UC_ADA_none	UC_ADA_BT_E	UC_E	UC_no	UC_E_no	UC_Mo	UC_Mo_no	UC_none	UC_none	UC_BT_E	UC_visit_3	UC_visit_3	UC_ADA_visit_3	UC_ADA_visit_3	UC_ADA_no_no	P31_visit_3_no	P31_visit_3_no	P31_visit_3_E_no	P31_visit_3_E_no	P31_visit_3_none	P31_visit_3_none	P31_visit_3_none	P31_visit_3_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_E_no_Full	UC_Mo_no_Full
P31_RK85_IV_A	IS_P31_RK85_IV_A	plate_3	H10	AGGGTAGCGCCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGCGCCC	CTTGTA	P31	patient	33	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	ADA	Hulio	5	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	04/07/2019	SC	40	yes	Pentasa	no	none	no	none	no	none	0.3	low	7.4	316	47.73	153	17	normal	20	negative	UC		0	0	0	inactive	remission	response	full_response	Full	A	Dr	no	none	BT_A	ADA_A	ADA_Dr	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_Dr	UC_ADA_no	UC_ADA_none	UC_ADA_BT_A	UC_A	UC_no	UC_A_no	UC_Dr	UC_Dr_no	UC_none	UC_none	UC_BT_A	UC_visit_4	UC_visit_4	UC_ADA_visit_4	UC_ADA_visit_4	UC_ADA_no_no	P31_visit_4_no	P31_visit_4_no	P31_visit_4_A_no	P31_visit_4_A_no	P31_visit_4_none	P31_visit_4_none	P31_visit_4_none	P31_visit_4_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_A_no_Full	UC_Dr_no_Full
P31_RK85_IV_D	IS_P31_RK85_IV_D	plate_3	A11	AGGGTAATTAGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AATTAGC	CTTGTA	P31	patient	33	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	ADA	Hulio	5	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	04/07/2019	SC	40	yes	Pentasa	no	none	no	none	no	none	0.3	low	7.4	316	47.73	153	17	normal	20	negative	UC		0	0	0	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_4	UC_visit_4	UC_ADA_visit_4	UC_ADA_visit_4	UC_ADA_no_no	P31_visit_4_no	P31_visit_4_no	P31_visit_4_D_no	P31_visit_4_D_no	P31_visit_4_none	P31_visit_4_none	P31_visit_4_none	P31_visit_4_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
P31_RK85_IV_E	IS_P31_RK85_IV_E	plate_3	B11	AGGGTATCCTCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ATCCTCC	CTTGTA	P31	patient	33	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	ADA	Hulio	5	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	04/07/2019	SC	40	yes	Pentasa	no	none	no	none	no	none	0.3	low	7.4	316	47.73	153	17	normal	20	negative	UC		0	0	0	inactive	remission	response	full_response	Full	E	Mo	no	none	BT_E	ADA_E	ADA_Mo	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_Mo	UC_ADA_no	UC_ADA_none	UC_ADA_BT_E	UC_E	UC_no	UC_E_no	UC_Mo	UC_Mo_no	UC_none	UC_none	UC_BT_E	UC_visit_4	UC_visit_4	UC_ADA_visit_4	UC_ADA_visit_4	UC_ADA_no_no	P31_visit_4_no	P31_visit_4_no	P31_visit_4_E_no	P31_visit_4_E_no	P31_visit_4_none	P31_visit_4_none	P31_visit_4_none	P31_visit_4_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_E_no_Full	UC_Mo_no_Full
P31_RK85_V_A	IS_P31_RK85_V_A	plate_3	C11	AGGGTAACCCGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AACCCGC	CTTGTA	P31	patient	33	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	ADA	Hulio	5	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_20	week_20	20	15/08/2019	SC	40	yes	Pentasa	no	none	no	none	no	none	0.3	low	7.4	316	47.73	153	22	normal	20	negative	UC		0	0	0	inactive	remission	response	full_response	Full	A	Dr	no	none	BT_A	ADA_A	ADA_Dr	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_Dr	UC_ADA_no	UC_ADA_none	UC_ADA_BT_A	UC_A	UC_no	UC_A_no	UC_Dr	UC_Dr_no	UC_none	UC_none	UC_BT_A	UC_visit_5	UC_visit_5	UC_ADA_visit_5	UC_ADA_visit_5	UC_ADA_no_no	P31_visit_5_no	P31_visit_5_no	P31_visit_5_A_no	P31_visit_5_A_no	P31_visit_5_none	P31_visit_5_none	P31_visit_5_none	P31_visit_5_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_A_no_Full	UC_Dr_no_Full
P31_RK85_V_D	IS_P31_RK85_V_D	plate_3	D11	AGGGTATCCCTCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ATCCCTC	CTTGTA	P31	patient	33	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	ADA	Hulio	5	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_20	week_20	20	15/08/2019	SC	40	yes	Pentasa	no	none	no	none	no	none	0.3	low	7.4	316	47.73	153	22	normal	20	negative	UC		0	0	0	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_5	UC_visit_5	UC_ADA_visit_5	UC_ADA_visit_5	UC_ADA_no_no	P31_visit_5_no	P31_visit_5_no	P31_visit_5_D_no	P31_visit_5_D_no	P31_visit_5_none	P31_visit_5_none	P31_visit_5_none	P31_visit_5_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
P31_RK85_V_E	IS_P31_RK85_V_E	plate_3	E11	AGGGTACTCGCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACTCGCC	CTTGTA	P31	patient	33	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	ADA	Hulio	5	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	ADA_	UC_ADA_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_20	week_20	20	15/08/2019	SC	40	yes	Pentasa	no	none	no	none	no	none	0.3	low	7.4	316	47.73	153	22	normal	20	negative	UC		0	0	0	inactive	remission	response	full_response	Full	E	Mo	no	none	BT_E	ADA_E	ADA_Mo	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_Mo	UC_ADA_no	UC_ADA_none	UC_ADA_BT_E	UC_E	UC_no	UC_E_no	UC_Mo	UC_Mo_no	UC_none	UC_none	UC_BT_E	UC_visit_5	UC_visit_5	UC_ADA_visit_5	UC_ADA_visit_5	UC_ADA_no_no	P31_visit_5_no	P31_visit_5_no	P31_visit_5_E_no	P31_visit_5_E_no	P31_visit_5_none	P31_visit_5_none	P31_visit_5_none	P31_visit_5_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_E_no_Full	UC_Mo_no_Full
P31_RK85_VI_A	IS_P31_RK85_VI_A	plate_3	F11	AGGGTAGGCCTCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGGCCTC	CTTGTA	P31	patient	33	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	ADA	Hulio	5	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_Finish	ADA_Finish	UC_ADA_Finish	Finish	Finish	Finish.26	Finish.26	visit_6	visit_6	week_26	week_26	26	26/09/2019	SC	40	yes	Pentasa	no	none	no	none	no	none	0.3	low	7.7	304	40.34	150	381	significantly_increased	20	negative	UC		0	0	0	inactive	remission	response	full_response	Full	A	Dr	no	none	BT_A	ADA_A	ADA_Dr	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_Dr	UC_ADA_no	UC_ADA_none	UC_ADA_BT_A	UC_A	UC_no	UC_A_no	UC_Dr	UC_Dr_no	UC_none	UC_none	UC_BT_A	UC_visit_6	UC_visit_6	UC_ADA_visit_6	UC_ADA_visit_6	UC_ADA_no_no	P31_visit_6_no	P31_visit_6_no	P31_visit_6_A_no	P31_visit_6_A_no	P31_visit_6_none	P31_visit_6_none	P31_visit_6_none	P31_visit_6_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_A_no_Full	UC_Dr_no_Full
P31_RK85_VI_D	IS_P31_RK85_VI_D	plate_3	G11	AGGGTACCCAGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACCCAGC	CTTGTA	P31	patient	33	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	ADA	Hulio	5	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_Finish	ADA_Finish	UC_ADA_Finish	Finish	Finish	Finish.26	Finish.26	visit_6	visit_6	week_26	week_26	26	26/09/2019	SC	40	yes	Pentasa	no	none	no	none	no	none	0.3	low	7.7	304	40.34	150	381	significantly_increased	20	negative	UC		0	0	0	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_SeT	UC_ADA_no	UC_ADA_none	UC_ADA_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_6	UC_visit_6	UC_ADA_visit_6	UC_ADA_visit_6	UC_ADA_no_no	P31_visit_6_no	P31_visit_6_no	P31_visit_6_D_no	P31_visit_6_D_no	P31_visit_6_none	P31_visit_6_none	P31_visit_6_none	P31_visit_6_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
P31_RK85_VI_E	IS_P31_RK85_VI_E	plate_3	H11	AGGGTAAAGAGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AAAGAGC	CTTGTA	P31	patient	33	F	UC_F	167	55	19.72	normal	non-smoker	UC_non-smoker	UC	ADA	Hulio	5	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_Finish	ADA_Finish	UC_ADA_Finish	Finish	Finish	Finish.26	Finish.26	visit_6	visit_6	week_26	week_26	26	26/09/2019	SC	40	yes	Pentasa	no	none	no	none	no	none	0.3	low	7.7	304	40.34	150	381	significantly_increased	20	negative	UC		0	0	0	inactive	remission	response	full_response	Full	E	Mo	no	none	BT_E	ADA_E	ADA_Mo	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_ADA	UC_ADA_Mo	UC_ADA_no	UC_ADA_none	UC_ADA_BT_E	UC_E	UC_no	UC_E_no	UC_Mo	UC_Mo_no	UC_none	UC_none	UC_BT_E	UC_visit_6	UC_visit_6	UC_ADA_visit_6	UC_ADA_visit_6	UC_ADA_no_no	P31_visit_6_no	P31_visit_6_no	P31_visit_6_E_no	P31_visit_6_E_no	P31_visit_6_none	P31_visit_6_none	P31_visit_6_none	P31_visit_6_none	UC_Full	UC_ADA_Full	UC_no_Full	UC_E_no_Full	UC_Mo_no_Full
P52_KB72_I_D	IS_P52_KB72_I_D	plate_3	A12	AGGGTACGGCTCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACGGCTC	CTTGTA	P52	patient	47	M	CD_M	178	86	27.14	overweight	smoker	CD_smoker	CD	ADA	Hulio	3	44	yes	polio	conventiol_therapy_ineffectiveness	no	none	A3	B1	L2	non-L4	CD	no	none	no	none	CD_Start	ADA_Start	CD_ADA_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	21/08/2019	SC	160	yes	Pentasa	no	none	no	none	no	none	5.7	low	8.5	275	40.6	148	947	significantly_increased	0	negative	3	3	CD		3	inactive	remission	baseline	baseline	Base	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_1	CD_visit_1	CD_ADA_visit_1	CD_ADA_visit_1	CD_ADA_no_no	P52_visit_1_no	P52_visit_1_no	P52_visit_1_D_no	P52_visit_1_D_no	P52_visit_1_none	P52_visit_1_none	P52_visit_1_none	P52_visit_1_none	CD_Base	CD_ADA_Base	CD_no_Base	CD_D_no_Base	CD_SeT_no_Base
P52_KB72_II_D	IS_P52_KB72_II_D	plate_3	B12	AGGGTACGACATA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACGACAT	CTTGTA	P52	patient	47	M	CD_M	178	86	27.14	overweight	smoker	CD_smoker	CD	ADA	Hulio	3	44	yes	polio	conventiol_therapy_ineffectiveness	no	none	A3	B1	L2	non-L4	CD	no	none	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	04/09/2019	SC	80	no	none	no	none	no	none	no	none	2.5	low	7.2	253	65.66	162	21	normal	14.6	positive	1	1	CD		1	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_2	CD_visit_2	CD_ADA_visit_2	CD_ADA_visit_2	CD_ADA_no_no	P52_visit_2_no	P52_visit_2_no	P52_visit_2_D_no	P52_visit_2_D_no	P52_visit_2_none	P52_visit_2_none	P52_visit_2_none	P52_visit_2_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P52_KB72_VIII_D	IS_P52_KB72_VIII_D	plate_3	C12	AGGGTATCCCGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ATCCCGC	CTTGTA	P52	patient	47	M	CD_M	178	87	27.46	overweight	smoker	CD_smoker	CD	ADA	Hulio	3	44	yes	polio	conventiol_therapy_ineffectiveness	no	none	A3	B1	L2	non-L4	CD	no	none	no	none	CD_Finish	ADA_Finish	CD_ADA_Finish	Finish	Finish	Finish.38	Finish.38	visit_8	visit_8	week_38	week_38	38	26/06/2020	SC	40	no	none	no	none	no	none	no	none	5.7	low	4.9	215	121	143	80	slightly_increased	0.7	positive	1	1	CD		1	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_8	CD_visit_8	CD_ADA_visit_8	CD_ADA_visit_8	CD_ADA_no_no	P52_visit_8_no	P52_visit_8_no	P52_visit_8_D_no	P52_visit_8_D_no	P52_visit_8_none	P52_visit_8_none	P52_visit_8_none	P52_visit_8_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P52_KB72_IV_D	IS_P52_KB72_IV_D	plate_3	D12	AGGGTAGTGCGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGTGCGC	CTTGTA	P52	patient	47	M	CD_M	178	86	27.14	overweight	smoker	CD_smoker	CD	ADA	Hulio	3	44	yes	polio	conventiol_therapy_ineffectiveness	no	none	A3	B1	L2	non-L4	CD	no	none	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	26/11/2019	SC	40	no	none	no	none	no	none	no	none	4	low	5.3	202	82.07	158	20	normal	12.1	negative	1	1	CD		1	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_4	CD_visit_4	CD_ADA_visit_4	CD_ADA_visit_4	CD_ADA_no_no	P52_visit_4_no	P52_visit_4_no	P52_visit_4_D_no	P52_visit_4_D_no	P52_visit_4_none	P52_visit_4_none	P52_visit_4_none	P52_visit_4_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
P52_KB72_V_D	IS_P52_KB72_V_D	plate_3	E12	AGGGTAGACTCTA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGACTCT	CTTGTA	P52	patient	47	M	CD_M	178	86	27.14	overweight	smoker	CD_smoker	CD	ADA	Hulio	3	44	yes	polio	conventiol_therapy_ineffectiveness	no	none	A3	B1	L2	non-L4	CD	no	none	no	none	CD_	ADA_	CD_ADA_	exclude	exclude	exclude	exclude	visit_5	visit_5	week_20	week_20	20	10/01/2020	SC	40	no	none	no	none	no	none	no	none	3.3	low	6.1	206	144.02	154	17	normal	10.1	negative	2	2	CD		2	inactive	remission	response	full_response	Full	D	SeT	no	none	BT_D	ADA_D	ADA_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	CD_ADA	CD_ADA_SeT	CD_ADA_no	CD_ADA_none	CD_ADA_BT_D	CD_D	CD_no	CD_D_no	CD_SeT	CD_SeT_no	CD_none	CD_none	CD_BT_D	CD_visit_5	CD_visit_5	CD_ADA_visit_5	CD_ADA_visit_5	CD_ADA_no_no	P52_visit_5_no	P52_visit_5_no	P52_visit_5_D_no	P52_visit_5_D_no	P52_visit_5_none	P52_visit_5_none	P52_visit_5_none	P52_visit_5_none	CD_Full	CD_ADA_Full	CD_no_Full	CD_D_no_Full	CD_SeT_no_Full
PCR_neg_16S_B3	PCR_neg_16S_B3	plate_3	F12	AGGGTAGGGGTTA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGGGGTT	CTTGTA	CTRL																																																																																								none	none																							CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_					
P49_LT90_I_C	IS_P49_LT90_I_C	plate_3	G12	AGGGTACTAGGGA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACTAGGG	CTTGTA	P49	patient	29	F	UC_F	166	51	18.51	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	1	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_Start	IFX_Start	UC_IFX_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	14/08/2019	IV	5	no	none	yes	AZA	yes	Prednison	yes	KCl_Caltrate_Contoloc_Magnosolv_Budenofalk_Sumatriptan	49.5	high	10.9	269	13.94	104	332	significantly_increased	0	negative	UC		9	9	9	active	severe	baseline	baseline	Base	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeS	UC_IFX_no	UC_IFX_none	UC_IFX_BT_C	UC_C	UC_no	UC_C_no	UC_SeS	UC_SeS_no	UC_none	UC_none	UC_BT_C	UC_visit_1	UC_visit_1	UC_IFX_visit_1	UC_IFX_visit_1	UC_IFX_no_yes	P49_visit_1_no	P49_visit_1_no	P49_visit_1_C_no	P49_visit_1_C_no	P49_visit_1_none	P49_visit_1_none	P49_visit_1_none	P49_visit_1_none	UC_Base	UC_IFX_Base	UC_no_Base	UC_C_no_Base	UC_SeS_no_Base
P49_LT90_I_D	IS_P49_LT90_I_D	plate_3	H12	AGGGTATAGCCGA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ATAGCCG	CTTGTA	P49	patient	29	F	UC_F	166	51	18.51	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	1	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_Start	IFX_Start	UC_IFX_Start	Start	Start	Start.0	Start.0	visit_1	visit_1	week_0	week_0	0	14/08/2019	IV	5	no	none	yes	AZA	yes	Prednison	yes	KCl_Caltrate_Contoloc_Magnosolv_Budenofalk_Sumatriptan	49.5	high	10.9	269	13.94	104	332	significantly_increased	0	negative	UC		9	9	9	active	severe	baseline	baseline	Base	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeT	UC_IFX_no	UC_IFX_none	UC_IFX_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_1	UC_visit_1	UC_IFX_visit_1	UC_IFX_visit_1	UC_IFX_no_yes	P49_visit_1_no	P49_visit_1_no	P49_visit_1_D_no	P49_visit_1_D_no	P49_visit_1_none	P49_visit_1_none	P49_visit_1_none	P49_visit_1_none	UC_Base	UC_IFX_Base	UC_no_Base	UC_D_no_Base	UC_SeT_no_Base
P49_LT90_II_C	IS_P49_LT90_II_C	plate_4	A1	AAAGCACCTTCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACCTTCC	GTGAAA	P49	patient	29	F	UC_F	166	51	18.51	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	1	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	26/08/2019	IV	5	no	none	yes	AZA	yes	Prednison	yes	KCl_Caltrate_Contoloc_Magnosolv_Budenofalk_Sumatriptan	12.8	high	10.7	298	6.24	90	6000	significantly_increased	9.5	negative	UC		5	5	5	active	moderate	response	full_response	Full	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeS	UC_IFX_no	UC_IFX_none	UC_IFX_BT_C	UC_C	UC_no	UC_C_no	UC_SeS	UC_SeS_no	UC_none	UC_none	UC_BT_C	UC_visit_2	UC_visit_2	UC_IFX_visit_2	UC_IFX_visit_2	UC_IFX_no_yes	P49_visit_2_no	P49_visit_2_no	P49_visit_2_C_no	P49_visit_2_C_no	P49_visit_2_none	P49_visit_2_none	P49_visit_2_none	P49_visit_2_none	UC_Full	UC_IFX_Full	UC_no_Full	UC_C_no_Full	UC_SeS_no_Full
P49_LT90_II_D	IS_P49_LT90_II_D	plate_4	B1	AAAGCAGCCACCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGCCACC	GTGAAA	P49	patient	29	F	UC_F	166	51	18.51	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	1	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_2	visit_2	week_2	week_2	2	26/08/2019	IV	5	no	none	yes	AZA	yes	Prednison	yes	KCl_Caltrate_Contoloc_Magnosolv_Budenofalk_Sumatriptan	12.8	high	10.7	298	6.24	90	6000	significantly_increased	9.5	negative	UC		5	5	5	active	moderate	response	full_response	Full	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeT	UC_IFX_no	UC_IFX_none	UC_IFX_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_2	UC_visit_2	UC_IFX_visit_2	UC_IFX_visit_2	UC_IFX_no_yes	P49_visit_2_no	P49_visit_2_no	P49_visit_2_D_no	P49_visit_2_D_no	P49_visit_2_none	P49_visit_2_none	P49_visit_2_none	P49_visit_2_none	UC_Full	UC_IFX_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
P49_LT90_III_C	IS_P49_LT90_III_C	plate_4	C1	AAAGCAACAGCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AACAGCC	GTGAAA	P49	patient	29	F	UC_F	166	53	19.23	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	1	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_6	week_6	6	25/09/2019	IV	5	no	none	yes	AZA	yes	Prednison	yes	KCl_Caltrate_Contoloc_Eliquis_Sumatriptan	7.4	low	8.7	348	36.06	114	3622	significantly_increased	4.2	negative	UC		5	5	5	active	moderate	response	partial_response	Part	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeS	UC_IFX_no	UC_IFX_none	UC_IFX_BT_C	UC_C	UC_no	UC_C_no	UC_SeS	UC_SeS_no	UC_none	UC_none	UC_BT_C	UC_visit_3	UC_visit_3	UC_IFX_visit_3	UC_IFX_visit_3	UC_IFX_no_yes	P49_visit_3_no	P49_visit_3_no	P49_visit_3_C_no	P49_visit_3_C_no	P49_visit_3_none	P49_visit_3_none	P49_visit_3_none	P49_visit_3_none	UC_Part	UC_IFX_Part	UC_no_Part	UC_C_no_Part	UC_SeS_no_Part
P49_LT90_III_D	IS_P49_LT90_III_D	plate_4	D1	AAAGCACGGCCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACGGCCC	GTGAAA	P49	patient	29	F	UC_F	166	53	19.23	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	1	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_3	visit_3	week_6	week_6	6	25/09/2019	IV	5	no	none	yes	AZA	yes	Prednison	yes	KCl_Caltrate_Contoloc_Eliquis_Sumatriptan	7.4	low	8.7	348	36.06	114	3622	significantly_increased	4.2	negative	UC		5	5	5	active	moderate	response	partial_response	Part	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeT	UC_IFX_no	UC_IFX_none	UC_IFX_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_3	UC_visit_3	UC_IFX_visit_3	UC_IFX_visit_3	UC_IFX_no_yes	P49_visit_3_no	P49_visit_3_no	P49_visit_3_D_no	P49_visit_3_D_no	P49_visit_3_none	P49_visit_3_none	P49_visit_3_none	P49_visit_3_none	UC_Part	UC_IFX_Part	UC_no_Part	UC_D_no_Part	UC_SeT_no_Part
P49_LT90_IV_C	IS_P49_LT90_IV_C	plate_4	E1	AAAGCACTGGCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACTGGCC	GTGAAA	P49	patient	29	F	UC_F	166	55	19.96	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	1	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	06/11/2019	IV	10	no	none	yes	AZA	yes	Prednison	yes	KCl_Caltrate_Contoloc_Sumatriptan_Eliquis	0.3	low	6	287	4.06	118	308	significantly_increased	5.3	negative	UC		3	3	3	inactive	mild	response	full_response	Full	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeS	UC_IFX_no	UC_IFX_none	UC_IFX_BT_C	UC_C	UC_no	UC_C_no	UC_SeS	UC_SeS_no	UC_none	UC_none	UC_BT_C	UC_visit_4	UC_visit_4	UC_IFX_visit_4	UC_IFX_visit_4	UC_IFX_no_yes	P49_visit_4_no	P49_visit_4_no	P49_visit_4_C_no	P49_visit_4_C_no	P49_visit_4_none	P49_visit_4_none	P49_visit_4_none	P49_visit_4_none	UC_Full	UC_IFX_Full	UC_no_Full	UC_C_no_Full	UC_SeS_no_Full
P49_LT90_IV_D	IS_P49_LT90_IV_D	plate_4	F1	AAAGCAAGGACCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AAGGACC	GTGAAA	P49	patient	29	F	UC_F	166	55	19.96	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	1	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_4	visit_4	week_14	week_14	14	06/11/2019	IV	10	no	none	yes	AZA	yes	Prednison	yes	KCl_Caltrate_Contoloc_Sumatriptan_Eliquis	0.3	low	6	287	4.06	118	308	significantly_increased	5.3	negative	UC		3	3	3	inactive	mild	response	full_response	Full	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeT	UC_IFX_no	UC_IFX_none	UC_IFX_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_4	UC_visit_4	UC_IFX_visit_4	UC_IFX_visit_4	UC_IFX_no_yes	P49_visit_4_no	P49_visit_4_no	P49_visit_4_D_no	P49_visit_4_D_no	P49_visit_4_none	P49_visit_4_none	P49_visit_4_none	P49_visit_4_none	UC_Full	UC_IFX_Full	UC_no_Full	UC_D_no_Full	UC_SeT_no_Full
P49_LT90_VI_C	IS_P49_LT90_VI_C	plate_4	G1	AAAGCACGCTCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACGCTCC	GTGAAA	P49	patient	29	F	UC_F	166	55	19.96	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	1	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_6	visit_6	week_30	week_30	30	12/02/2020	IV	5	no	none	yes	AZA	yes	Prednison	yes	Eliquis_Sumatriptan	0.8	low	5.9	334	4.79	118	341	significantly_increased	16.9	negative	UC		3	3	3	inactive	mild	response	partial_response	Part	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeS	UC_IFX_no	UC_IFX_none	UC_IFX_BT_C	UC_C	UC_no	UC_C_no	UC_SeS	UC_SeS_no	UC_none	UC_none	UC_BT_C	UC_visit_6	UC_visit_6	UC_IFX_visit_6	UC_IFX_visit_6	UC_IFX_no_yes	P49_visit_6_no	P49_visit_6_no	P49_visit_6_C_no	P49_visit_6_C_no	P49_visit_6_none	P49_visit_6_none	P49_visit_6_none	P49_visit_6_none	UC_Part	UC_IFX_Part	UC_no_Part	UC_C_no_Part	UC_SeS_no_Part
P49_LT90_VI_D	IS_P49_LT90_VI_D	plate_4	H1	AAAGCAGCGCCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGCGCCC	GTGAAA	P49	patient	29	F	UC_F	166	55	19.96	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	1	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_	IFX_	UC_IFX_	exclude	exclude	exclude	exclude	visit_6	visit_6	week_30	week_30	30	12/02/2020	IV	5	no	none	yes	AZA	yes	Prednison	yes	Eliquis_Sumatriptan	0.8	low	5.9	334	4.79	118	341	significantly_increased	16.9	negative	UC		3	3	3	inactive	mild	response	partial_response	Part	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeT	UC_IFX_no	UC_IFX_none	UC_IFX_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_6	UC_visit_6	UC_IFX_visit_6	UC_IFX_visit_6	UC_IFX_no_yes	P49_visit_6_no	P49_visit_6_no	P49_visit_6_D_no	P49_visit_6_D_no	P49_visit_6_none	P49_visit_6_none	P49_visit_6_none	P49_visit_6_none	UC_Part	UC_IFX_Part	UC_no_Part	UC_D_no_Part	UC_SeT_no_Part
P49_LT90_VII_C	IS_P49_LT90_VII_C	plate_4	A2	AAAGCAATTAGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AATTAGC	GTGAAA	P49	patient	29	F	UC_F	166	55	19.96	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	1	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_Finish	IFX_Finish	UC_IFX_Finish	Finish	Finish	Finish.38	Finish.38	visit_7	visit_7	week_38	week_38	38	13/05/2020	IV	5	no	none	yes	AZA	no	none	yes	Sumatriptan	1.2	low	4.4	307	8.15	123	229	significantly_increased	5.5	negative	UC		4	4	4	inactive	mild	response	partial_response	Part	C	SeS	no	none	BT_C	IFX_C	IFX_SeS	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeS	UC_IFX_no	UC_IFX_none	UC_IFX_BT_C	UC_C	UC_no	UC_C_no	UC_SeS	UC_SeS_no	UC_none	UC_none	UC_BT_C	UC_visit_7	UC_visit_7	UC_IFX_visit_7	UC_IFX_visit_7	UC_IFX_no_yes	P49_visit_7_no	P49_visit_7_no	P49_visit_7_C_no	P49_visit_7_C_no	P49_visit_7_none	P49_visit_7_none	P49_visit_7_none	P49_visit_7_none	UC_Part	UC_IFX_Part	UC_no_Part	UC_C_no_Part	UC_SeS_no_Part
P49_LT90_VII_D	IS_P49_LT90_VII_D	plate_4	B2	AAAGCATCCTCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ATCCTCC	GTGAAA	P49	patient	29	F	UC_F	166	55	19.96	normal	non-smoker	UC_non-smoker	UC	IFX	Remsima	1	28	no	none	conventiol_therapy_ineffectiveness	no	none	A2	UC	UC	UC	E2	no	none	no	none	UC_Finish	IFX_Finish	UC_IFX_Finish	Finish	Finish	Finish.38	Finish.38	visit_7	visit_7	week_38	week_38	38	13/05/2020	IV	5	no	none	yes	AZA	no	none	yes	Sumatriptan	1.2	low	4.4	307	8.15	123	229	significantly_increased	5.5	negative	UC		4	4	4	inactive	mild	response	partial_response	Part	D	SeT	no	none	BT_D	IFX_D	IFX_SeT	none	none	none	none	none	none	none	none	none	none	none	none	none	none	UC_IFX	UC_IFX_SeT	UC_IFX_no	UC_IFX_none	UC_IFX_BT_D	UC_D	UC_no	UC_D_no	UC_SeT	UC_SeT_no	UC_none	UC_none	UC_BT_D	UC_visit_7	UC_visit_7	UC_IFX_visit_7	UC_IFX_visit_7	UC_IFX_no_yes	P49_visit_7_no	P49_visit_7_no	P49_visit_7_D_no	P49_visit_7_D_no	P49_visit_7_none	P49_visit_7_none	P49_visit_7_none	P49_visit_7_none	UC_Part	UC_IFX_Part	UC_no_Part	UC_D_no_Part	UC_SeT_no_Part
K2_NL71_I_C	K2_NL71_I_C	plate_4	C2	AAAGCAACCCGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AACCCGC	GTGAAA	HC2	healthy_control	47	F	HC_F	171	98	33.51	HC_obesity	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	15/04/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.9	HC_low	6	289		143			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC2_visit_1HC_HC	HC2_visit_1HC_HC	HC2_visit_1HC_C_HC	HC2_visit_1HC_C_HC	HC2_visit_1HC_HC	HC2_visit_1HC_HC	HC2_visit_1HC_HC	HC2_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K2_NL71_I_D	K2_NL71_I_D	plate_4	D2	AAAGCATCCCTCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ATCCCTC	GTGAAA	HC2	healthy_control	47	F	HC_F	171	98	33.51	HC_obesity	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	15/04/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.9	HC_low	6	289		143			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC2_visit_1HC_HC	HC2_visit_1HC_HC	HC2_visit_1HC_D_HC	HC2_visit_1HC_D_HC	HC2_visit_1HC_HC	HC2_visit_1HC_HC	HC2_visit_1HC_HC	HC2_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K2_NL71_IV_C	K2_NL71_IV_C	plate_4	E2	AAAGCACTCGCCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACTCGCC	GTGAAA	HC2	healthy_control	47	F	HC_F	171	98	33.51	HC_obesity	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	18/10/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	2.2	HC_low	6.3	298		132			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC2_visit_4HC_HC	HC2_visit_4HC_HC	HC2_visit_4HC_C_HC	HC2_visit_4HC_C_HC	HC2_visit_4HC_HC	HC2_visit_4HC_HC	HC2_visit_4HC_HC	HC2_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K2_NL71_IV_D	K2_NL71_IV_D	plate_4	F2	AAAGCAGGCCTCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGGCCTC	GTGAAA	HC2	healthy_control	47	F	HC_F	171	98	33.51	HC_obesity	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	18/10/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	2.2	HC_low	6.3	298		132			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC2_visit_4HC_HC	HC2_visit_4HC_HC	HC2_visit_4HC_D_HC	HC2_visit_4HC_D_HC	HC2_visit_4HC_HC	HC2_visit_4HC_HC	HC2_visit_4HC_HC	HC2_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K3_KM78_I_C	K3_KM78_I_C	plate_4	G2	AAAGCACCCAGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACCCAGC	GTGAAA	HC3	healthy_control	40	M	HC_M	175	98	32	HC_obesity	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	15/04/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	1.3	HC_low	5.5	192		163			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC3_visit_1HC_HC	HC3_visit_1HC_HC	HC3_visit_1HC_C_HC	HC3_visit_1HC_C_HC	HC3_visit_1HC_HC	HC3_visit_1HC_HC	HC3_visit_1HC_HC	HC3_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K3_KM78_I_D	K3_KM78_I_D	plate_4	H2	AAAGCAAAGAGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AAAGAGC	GTGAAA	HC3	healthy_control	40	M	HC_M	175	98	32	HC_obesity	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	15/04/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	1.3	HC_low	5.5	192		163			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC3_visit_1HC_HC	HC3_visit_1HC_HC	HC3_visit_1HC_D_HC	HC3_visit_1HC_D_HC	HC3_visit_1HC_HC	HC3_visit_1HC_HC	HC3_visit_1HC_HC	HC3_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K3_KM78_IV_C	K3_KM78_IV_C	plate_4	A3	AAAGCACGGCTCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACGGCTC	GTGAAA	HC3	healthy_control	40	M	HC_M	175	98	32	HC_obesity	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	18/10/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	1.5	HC_low	5.3	190		155			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC3_visit_4HC_HC	HC3_visit_4HC_HC	HC3_visit_4HC_C_HC	HC3_visit_4HC_C_HC	HC3_visit_4HC_HC	HC3_visit_4HC_HC	HC3_visit_4HC_HC	HC3_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K3_KM78_IV_D	K3_KM78_IV_D	plate_4	B3	AAAGCACGACATA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACGACAT	GTGAAA	HC3	healthy_control	40	M	HC_M	175	98	32	HC_obesity	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	18.102019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	1.5	HC_low	5.3	190		155			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC3_visit_4HC_HC	HC3_visit_4HC_HC	HC3_visit_4HC_D_HC	HC3_visit_4HC_D_HC	HC3_visit_4HC_HC	HC3_visit_4HC_HC	HC3_visit_4HC_HC	HC3_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K4_RR79_I_C	K4_RR79_I_C	plate_4	C3	AAAGCATCCCGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ATCCCGC	GTGAAA	HC4	healthy_control	40	F	HC_F	164	58	21.57	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	15/04/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	1.7	HC_low	5.4	266		135			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC4_visit_1HC_HC	HC4_visit_1HC_HC	HC4_visit_1HC_C_HC	HC4_visit_1HC_C_HC	HC4_visit_1HC_HC	HC4_visit_1HC_HC	HC4_visit_1HC_HC	HC4_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K4_RR79_I_D	K4_RR79_I_D	plate_4	D3	AAAGCAGTGCGCA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGTGCGC	GTGAAA	HC4	healthy_control	40	F	HC_F	164	58	21.57	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	15/04/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	1.7	HC_low	5.4	266		135			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC4_visit_1HC_HC	HC4_visit_1HC_HC	HC4_visit_1HC_D_HC	HC4_visit_1HC_D_HC	HC4_visit_1HC_HC	HC4_visit_1HC_HC	HC4_visit_1HC_HC	HC4_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K5_JZ92_I_C	K5_JZ92_I_C	plate_4	E3	AAAGCAGACTCTA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGACTCT	GTGAAA	HC5	healthy_control	27	F	HC_F	161	80	30.86	HC_obesity	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	15/04/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	2	HC_low	7	335		138			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC5_visit_1HC_HC	HC5_visit_1HC_HC	HC5_visit_1HC_C_HC	HC5_visit_1HC_C_HC	HC5_visit_1HC_HC	HC5_visit_1HC_HC	HC5_visit_1HC_HC	HC5_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K5_JZ92_I_D	K5_JZ92_I_D	plate_4	F3	AAAGCAGGGGTTA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	AGGGGTT	GTGAAA	HC5	healthy_control	27	F	HC_F	161	80	30.86	HC_obesity	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	15/04/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	2	HC_low	7	335		138			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC5_visit_1HC_HC	HC5_visit_1HC_HC	HC5_visit_1HC_D_HC	HC5_visit_1HC_D_HC	HC5_visit_1HC_HC	HC5_visit_1HC_HC	HC5_visit_1HC_HC	HC5_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K5_JZ92_IV_C	K5_JZ92_IV_C	plate_4	G3	AAAGCACTAGGGA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ACTAGGG	GTGAAA	HC5	healthy_control	27	F	HC_F	161	80	30.86	HC_obesity	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	14/11/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	7	HC_low	6.5	349		132			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC5_visit_4HC_HC	HC5_visit_4HC_HC	HC5_visit_4HC_C_HC	HC5_visit_4HC_C_HC	HC5_visit_4HC_HC	HC5_visit_4HC_HC	HC5_visit_4HC_HC	HC5_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K5_JZ92_IV_D	K5_JZ92_IV_D	plate_4	H3	AAAGCATAGCCGA	GTCCTACGGGNGGCWGCAG	AAAGC	GGACTACHVGGGTWTCTAAT	ATAGCCG	GTGAAA	HC5	healthy_control	27	F	HC_F	161	80	30.86	HC_obesity	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	14/11/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	7	HC_low	6.5	349		132			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC5_visit_4HC_HC	HC5_visit_4HC_HC	HC5_visit_4HC_D_HC	HC5_visit_4HC_D_HC	HC5_visit_4HC_HC	HC5_visit_4HC_HC	HC5_visit_4HC_HC	HC5_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K8_KP79_I_C	K8_KP79_I_C	plate_4	A4	ACGAAACCTTCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACCTTCC	GTGAAA	HC8	healthy_control	40	F	HC_F	164	58	21.56	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	17/04/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.4	HC_low	4.8	212		132			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC8_visit_1HC_HC	HC8_visit_1HC_HC	HC8_visit_1HC_C_HC	HC8_visit_1HC_C_HC	HC8_visit_1HC_HC	HC8_visit_1HC_HC	HC8_visit_1HC_HC	HC8_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K8_KP79_I_D	K8_KP79_I_D	plate_4	B4	ACGAAAGCCACCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGCCACC	GTGAAA	HC8	healthy_control	40	F	HC_F	164	58	21.56	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	17/04/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.4	HC_low	4.8	212		132			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC8_visit_1HC_HC	HC8_visit_1HC_HC	HC8_visit_1HC_D_HC	HC8_visit_1HC_D_HC	HC8_visit_1HC_HC	HC8_visit_1HC_HC	HC8_visit_1HC_HC	HC8_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K9_KM80_I_C	K9_KM80_I_C	plate_4	C4	ACGAAAACAGCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AACAGCC	GTGAAA	HC9	healthy_control	39	F	HC_F	179	70	21.85	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	18/04/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.1	HC_low	4.9	246		139			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC9_visit_1HC_HC	HC9_visit_1HC_HC	HC9_visit_1HC_C_HC	HC9_visit_1HC_C_HC	HC9_visit_1HC_HC	HC9_visit_1HC_HC	HC9_visit_1HC_HC	HC9_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K9_KM80_I_D	K9_KM80_I_D	plate_4	D4	ACGAAACGGCCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACGGCCC	GTGAAA	HC9	healthy_control	39	F	HC_F	179	70	21.85	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	18/04/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.1	HC_low	4.9	246		139			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC9_visit_1HC_HC	HC9_visit_1HC_HC	HC9_visit_1HC_D_HC	HC9_visit_1HC_D_HC	HC9_visit_1HC_HC	HC9_visit_1HC_HC	HC9_visit_1HC_HC	HC9_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K9_KM80_IV_C	K9_KM80_IV_C	plate_4	E4	ACGAAACTGGCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACTGGCC	GTGAAA	HC9	healthy_control	39	F	HC_F	179	70	21.85	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	14/09/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.3	HC_low	6.1	253		128			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC9_visit_4HC_HC	HC9_visit_4HC_HC	HC9_visit_4HC_C_HC	HC9_visit_4HC_C_HC	HC9_visit_4HC_HC	HC9_visit_4HC_HC	HC9_visit_4HC_HC	HC9_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K9_KM80_IV_D	K9_KM80_IV_D	plate_4	F4	ACGAAAAGGACCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AAGGACC	GTGAAA	HC9	healthy_control	39	F	HC_F	179	70	21.85	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	14/09/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.3	HC_low	6.1	253		128			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC9_visit_4HC_HC	HC9_visit_4HC_HC	HC9_visit_4HC_D_HC	HC9_visit_4HC_D_HC	HC9_visit_4HC_HC	HC9_visit_4HC_HC	HC9_visit_4HC_HC	HC9_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K11_JV87_I_D	K11_JV87_I_D	plate_4	G4	ACGAAACGCTCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACGCTCC	GTGAAA	HC11	healthy_control	31	M	HC_M	200	80	20	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	18/04/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.3	HC_low	5.6	270		166			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC11_visit_1HC_HC	HC11_visit_1HC_HC	HC11_visit_1HC_D_HC	HC11_visit_1HC_D_HC	HC11_visit_1HC_HC	HC11_visit_1HC_HC	HC11_visit_1HC_HC	HC11_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K11_JV87_IV_D	K11_JV87_IV_D	plate_4	H4	ACGAAAGCGCCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGCGCCC	GTGAAA	HC11	healthy_control	31	M	HC_M	200	80	20	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	24/10/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.9	HC_low	5.1	302		160			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC11_visit_4HC_HC	HC11_visit_4HC_HC	HC11_visit_4HC_D_HC	HC11_visit_4HC_D_HC	HC11_visit_4HC_HC	HC11_visit_4HC_HC	HC11_visit_4HC_HC	HC11_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K11_JV87_I_O	K11_JV87_I_O	plate_4	A5	ACGAAAATTAGCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AATTAGC	GTGAAA	HC11	healthy_control	31	M	HC_M	200	80	20	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	18/04/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.3	HC_low	5.6	270		166			HC	HC	HC		HC			HC	HC	HC	HC	HC	O	Dr	HC	HC	HC_O	HC_O	HC_Dr	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_Dr	HC_HC_HC	HC_HC_HC	HC_HC_HC_O	HC_O	HC_HC	HC_O_HC	HC_Dr	HC_Dr_HC	HC_HC	HC_HC	HC_HC_O	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC11_visit_1HC_HC	HC11_visit_1HC_HC	HC11_visit_1HC_O_HC	HC11_visit_1HC_O_HC	HC11_visit_1HC_HC	HC11_visit_1HC_HC	HC11_visit_1HC_HC	HC11_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_O_HC_HC	HC_Dr_HC_HC
K11_JV87_IV_P	K11_JV87_IV_P	plate_4	B5	ACGAAATCCTCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ATCCTCC	GTGAAA	HC11	healthy_control	31	M	HC_M	200	80	20	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	24/10/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.9	HC_low	5.1	302		160			HC	HC	HC		HC			HC	HC	HC	HC	HC	P	Mo	HC	HC	HC_P	HC_P	HC_Mo	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_Mo	HC_HC_HC	HC_HC_HC	HC_HC_HC_P	HC_P	HC_HC	HC_P_HC	HC_Mo	HC_Mo_HC	HC_HC	HC_HC	HC_HC_P	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC11_visit_4HC_HC	HC11_visit_4HC_HC	HC11_visit_4HC_P_HC	HC11_visit_4HC_P_HC	HC11_visit_4HC_HC	HC11_visit_4HC_HC	HC11_visit_4HC_HC	HC11_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_P_HC_HC	HC_Mo_HC_HC
K12_KJ78_I_D	K12_KJ78_I_D	plate_4	C5	ACGAAAACCCGCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AACCCGC	GTGAAA	HC12	healthy_control	41	M	HC_M	195	97	25.51	HC_overweight	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	25/04/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.4	HC_low	4.3	180		152			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC12_visit_1HC_HC	HC12_visit_1HC_HC	HC12_visit_1HC_D_HC	HC12_visit_1HC_D_HC	HC12_visit_1HC_HC	HC12_visit_1HC_HC	HC12_visit_1HC_HC	HC12_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K12_KJ78_IV_D	K12_KJ78_IV_D	plate_4	D5	ACGAAATCCCTCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ATCCCTC	GTGAAA	HC12	healthy_control	41	M	HC_M	195	97	25.51	HC_overweight	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	24/10/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.1	HC_low	4.3	160		149			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC12_visit_4HC_HC	HC12_visit_4HC_HC	HC12_visit_4HC_D_HC	HC12_visit_4HC_D_HC	HC12_visit_4HC_HC	HC12_visit_4HC_HC	HC12_visit_4HC_HC	HC12_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K16_PP75_I_C	K16_PP75_I_C	plate_4	E5	ACGAAACTCGCCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACTCGCC	GTGAAA	HC16	healthy_control	44	F	HC_F	163	80	30.12	HC_obesity	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	06/05/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	2.7	HC_low	6.5	287		150			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC16_visit_1HC_HC	HC16_visit_1HC_HC	HC16_visit_1HC_C_HC	HC16_visit_1HC_C_HC	HC16_visit_1HC_HC	HC16_visit_1HC_HC	HC16_visit_1HC_HC	HC16_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K16_PP75_I_D	K16_PP75_I_D	plate_4	F5	ACGAAAGGCCTCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGGCCTC	GTGAAA	HC16	healthy_control	44	F	HC_F	163	80	30.12	HC_obesity	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	06/05/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	2.7	HC_low	6.5	287		150			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC16_visit_1HC_HC	HC16_visit_1HC_HC	HC16_visit_1HC_D_HC	HC16_visit_1HC_D_HC	HC16_visit_1HC_HC	HC16_visit_1HC_HC	HC16_visit_1HC_HC	HC16_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K16_PP75_IV_C	K16_PP75_IV_C	plate_4	G5	ACGAAACCCAGCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACCCAGC	GTGAAA	HC16	healthy_control	44	F	HC_F	163	80	30.12	HC_obesity	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	14/11/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	6.1	HC_low	6.6	289		143			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC16_visit_4HC_HC	HC16_visit_4HC_HC	HC16_visit_4HC_C_HC	HC16_visit_4HC_C_HC	HC16_visit_4HC_HC	HC16_visit_4HC_HC	HC16_visit_4HC_HC	HC16_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K16_PP75_IV_D	K16_PP75_IV_D	plate_4	H5	AAAGAGCACGAAA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AAAGAGC	GTGAAA	HC16	healthy_control	44	F	HC_F	163	80	30.12	HC_obesity	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	14/11/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	6.1	HC_low	6.6	289		143			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC16_visit_4HC_HC	HC16_visit_4HC_HC	HC16_visit_4HC_D_HC	HC16_visit_4HC_D_HC	HC16_visit_4HC_HC	HC16_visit_4HC_HC	HC16_visit_4HC_HC	HC16_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K17_SS75_I_C	K17_SS75_I_C	plate_4	A6	ACGAAACGGCTCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACGGCTC	GTGAAA	HC17	healthy_control	43	F	HC_F	168	61	21.61	HC_normal	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	06/05/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.5	HC_low	6	245		144			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC43_visit_1HC_HC	HC43_visit_1HC_HC	HC43_visit_1HC_C_HC	HC43_visit_1HC_C_HC	HC43_visit_1HC_HC	HC43_visit_1HC_HC	HC43_visit_1HC_HC	HC43_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K17_SS75_I_D	K17_SS75_I_D	plate_4	B6	ACGAAACGACATA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACGACAT	GTGAAA	HC17	healthy_control	43	F	HC_F	168	61	21.61	HC_normal	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	06/05/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.5	HC_low	6	245		144			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC43_visit_1HC_HC	HC43_visit_1HC_HC	HC43_visit_1HC_D_HC	HC43_visit_1HC_D_HC	HC43_visit_1HC_HC	HC43_visit_1HC_HC	HC43_visit_1HC_HC	HC43_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K17_SS75_IV_C	K17_SS75_IV_C	plate_4	C6	ACGAAATCCCGCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ATCCCGC	GTGAAA	HC17	healthy_control	43	F	HC_F	168	61	21.61	HC_normal	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	25/11/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.4	HC_low	5.3	231		131			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC43_visit_4HC_HC	HC43_visit_4HC_HC	HC43_visit_4HC_C_HC	HC43_visit_4HC_C_HC	HC43_visit_4HC_HC	HC43_visit_4HC_HC	HC43_visit_4HC_HC	HC43_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K17_SS75_IV_D	K17_SS75_IV_D	plate_4	D6	ACGAAAGTGCGCA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGTGCGC	GTGAAA	HC17	healthy_control	43	F	HC_F	168	61	21.61	HC_normal	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	25/11/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.4	HC_low	5.3	231		131			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC43_visit_4HC_HC	HC43_visit_4HC_HC	HC43_visit_4HC_D_HC	HC43_visit_4HC_D_HC	HC43_visit_4HC_HC	HC43_visit_4HC_HC	HC43_visit_4HC_HC	HC43_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K18_TB93_I_C	K18_TB93_I_C	plate_4	E6	ACGAAAGACTCTA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGACTCT	GTGAAA	HC18	healthy_control	26	F	HC_F	170	56	19.34	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	06/05/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	1.8	HC_low	4.9	272		134			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC18_visit_1HC_HC	HC18_visit_1HC_HC	HC18_visit_1HC_C_HC	HC18_visit_1HC_C_HC	HC18_visit_1HC_HC	HC18_visit_1HC_HC	HC18_visit_1HC_HC	HC18_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K18_TB93_I_E	K18_TB93_I_E	plate_4	F6	ACGAAAGGGGTTA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	AGGGGTT	GTGAAA	HC18	healthy_control	26	F	HC_F	170	56	19.34	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	06/05/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	1.8	HC_low	4.9	272		134			HC	HC	HC		HC			HC	HC	HC	HC	HC	E	Mo	HC	HC	HC_E	HC_E	HC_Mo	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_Mo	HC_HC_HC	HC_HC_HC	HC_HC_HC_E	HC_E	HC_HC	HC_E_HC	HC_Mo	HC_Mo_HC	HC_HC	HC_HC	HC_HC_E	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC18_visit_1HC_HC	HC18_visit_1HC_HC	HC18_visit_1HC_E_HC	HC18_visit_1HC_E_HC	HC18_visit_1HC_HC	HC18_visit_1HC_HC	HC18_visit_1HC_HC	HC18_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_E_HC_HC	HC_Mo_HC_HC
K18_TB93_IV_C	K18_TB93_IV_C	plate_4	G6	ACGAAACTAGGGA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ACTAGGG	GTGAAA	HC18	healthy_control	26	F	HC_F	170	56	19.34	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	14/11/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.4	HC_low	4.3	216		132			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	Se	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_Se	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_Se	HC_Se_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC18_visit_4HC_HC	HC18_visit_4HC_HC	HC18_visit_4HC_C_HC	HC18_visit_4HC_C_HC	HC18_visit_4HC_HC	HC18_visit_4HC_HC	HC18_visit_4HC_HC	HC18_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_Se_HC_HC
K18_TB93_IV_E	K18_TB93_IV_E	plate_4	H6	ACGAAATAGCCGA	GTCCTACGGGNGGCWGCAG	ACGAA	GGACTACHVGGGTWTCTAAT	ATAGCCG	GTGAAA	HC18	healthy_control	26	F	HC_F	170	56	19.34	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	14/11/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.4	HC_low	4.3	216		132			HC	HC	HC		HC			HC	HC	HC	HC	HC	E	Mo	HC	HC	HC_E	HC_E	HC_Mo	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_Mo	HC_HC_HC	HC_HC_HC	HC_HC_HC_E	HC_E	HC_HC	HC_E_HC	HC_Mo	HC_Mo_HC	HC_HC	HC_HC	HC_HC_E	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC18_visit_4HC_HC	HC18_visit_4HC_HC	HC18_visit_4HC_E_HC	HC18_visit_4HC_E_HC	HC18_visit_4HC_HC	HC18_visit_4HC_HC	HC18_visit_4HC_HC	HC18_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_E_HC_HC	HC_Mo_HC_HC
K20_HO76_I_C	K20_HO76_I_C	plate_4	A7	ATAATACCTTCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACCTTCC	GTGAAA	HC20	healthy_control	42	F	HC_F	170	79	27.34	HC_overweight	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	09/05/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	9.1	HC_low	7.9	273		139			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC20_visit_1HC_HC	HC20_visit_1HC_HC	HC20_visit_1HC_C_HC	HC20_visit_1HC_C_HC	HC20_visit_1HC_HC	HC20_visit_1HC_HC	HC20_visit_1HC_HC	HC20_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K20_HO76_I_D	K20_HO76_I_D	plate_4	B7	ATAATAGCCACCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGCCACC	GTGAAA	HC20	healthy_control	42	F	HC_F	170	79	27.34	HC_overweight	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	09/05/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	9.1	HC_low	7.9	273		139			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC20_visit_1HC_HC	HC20_visit_1HC_HC	HC20_visit_1HC_D_HC	HC20_visit_1HC_D_HC	HC20_visit_1HC_HC	HC20_visit_1HC_HC	HC20_visit_1HC_HC	HC20_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K20_HO76_IV_C	K20_HO76_IV_C	plate_4	C7	ATAATAACAGCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AACAGCC	GTGAAA	HC20	healthy_control	42	F	HC_F	170	79	27.34	HC_overweight	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	12/11/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	6.2	HC_low	8.1	259		136			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC20_visit_4HC_HC	HC20_visit_4HC_HC	HC20_visit_4HC_C_HC	HC20_visit_4HC_C_HC	HC20_visit_4HC_HC	HC20_visit_4HC_HC	HC20_visit_4HC_HC	HC20_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K20_HO76_IV_D	K20_HO76_IV_D	plate_4	D7	ATAATACGGCCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACGGCCC	GTGAAA	HC20	healthy_control	42	F	HC_F	170	79	27.34	HC_overweight	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	12/11/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	6.2	HC_low	8.1	259		136			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC20_visit_4HC_HC	HC20_visit_4HC_HC	HC20_visit_4HC_D_HC	HC20_visit_4HC_D_HC	HC20_visit_4HC_HC	HC20_visit_4HC_HC	HC20_visit_4HC_HC	HC20_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K21_KT86_I_C	K21_KT86_I_C	plate_4	E7	ATAATACTGGCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACTGGCC	GTGAAA	HC21	healthy_control	33	M	HC_M	187	68	19.45	HC_normal	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	19/05/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.8	HC_low	8.5	247		158			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC21_visit_1HC_HC	HC21_visit_1HC_HC	HC21_visit_1HC_C_HC	HC21_visit_1HC_C_HC	HC21_visit_1HC_HC	HC21_visit_1HC_HC	HC21_visit_1HC_HC	HC21_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K21_KT86_I_D	K21_KT86_I_D	plate_4	F7	ATAATAAGGACCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AAGGACC	GTGAAA	HC21	healthy_control	33	M	HC_M	187	68	19.45	HC_normal	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	19/05/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.8	HC_low	8.5	247		158			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC21_visit_1HC_HC	HC21_visit_1HC_HC	HC21_visit_1HC_D_HC	HC21_visit_1HC_D_HC	HC21_visit_1HC_HC	HC21_visit_1HC_HC	HC21_visit_1HC_HC	HC21_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K23_JM85_I_C	K23_JM85_I_C	plate_4	G7	ATAATACGCTCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACGCTCC	GTGAAA	HC23	healthy_control	33	M	HC_M	186	95	27.46	HC_overweight	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	21/05/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.5	HC_low	3.6	251		156			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC23_visit_1HC_HC	HC23_visit_1HC_HC	HC23_visit_1HC_C_HC	HC23_visit_1HC_C_HC	HC23_visit_1HC_HC	HC23_visit_1HC_HC	HC23_visit_1HC_HC	HC23_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K23_JM85_I_D	K23_JM85_I_D	plate_4	H7	ATAATAGCGCCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGCGCCC	GTGAAA	HC23	healthy_control	33	M	HC_M	186	95	27.46	HC_overweight	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	21/05/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.5	HC_low	3.6	251		156			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC23_visit_1HC_HC	HC23_visit_1HC_HC	HC23_visit_1HC_D_HC	HC23_visit_1HC_D_HC	HC23_visit_1HC_HC	HC23_visit_1HC_HC	HC23_visit_1HC_HC	HC23_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K27_BA81_II_D	K27_BA81_II_D	plate_4	A8	ATAATAATTAGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AATTAGC	GTGAAA	HC27	healthy_control	37	M	HC_M	182	68	20.5	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	05/06/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.1	HC_low	3.5	238		144			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC27_visit_1HC_HC	HC27_visit_1HC_HC	HC27_visit_1HC_D_HC	HC27_visit_1HC_D_HC	HC27_visit_1HC_HC	HC27_visit_1HC_HC	HC27_visit_1HC_HC	HC27_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K28_KZ83_I_C	K28_KZ83_I_C	plate_4	B8	ATAATATCCTCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ATCCTCC	GTGAAA	HC28	healthy_control	36	M	HC_M	175	77	24.86	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	18/06/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.6	HC_low	6.9	220		161			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC28_visit_1HC_HC	HC28_visit_1HC_HC	HC28_visit_1HC_C_HC	HC28_visit_1HC_C_HC	HC28_visit_1HC_HC	HC28_visit_1HC_HC	HC28_visit_1HC_HC	HC28_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K28_KZ83_I_D	K28_KZ83_I_D	plate_4	C8	ATAATAACCCGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AACCCGC	GTGAAA	HC28	healthy_control	36	M	HC_M	175	77	24.86	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	18/06/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.6	HC_low	6.9	220		161			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC28_visit_1HC_HC	HC28_visit_1HC_HC	HC28_visit_1HC_D_HC	HC28_visit_1HC_D_HC	HC28_visit_1HC_HC	HC28_visit_1HC_HC	HC28_visit_1HC_HC	HC28_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K30_SF95_I_C	K30_SF95_I_C	plate_4	D8	ATAATATCCCTCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ATCCCTC	GTGAAA	HC30	healthy_control	24	M	HC_M	185	68	19.87	HC_normal	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	21/06/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.4	HC_low	6.1	273		149			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC30_visit_1HC_HC	HC30_visit_1HC_HC	HC30_visit_1HC_C_HC	HC30_visit_1HC_C_HC	HC30_visit_1HC_HC	HC30_visit_1HC_HC	HC30_visit_1HC_HC	HC30_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K30_SF95_I_D	K30_SF95_I_D	plate_4	E8	ATAATACTCGCCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACTCGCC	GTGAAA	HC30	healthy_control	24	M	HC_M	185	68	19.87	HC_normal	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	21/06/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.4	HC_low	6.1	273		149			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC30_visit_1HC_HC	HC30_visit_1HC_HC	HC30_visit_1HC_D_HC	HC30_visit_1HC_D_HC	HC30_visit_1HC_HC	HC30_visit_1HC_HC	HC30_visit_1HC_HC	HC30_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K31_MM80_I_C	K31_MM80_I_C	plate_4	F8	ATAATAGGCCTCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGGCCTC	GTGAAA	HC31	healthy_control	39	F	HC_F	173	68	22.72	HC_normal	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	09/06/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.4	HC_low	4.3	220		127			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	dry_peeling_skin_acne	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC31_visit_1HC_HC	HC31_visit_1HC_HC	HC31_visit_1HC_C_HC	HC31_visit_1HC_C_HC	HC31_visit_1HC_HC	HC31_visit_1HC_HC	HC31_visit_1HC_HC	HC31_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K31_MM80_I_D	K31_MM80_I_D	plate_4	G8	ATAATACCCAGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACCCAGC	GTGAAA	HC31	healthy_control	39	F	HC_F	173	68	22.72	HC_normal	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	09/06/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.4	HC_low	4.3	220		127			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	D	SeT	HC	HC	HC	D	HC	HC	HC	HC	HC	HC	HC	dry_peeling_skin_acne	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_SeT	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_D	HC_SeT	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC31_visit_1HC_HC	HC31_visit_1HC_HC	HC31_visit_1HC_D_HC	HC31_visit_1HC_D_HC	HC31_visit_1HC_D	HC31_visit_1HC_D	HC31_visit_1HC_SeT	HC31_visit_1HC_SeT	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K31_MM80_I_E	K31_MM80_I_E	plate_4	H8	ATAATAAAGAGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AAAGAGC	GTGAAA	HC31	healthy_control	39	F	HC_F	173	68	22.72	HC_normal	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	09/06/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.4	HC_low	4.3	220		127			HC	HC	HC		HC			HC	HC	HC	HC	HC	E	Mo	HC	HC	HC_E	HC_E	HC_Mo	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	dry_peeling_skin_acne	HC_HC	HC_HC_Mo	HC_HC_HC	HC_HC_HC	HC_HC_HC_E	HC_E	HC_HC	HC_E_HC	HC_Mo	HC_Mo_HC	HC_HC	HC_HC	HC_HC_E	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC31_visit_1HC_HC	HC31_visit_1HC_HC	HC31_visit_1HC_E_HC	HC31_visit_1HC_E_HC	HC31_visit_1HC_HC	HC31_visit_1HC_HC	HC31_visit_1HC_HC	HC31_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_E_HC_HC	HC_Mo_HC_HC
K31_MM80_IV_C	K31_MM80_IV_C	plate_4	A9	ATAATACGGCTCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACGGCTC	GTGAAA	HC31	healthy_control	39	F	HC_F	173	68	22.72	HC_normal	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	18/12/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.6	HC_low	4.8	269		135			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	dry_peeling_skin_acne	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC31_visit_4HC_HC	HC31_visit_4HC_HC	HC31_visit_4HC_C_HC	HC31_visit_4HC_C_HC	HC31_visit_4HC_HC	HC31_visit_4HC_HC	HC31_visit_4HC_HC	HC31_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K31_MM80_IV_D	K31_MM80_IV_D	plate_4	B9	ATAATACGACATA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACGACAT	GTGAAA	HC31	healthy_control	39	F	HC_F	173	68	22.72	HC_normal	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	18/12/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.6	HC_low	4.8	269		135			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	D	SeT	HC	HC	HC	D	HC	HC	HC	HC	HC	HC	HC	dry_peeling_skin_acne	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_SeT	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_D	HC_SeT	HC_HC_D	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC31_visit_4HC_HC	HC31_visit_4HC_HC	HC31_visit_4HC_D_HC	HC31_visit_4HC_D_HC	HC31_visit_4HC_D	HC31_visit_4HC_D	HC31_visit_4HC_SeT	HC31_visit_4HC_SeT	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K31_MM80_IV_E	K31_MM80_IV_E	plate_4	C9	ATAATATCCCGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ATCCCGC	GTGAAA	HC31	healthy_control	39	F	HC_F	173	68	22.72	HC_normal	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	18/12/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.6	HC_low	4.8	269		135			HC	HC	HC		HC			HC	HC	HC	HC	HC	E	Mo	HC	HC	HC_E	HC_E	HC_Mo	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	dry_peeling_skin_acne	HC_HC	HC_HC_Mo	HC_HC_HC	HC_HC_HC	HC_HC_HC_E	HC_E	HC_HC	HC_E_HC	HC_Mo	HC_Mo_HC	HC_HC	HC_HC	HC_HC_E	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC31_visit_4HC_HC	HC31_visit_4HC_HC	HC31_visit_4HC_E_HC	HC31_visit_4HC_E_HC	HC31_visit_4HC_HC	HC31_visit_4HC_HC	HC31_visit_4HC_HC	HC31_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_E_HC_HC	HC_Mo_HC_HC
K32_KS89_I_C	K32_KS89_I_C	plate_4	D9	ATAATAGTGCGCA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGTGCGC	GTGAAA	HC32	healthy_control	29	F	HC_F	180	70	21.6	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	25/06/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	1.5	HC_low	6.6	250		130			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC32_visit_1HC_HC	HC32_visit_1HC_HC	HC32_visit_1HC_C_HC	HC32_visit_1HC_C_HC	HC32_visit_1HC_HC	HC32_visit_1HC_HC	HC32_visit_1HC_HC	HC32_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K32_KS89_I_D	K32_KS89_I_D	plate_4	E9	ATAATAGACTCTA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGACTCT	GTGAAA	HC32	healthy_control	29	F	HC_F	180	70	21.6	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	25/06/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	1.5	HC_low	6.6	250		130			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC32_visit_1HC_HC	HC32_visit_1HC_HC	HC32_visit_1HC_D_HC	HC32_visit_1HC_D_HC	HC32_visit_1HC_HC	HC32_visit_1HC_HC	HC32_visit_1HC_HC	HC32_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K34_BI96_I_C	K34_BI96_I_C	plate_4	F9	ATAATAGGGGTTA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	AGGGGTT	GTGAAA	HC34	healthy_control	23	F	HC_F	170	73	25.26	HC_overweight	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	01/07/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	2.8	HC_low	4.3	295		126			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC34_visit_1HC_HC	HC34_visit_1HC_HC	HC34_visit_1HC_C_HC	HC34_visit_1HC_C_HC	HC34_visit_1HC_HC	HC34_visit_1HC_HC	HC34_visit_1HC_HC	HC34_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K34_BI96_I_D	K34_BI96_I_D	plate_4	G9	ATAATACTAGGGA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ACTAGGG	GTGAAA	HC34	healthy_control	23	F	HC_F	170	73	25.26	HC_overweight	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	01/07/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	2.8	HC_low	4.3	295		126			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC34_visit_1HC_HC	HC34_visit_1HC_HC	HC34_visit_1HC_D_HC	HC34_visit_1HC_D_HC	HC34_visit_1HC_HC	HC34_visit_1HC_HC	HC34_visit_1HC_HC	HC34_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K34_BI96_I_E	K34_BI96_I_E	plate_4	H9	ATAATATAGCCGA	GTCCTACGGGNGGCWGCAG	ATAAT	GGACTACHVGGGTWTCTAAT	ATAGCCG	GTGAAA	HC34	healthy_control	23	F	HC_F	170	73	25.26	HC_overweight	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	01/07/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	2.8	HC_low	4.3	295		126			HC	HC	HC		HC			HC	HC	HC	HC	HC	E	Mo	HC	HC	HC_E	HC_E	HC_Mo	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_Mo	HC_HC_HC	HC_HC_HC	HC_HC_HC_E	HC_E	HC_HC	HC_E_HC	HC_Mo	HC_Mo_HC	HC_HC	HC_HC	HC_HC_E	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC34_visit_1HC_HC	HC34_visit_1HC_HC	HC34_visit_1HC_E_HC	HC34_visit_1HC_E_HC	HC34_visit_1HC_HC	HC34_visit_1HC_HC	HC34_visit_1HC_HC	HC34_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_E_HC_HC	HC_Mo_HC_HC
K34_BI96_IV_C	K34_BI96_IV_C	plate_4	A10	AGGGTACCTTCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACCTTCC	GTGAAA	HC34	healthy_control	23	F	HC_F	170	73	25.26	HC_overweight	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	24/01/2020	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.9	HC_low	5.9	269		136			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC34_visit_4HC_HC	HC34_visit_4HC_HC	HC34_visit_4HC_C_HC	HC34_visit_4HC_C_HC	HC34_visit_4HC_HC	HC34_visit_4HC_HC	HC34_visit_4HC_HC	HC34_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K34_BI96_IV_D	K34_BI96_IV_D	plate_4	B10	AGGGTAGCCACCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGCCACC	GTGAAA	HC34	healthy_control	23	F	HC_F	170	73	25.26	HC_overweight	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	24/01/2020	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.9	HC_low	5.9	269		136			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC34_visit_4HC_HC	HC34_visit_4HC_HC	HC34_visit_4HC_D_HC	HC34_visit_4HC_D_HC	HC34_visit_4HC_HC	HC34_visit_4HC_HC	HC34_visit_4HC_HC	HC34_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K34_BI96_IV_E	K34_BI96_IV_E	plate_4	C10	AGGGTAACAGCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AACAGCC	GTGAAA	HC34	healthy_control	23	F	HC_F	170	73	25.26	HC_overweight	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	24/01/2020	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.9	HC_low	5.9	269		136			HC	HC	HC		HC			HC	HC	HC	HC	HC	E	Mo	HC	HC	HC_E	HC_E	HC_Mo	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_Mo	HC_HC_HC	HC_HC_HC	HC_HC_HC_E	HC_E	HC_HC	HC_E_HC	HC_Mo	HC_Mo_HC	HC_HC	HC_HC	HC_HC_E	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC34_visit_4HC_HC	HC34_visit_4HC_HC	HC34_visit_4HC_E_HC	HC34_visit_4HC_E_HC	HC34_visit_4HC_HC	HC34_visit_4HC_HC	HC34_visit_4HC_HC	HC34_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_E_HC_HC	HC_Mo_HC_HC
K35_SJ96_II_C	K35_SJ96_II_C	plate_4	D10	AGGGTACGGCCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACGGCCC	GTGAAA	HC35	healthy_control	20	M	HC_M	196	78	20.3	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	30/07/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.2	HC_low	5.3	216		149			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC35_visit_1HC_HC	HC35_visit_1HC_HC	HC35_visit_1HC_C_HC	HC35_visit_1HC_C_HC	HC35_visit_1HC_HC	HC35_visit_1HC_HC	HC35_visit_1HC_HC	HC35_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K35_SJ96_II_E	K35_SJ96_II_E	plate_4	E10	AGGGTACTGGCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACTGGCC	GTGAAA	HC35	healthy_control	20	M	HC_M	196	78	20.3	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	30/07/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.2	HC_low	5.3	216		149			HC	HC	HC		HC			HC	HC	HC	HC	HC	E	Mo	HC	HC	HC_E	HC_E	HC_Mo	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_Mo	HC_HC_HC	HC_HC_HC	HC_HC_HC_E	HC_E	HC_HC	HC_E_HC	HC_Mo	HC_Mo_HC	HC_HC	HC_HC	HC_HC_E	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC35_visit_1HC_HC	HC35_visit_1HC_HC	HC35_visit_1HC_E_HC	HC35_visit_1HC_E_HC	HC35_visit_1HC_HC	HC35_visit_1HC_HC	HC35_visit_1HC_HC	HC35_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_E_HC_HC	HC_Mo_HC_HC
K39_DS96_I_C	K39_DS96_I_C	plate_4	F10	AGGGTAAGGACCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AAGGACC	GTGAAA	HC39	healthy_control	22	F	HC_F	167	64	22.95	HC_normal	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	08/07/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	2.1	HC_low	5.5	298		136			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC39_visit_1HC_HC	HC39_visit_1HC_HC	HC39_visit_1HC_C_HC	HC39_visit_1HC_C_HC	HC39_visit_1HC_HC	HC39_visit_1HC_HC	HC39_visit_1HC_HC	HC39_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K39_DS96_I_D	K39_DS96_I_D	plate_4	G10	AGGGTACGCTCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACGCTCC	GTGAAA	HC39	healthy_control	22	F	HC_F	167	64	22.95	HC_normal	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	08/07/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	2.1	HC_low	5.5	298		136			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC39_visit_1HC_HC	HC39_visit_1HC_HC	HC39_visit_1HC_D_HC	HC39_visit_1HC_D_HC	HC39_visit_1HC_HC	HC39_visit_1HC_HC	HC39_visit_1HC_HC	HC39_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K40_WV86_I_A	K40_WV86_I_A	plate_4	H10	AGGGTAGCGCCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGCGCCC	GTGAAA	HC40	healthy_control	33	F	HC_F	158	64	25.64	HC_overweight	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	12/07/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	3.3	HC_low	5.7	315		127			HC	HC	HC		HC			HC	HC	HC	HC	HC	A	Dr	HC	HC	HC_A	HC_A	HC_Dr	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_Dr	HC_HC_HC	HC_HC_HC	HC_HC_HC_A	HC_A	HC_HC	HC_A_HC	HC_Dr	HC_Dr_HC	HC_HC	HC_HC	HC_HC_A	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC40_visit_1HC_HC	HC40_visit_1HC_HC	HC40_visit_1HC_A_HC	HC40_visit_1HC_A_HC	HC40_visit_1HC_HC	HC40_visit_1HC_HC	HC40_visit_1HC_HC	HC40_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_A_HC_HC	HC_Dr_HC_HC
K40_WV86_I_C	K40_WV86_I_C	plate_4	A11	AGGGTAATTAGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AATTAGC	GTGAAA	HC40	healthy_control	33	F	HC_F	158	64	25.64	HC_overweight	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	12/07/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	3.3	HC_low	5.7	315		127			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC40_visit_1HC_HC	HC40_visit_1HC_HC	HC40_visit_1HC_C_HC	HC40_visit_1HC_C_HC	HC40_visit_1HC_HC	HC40_visit_1HC_HC	HC40_visit_1HC_HC	HC40_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K40_WV86_I_D	K40_WV86_I_D	plate_4	B11	AGGGTATCCTCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ATCCTCC	GTGAAA	HC40	healthy_control	33	F	HC_F	158	64	25.64	HC_overweight	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	12/07/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	3.3	HC_low	5.7	315		127			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC40_visit_1HC_HC	HC40_visit_1HC_HC	HC40_visit_1HC_D_HC	HC40_visit_1HC_D_HC	HC40_visit_1HC_HC	HC40_visit_1HC_HC	HC40_visit_1HC_HC	HC40_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K40_WV86_I_E	K40_WV86_I_E	plate_4	C11	AGGGTAACCCGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AACCCGC	GTGAAA	HC40	healthy_control	33	F	HC_F	158	64	25.64	HC_overweight	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	12/07/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	3.3	HC_low	5.7	315		127			HC	HC	HC		HC			HC	HC	HC	HC	HC	E	Mo	HC	HC	HC_E	HC_E	HC_Mo	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_Mo	HC_HC_HC	HC_HC_HC	HC_HC_HC_E	HC_E	HC_HC	HC_E_HC	HC_Mo	HC_Mo_HC	HC_HC	HC_HC	HC_HC_E	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC40_visit_1HC_HC	HC40_visit_1HC_HC	HC40_visit_1HC_E_HC	HC40_visit_1HC_E_HC	HC40_visit_1HC_HC	HC40_visit_1HC_HC	HC40_visit_1HC_HC	HC40_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_E_HC_HC	HC_Mo_HC_HC
K40_WV86_IV_A	K40_WV86_IV_A	plate_4	D11	AGGGTATCCCTCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ATCCCTC	GTGAAA	HC40	healthy_control	33	F	HC_F	158	64	25.64	HC_overweight	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	23/01/2020	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.4	HC_low	4.7	328		130			HC	HC	HC		HC			HC	HC	HC	HC	HC	A	Dr	HC	HC	HC_A	HC_A	HC_Dr	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_Dr	HC_HC_HC	HC_HC_HC	HC_HC_HC_A	HC_A	HC_HC	HC_A_HC	HC_Dr	HC_Dr_HC	HC_HC	HC_HC	HC_HC_A	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC40_visit_4HC_HC	HC40_visit_4HC_HC	HC40_visit_4HC_A_HC	HC40_visit_4HC_A_HC	HC40_visit_4HC_HC	HC40_visit_4HC_HC	HC40_visit_4HC_HC	HC40_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_A_HC_HC	HC_Dr_HC_HC
K40_WV86_IV_C	K40_WV86_IV_C	plate_4	E11	AGGGTACTCGCCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACTCGCC	GTGAAA	HC40	healthy_control	33	F	HC_F	158	64	25.64	HC_overweight	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	23/01/2020	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.4	HC_low	4.7	328		130			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC40_visit_4HC_HC	HC40_visit_4HC_HC	HC40_visit_4HC_C_HC	HC40_visit_4HC_C_HC	HC40_visit_4HC_HC	HC40_visit_4HC_HC	HC40_visit_4HC_HC	HC40_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K40_WV86_IV_D	K40_WV86_IV_D	plate_4	F11	AGGGTAGGCCTCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGGCCTC	GTGAAA	HC40	healthy_control	33	F	HC_F	158	64	25.64	HC_overweight	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	23/01/2020	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.4	HC_low	4.7	328		130			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC40_visit_4HC_HC	HC40_visit_4HC_HC	HC40_visit_4HC_D_HC	HC40_visit_4HC_D_HC	HC40_visit_4HC_HC	HC40_visit_4HC_HC	HC40_visit_4HC_HC	HC40_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K40_WV86_IV_E	K40_WV86_IV_E	plate_4	G11	AGGGTACCCAGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACCCAGC	GTGAAA	HC40	healthy_control	33	F	HC_F	158	64	25.64	HC_overweight	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	23/01/2020	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.4	HC_low	4.7	328		130			HC	HC	HC		HC			HC	HC	HC	HC	HC	E	Mo	HC	HC	HC_E	HC_E	HC_Mo	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_Mo	HC_HC_HC	HC_HC_HC	HC_HC_HC_E	HC_E	HC_HC	HC_E_HC	HC_Mo	HC_Mo_HC	HC_HC	HC_HC	HC_HC_E	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC40_visit_4HC_HC	HC40_visit_4HC_HC	HC40_visit_4HC_E_HC	HC40_visit_4HC_E_HC	HC40_visit_4HC_HC	HC40_visit_4HC_HC	HC40_visit_4HC_HC	HC40_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_E_HC_HC	HC_Mo_HC_HC
PCR_neg_16S_B4	PCR_neg_16S_B4	plate_4	H11	AGGGTAAAGAGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AAAGAGC	GTGAAA	CTRL																																																																																																																CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_					
K41_NE90_I_C	K41_NE90_I_C	plate_4	A12	AGGGTACGGCTCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACGGCTC	GTGAAA	HC41	healthy_control	29	F	HC_F	170	71	24.57	HC_normal	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	17/07/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.2	HC_low	8.6	243		139			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC41_visit_1HC_HC	HC41_visit_1HC_HC	HC41_visit_1HC_C_HC	HC41_visit_1HC_C_HC	HC41_visit_1HC_HC	HC41_visit_1HC_HC	HC41_visit_1HC_HC	HC41_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K41_NE90_I_D	K41_NE90_I_D	plate_4	B12	AGGGTACGACATA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACGACAT	GTGAAA	HC41	healthy_control	29	F	HC_F	170	71	24.57	HC_normal	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	17/07/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.2	HC_low	8.6	243		139			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC41_visit_1HC_HC	HC41_visit_1HC_HC	HC41_visit_1HC_D_HC	HC41_visit_1HC_D_HC	HC41_visit_1HC_HC	HC41_visit_1HC_HC	HC41_visit_1HC_HC	HC41_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K41_NE90_IV_C	K41_NE90_IV_C	plate_4	C12	AGGGTATCCCGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ATCCCGC	GTGAAA	HC41	healthy_control	29	F	HC_F	170	71	24.57	HC_normal	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	06/02/2020	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.7	HC_low	5.7	232		127			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC41_visit_4HC_HC	HC41_visit_4HC_HC	HC41_visit_4HC_C_HC	HC41_visit_4HC_C_HC	HC41_visit_4HC_HC	HC41_visit_4HC_HC	HC41_visit_4HC_HC	HC41_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K41_NE90_IV_D	K41_NE90_IV_D	plate_4	D12	AGGGTAGTGCGCA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGTGCGC	GTGAAA	HC41	healthy_control	29	F	HC_F	170	71	24.57	HC_normal	smoker	HC_smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Finish	HC_Finish	HC_HC_Finish	HC_Finish	HC_Finish	HC_Finish.28	HC_Finish.28	visit_4HC	visit_4HC	week_28	week_28	28	06/02/2020	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	0.7	HC_low	5.7	232		127			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_4HC	HC_visit_4HC	HC_HC_visit_4HC	HC_HC_visit_4HC	HC_HC_HC_HC	HC41_visit_4HC_HC	HC41_visit_4HC_HC	HC41_visit_4HC_D_HC	HC41_visit_4HC_D_HC	HC41_visit_4HC_HC	HC41_visit_4HC_HC	HC41_visit_4HC_HC	HC41_visit_4HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
K43_KZ94_I_C	K43_KZ94_I_C	plate_4	E12	AGGGTAGACTCTA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGACTCT	GTGAAA	HC43	healthy_control	25	F	HC_F	166	51	18.5	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	30/07/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	1.8	HC_low	7.5	209		135			HC	HC	HC		HC			HC	HC	HC	HC	HC	C	SeS	HC	HC	HC_C	HC_C	HC_SeS	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeS	HC_HC_HC	HC_HC_HC	HC_HC_HC_C	HC_C	HC_HC	HC_C_HC	HC_SeS	HC_SeS_HC	HC_HC	HC_HC	HC_HC_C	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC43_visit_1HC_HC	HC43_visit_1HC_HC	HC43_visit_1HC_C_HC	HC43_visit_1HC_C_HC	HC43_visit_1HC_HC	HC43_visit_1HC_HC	HC43_visit_1HC_HC	HC43_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_C_HC_HC	HC_SeS_HC_HC
K43_KZ94_I_D	K43_KZ94_I_D	plate_4	F12	AGGGTAGGGGTTA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	AGGGGTT	GTGAAA	HC43	healthy_control	25	F	HC_F	166	51	18.5	HC_normal	non-smoker	HC_non-smoker	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_Start	HC_Start	HC_HC_Start	HC_Start	HC_Start	HC_Start.0	HC_Start.0	visit_1HC	visit_1HC	week_0	week_0	0	30/07/2019	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	1.8	HC_low	7.5	209		135			HC	HC	HC		HC			HC	HC	HC	HC	HC	D	SeT	HC	HC	HC_D	HC_D	HC_SeT	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC	HC_HC	HC_HC_SeT	HC_HC_HC	HC_HC_HC	HC_HC_HC_D	HC_D	HC_HC	HC_D_HC	HC_SeT	HC_SeT_HC	HC_HC	HC_HC	HC_HC_D	HC_visit_1HC	HC_visit_1HC	HC_HC_visit_1HC	HC_HC_visit_1HC	HC_HC_HC_HC	HC43_visit_1HC_HC	HC43_visit_1HC_HC	HC43_visit_1HC_D_HC	HC43_visit_1HC_D_HC	HC43_visit_1HC_HC	HC43_visit_1HC_HC	HC43_visit_1HC_HC	HC43_visit_1HC_HC	HC_HC	HC_HC_HC	HC_HC_HC	HC_D_HC_HC	HC_SeT_HC_HC
mockB_IZOL_I	mockB_IZOL_I	plate_4	G12	AGGGTACTAGGGA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ACTAGGG	GTGAAA	CTRL																																																																																																																CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_					
mockB_IZOL_II	mockB_IZOL_II	plate_4	H12	AGGGTATAGCCGA	GTCCTACGGGNGGCWGCAG	AGGGT	GGACTACHVGGGTWTCTAAT	ATAGCCG	GTGAAA	CTRL																																																																																																																CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_	CTRL_					